
<html lang="en"     class="pb-page"  data-request-id="bb9f24ac-29c0-4ad0-8dfb-d17188ebf022"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-13;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c00366;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases" /></meta><meta name="dc.Creator" content="Xiawei  Dang" /></meta><meta name="dc.Creator" content="Lihong  Zhang" /></meta><meta name="dc.Creator" content="Antonietta  Franco" /></meta><meta name="dc.Creator" content="Jiajia  Li" /></meta><meta name="dc.Creator" content="Agostinho G.  Rocha" /></meta><meta name="dc.Creator" content="Sriram  Devanathan" /></meta><meta name="dc.Creator" content="Roland E.  Dolle" /></meta><meta name="dc.Creator" content="Peter R.  Bernstein" /></meta><meta name="dc.Creator" content="Gerald W.  Dorn, II" /></meta><meta name="dc.Description" content="Mutations in the mitochondrial fusion protein mitofusin (MFN) 2 cause the chronic neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A), for which there is currently no treatment...." /></meta><meta name="Description" content="Mutations in the mitochondrial fusion protein mitofusin (MFN) 2 cause the chronic neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A), for which there is currently no treatment...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 8, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00366" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00366" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00366" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00366" /></link>
        
    
    

<title>Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00366" /></meta><meta property="og:title" content="Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0020.jpeg" /></meta><meta property="og:description" content="Mutations in the mitochondrial fusion protein mitofusin (MFN) 2 cause the chronic neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A), for which there is currently no treatment. Small-molecule activators of MFN1 and MFN2 enhance mitochondrial fusion and offer promise as therapy for this condition, but prototype compounds have poor pharmacokinetic properties. Herein, we describe a rational design of a series of 6-phenylhexanamide derivatives whose pharmacokinetic optimization yielded a 4-hydroxycyclohexyl analogue, 13, with the potency, selectivity, and oral bioavailability of a preclinical candidate. Studies of 13 cis- and trans-4-hydroxycyclohexyl isostereomers unexpectedly revealed functionality and protein engagement exclusively for the trans form, 13B. Preclinical absorption, distribution, metabolism, and excretion (ADME) and in vivo target engagement studies of 13B support further development of 6-phenylhexanamide derivatives as therapeutic agents for human CMT2A." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00366"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00366">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00366&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00366&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00366&amp;href=/doi/10.1021/acs.jmedchem.0c00366" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 7033-7051</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00359" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00372" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.0c01267"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xiawei Dang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiawei Dang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Cardiology, The First Affiliated Hospital of Xiâan Jiao Tong University, Xiâan 710061, Shaanxi, China</div><div class="loa-info-affiliations-info">Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiawei++Dang">Xiawei Dang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0343-7107" title="Orcid link">http://orcid.org/0000-0002-0343-7107</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lihong Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lihong Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lihong++Zhang">Lihong Zhang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Antonietta Franco</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonietta Franco</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</div><div class="loa-info-affiliations-info">Mitochondria in Motion, Inc. 4340 Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonietta++Franco">Antonietta Franco</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jiajia Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiajia Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiajia++Li">Jiajia Li</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Agostinho G. Rocha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agostinho G. Rocha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agostinho+G.++Rocha">Agostinho G. Rocha</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sriram Devanathan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sriram Devanathan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mitochondria in Motion, Inc. 4340 Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sriram++Devanathan">Sriram Devanathan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Roland E. Dolle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland E. Dolle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mitochondria in Motion, Inc. 4340 Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United States</div><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, 660 S. Euclid Ave. St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland+E.++Dolle">Roland E. Dolle</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5574-6019" title="Orcid link">http://orcid.org/0000-0001-5574-6019</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Peter R. Bernstein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter R. Bernstein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Harrington Discovery Institute at University Hospitals, 11407 Euclid Ave, Cleveland, Ohio 44106, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+R.++Bernstein">Peter R. Bernstein</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0407-9150" title="Orcid link">http://orcid.org/0000-0003-0407-9150</a></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Gerald W. Dorn II</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gerald W. Dorn, II</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</div><div class="loa-info-affiliations-info">Mitochondria in Motion, Inc. 4340 Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7e191a110c103e090b0d0a12501b1a0b"><span class="__cf_email__" data-cfemail="d5b2b1baa7bb95a2a0a6a1b9fbb0b1a0">[emailÂ protected]</span></a>. Phone: 314 362-4892. Fax: 314 362-8844.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gerald+W.++Dorn%2C++II">Gerald W. Dorn, II</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00366&amp;href=/doi/10.1021%2Facs.jmedchem.0c00366" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 7033â7051</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 March 2020</li><li><span class="item_label"><b>Published</b> online</span>8 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00366" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00366</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7033%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiawei%2BDang%252C%2BLihong%2BZhang%252C%2BAntonietta%2BFranco%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D13%26contentID%3Dacs.jmedchem.0c00366%26title%3DDiscovery%2Bof%2B6-Phenylhexanamide%2BDerivatives%2Bas%2BPotent%2BStereoselective%2BMitofusin%2BActivators%2Bfor%2Bthe%2BTreatment%2Bof%2BMitochondrial%2BDiseases%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7051%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00366"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1036</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00366" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiawei&quot;,&quot;last_name&quot;:&quot;Dang&quot;},{&quot;first_name&quot;:&quot;Lihong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Antonietta&quot;,&quot;last_name&quot;:&quot;Franco&quot;},{&quot;first_name&quot;:&quot;Jiajia&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Agostinho&quot;,&quot;last_name&quot;:&quot;G. Rocha&quot;},{&quot;first_name&quot;:&quot;Sriram&quot;,&quot;last_name&quot;:&quot;Devanathan&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;E. Dolle&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;R. Bernstein&quot;},{&quot;first_name&quot;:&quot;Gerald&quot;,&quot;last_name&quot;:&quot;W. Dorn&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7033-7051&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00366&quot;},&quot;abstract&quot;:&quot;Mutations in the mitochondrial fusion protein mitofusin (MFN) 2 cause the chronic neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A), for which there is currently no treatment. Small-molecule activators of MFN1 and MFN2 enhance mitochondrial fusion and offer promise as therapy for this condition, but prototype compounds have poor pharmacokinetic properties. Herein, we describe a rational design of a series of 6-phenylhexanamide derivatives whose pharmacokinetic optimization yielded a 4-hydroxycyclohexyl analogue, 13, with the potency, selectivity, and oral bioavailability of a preclinical candidate. Studies of 13 cis- and trans-4-hydroxycyclohexyl isostereomers unexpectedly revealed functionality and protein engagement exclusively for the trans form, 13B. Preclinical absorption, distribution, metabolism, and excretion (ADME) and in vivo target engagement studies of 13B support further development of 6-phenylhexanamide derivatives as therapeutic agents for human CMT2A.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00366&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00366" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00366&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00366" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00366&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00366" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00366&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00366&amp;href=/doi/10.1021/acs.jmedchem.0c00366" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00366" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00366" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00366%26sid%3Dliteratum%253Aachs%26pmid%3D32506913%26genre%3Darticle%26aulast%3DDang%26date%3D2020%26atitle%3DDiscovery%2Bof%2B6-Phenylhexanamide%2BDerivatives%2Bas%2BPotent%2BStereoselective%2BMitofusin%2BActivators%2Bfor%2Bthe%2BTreatment%2Bof%2BMitochondrial%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D13%26spage%3D7033%26epage%3D7051%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/jmcmar.2020.63.issue-13/20200709/jmcmar.2020.63.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mutations in the mitochondrial fusion protein mitofusin (MFN) 2 cause the chronic neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A), for which there is currently no treatment. Small-molecule activators of MFN1 and MFN2 enhance mitochondrial fusion and offer promise as therapy for this condition, but prototype compounds have poor pharmacokinetic properties. Herein, we describe a rational design of a series of 6-phenylhexanamide derivatives whose pharmacokinetic optimization yielded a 4-hydroxycyclohexyl analogue, <b>13</b>, with the potency, selectivity, and oral bioavailability of a preclinical candidate. Studies of <b>13</b><i>cis</i>- and <i>trans</i>-4-hydroxycyclohexyl isostereomers unexpectedly revealed functionality and protein engagement exclusively for the trans form, <b>13B</b>. Preclinical absorption, distribution, metabolism, and excretion (ADME) and <i>in vivo</i> target engagement studies of <b>13B</b> support further development of 6-phenylhexanamide derivatives as therapeutic agents for human CMT2A.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mitofusins (MFNs) 1 and 2, named for their central roles in mitochondrial fusion,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> are attractive drug targets because their regulatory functioning in mitochondrial dynamics and quality/quantity control is perturbed in several neurodegenerative disorders.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> In particular, genetic mutations that abrogate or impair MFN2 functioning, and therefore suppress mitochondrial fusion, cause the rare autosomal dominant neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A) for which there is currently no clinically available disease-altering therapy.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Moreover, accumulating experimental evidence supports an important role of MFN1 and MFN2 in heart diseases.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10 ref11">(6â11)</a> A pharmacological means of enhancing mitofusin function has the potential to correct the underlying cause of CMT2A and other cardiac or neurodegenerative diseases caused by mitochondrial dys-dynamism.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">MFN1 and MFN2 form homo- (MFN1âMFN1 or MFN2âMFN2) or hetero- (MFN1âMFN2) trans dimers between mitochondria. This process, referred to as mitochondrial tethering, is the requisite first step in mitochondrial fusion and is essential for metabolic cellular health.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12â14)</a> Mitochondrial tethering and fusion depend upon a shift in MFN protein conformation, from a closed resting state to an open active state.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> MFN conformation is regulated by intramolecular peptideâpeptide interactions (PPIs) between Î± helices in the stalk region of the protein.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Phosphorylation of human (h)MFN2 serine 378 by mitochondrial PINK1 kinase promotes a tight Î± helix within the interacting peptide, directing critical Val372, Met 376, and His380 amino acid side chains to their interacting partners, Leu727, Leu723, and Lys720, respectively.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A strong PPI promotes a folded protein conformation that decreases the probability of trans MFNâMFN dimer formation between mitochondria, i.e., is unfavorable for mitochondrial tethering/fusion. When serine 378 is not phosphorylated, the interacting peptide Î± helix partially unwinds, weakening the PPI and increasing the probability that the protein will unfold to permit MFN trans-dimerization and subsequent mitochondrial fusion.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Franco et al.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> described an 18 amino acid peptide, modified from hMFN2 amino acids 367â384, that competitively inhibited intramolecular PPI in MFN1 and MFN2, thus promoting the open protein conformation favoring mitochondrial fusion. By understanding the critical interacting amino acids within this activator peptide (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), Gavathiotis developed a pharmacophore model leading to identification of a prototype peptidomimetic small-molecule mitofusin activator, Chimera B-A/l (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B; <b>1</b>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>1</b> mimicked mitofusin activator peptide effects by promoting mitochondrial fusion after topical application to mitofusin-deficient cultured mouse cells and by increasing mitochondrial motility in <i>ex vivo</i> mouse CMT2A nerves.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Clinical application of small-molecule mitofusin activators having druglike properties promises the first disease-altering therapy for CMT2A and may open the door to a novel therapeutic approach of enhancing mitochondrial fusion in multiple diseases with impaired mitochondrial dynamics.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of action of mitofusin activators. (A) Computational model of PPI-regulated conformational changes in human MFN2. (Inset) Published pharmacophore model described by Gavathiotis<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> positing specific amino acid interactions of the green MFN2-derived activator minipeptide. (B) Prototype small-molecule mitofusin activator, <b>1</b>, was developed that mimics characteristics of critical amino acid side chains of the mitofusin-activating minipeptide.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, pharmacokinetic (PK) characterization of <b>1</b> and structurally diverse chemical derivatives revealed a reciprocal relationship between <i>in vitro</i> hepatic microsomal stability and <i>in vitro</i> passive permeability that are central to the target product profile of a putative clinically applicable mitofusin activator. Accordingly, a pharmacophore-based rational design was employed to develop a series of 6-phenylhexanamide derivative mitofusin activators having simplified chemical structures, thereby identifying candidate <b>13</b> as possibly suitable for preclinical <i>in vivo</i> evaluation in CMT2A rodent models. <i>In vitro</i> and <i>in vivo</i> pharmacokinetic studies show that <b>13</b> crosses the bloodâbrain barrier, engages mitochondrial targets in neuronal axons, and is otherwise pharmaceutically acceptable,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> suggesting that 6-phenylhexanamide-based mitofusin activators may be optimized as disease-altering therapeutics for CMT2A.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Pharmacokinetic Properties of Chimera B-A/l (<b>1</b>) Derivatives</h3><div class="NLM_p">The published description of Chimera B-A/l as the prototype small-molecule mitofusin activator indicated low nM potency to promote mitochondrial fusion <i>in vitro</i> measured as an increase in mitochondrial aspect ratio (length/width; EC<sub>50</sub> = 3 Â± 1 nM) and the ability to rapidly promote mitochondrial trafficking after topical application to mouse CMT2A neurons <i>ex vivo</i>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A preliminary analysis of <b>1</b> pharmacokinetics revealed it to be stable in mouse and human plasma <i>in vitro</i> with good passive artificial bloodâbrain barrier permeability (PAMPA-BBB Pe),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> but it was rapidly degraded when incubated <i>in vitro</i> with mouse or human liver microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Replacing the potentially reactive sulfur in <b>1</b> with either carbon (<b>2</b>) or oxygen (<b>3</b>) did not impair fusogenic activity, but neither did it meaningfully improve microsomal instability (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Fusogenic Potency and <i>In Vitro</i> Pharmacokinetic Characteristics of Prototype Mitofusin Activator, <b>1</b>, and S-substituted Analogues<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are for mitochondrial elongation in cultured MFN2-deficient mouse fibroblasts; mean with 95% confidence limits of 3â5 determinations. Solubility is in aqueous solution, pH 7.4; HLM and MLM indicate stability in human and mouse liver microsomes, respectively; and PAMPA-BBB measures passive membrane permeability. All PK results are means of assays performed in duplicate or triplicate.</p></div></div><div></div></div><div class="NLM_p">We posited that the terminal cyclohexyl or phenyl groups of <b>1</b>â<b>3</b> might be the targets of microsomal degradation. Fluorination of the phenyl group at the para position (<b>4</b>) did not improve microsomal stability, whereas adding fluorine to the fourth carbon of the cyclohexyl group (<b>5</b>) markedly increased compound half-life in hepatic microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This suggested that the cyclohexyl group was the source of microsomal instability, a notion supported by emergence of tetrahydropyran derivatives having excellent potency (EC<sub>50</sub> for mitochondrial elongation measured as increased aspect ratio) and high stability in both human and mouse liver microsome tests (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>; <b>6</b>). By contrast, altering the position of the phenyl group on the triazol ring (<b>7</b>, <b>8</b>) had little positive effect on microsomal stability, although mitofusin activator functionality could be preserved (<b>7</b>, <b>8</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Indeed, the most potent and stable derivative of <b>1</b> consisted of a simple tetrahydropyran-4-yl group at R1 linked by propylurea to a 3-cyclopropyl-4-ethyl-1,2,4-triazol group at R2 (<b>9</b>). However, tetrahydropyran analogues exhibited very poor PAMPA-BBB permeability (<b>6</b> and <b>9</b>), which we envisioned would impair central nervous system (CNS) penetration (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Moreover, comparative <i>in vivo</i> PK studies of <b>2</b>, <b>6</b>, and <b>9</b> demonstrated that increased microsomal stability conferred by the tetrahydropyran moiety did not translate into increased plasma half-life (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). An inverse relationship between stability in the <i>in vitro</i> liver microsome assay and membrane permeability in the PAMPA-BBB was observed for 53 analogues of <b>1</b> as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S1</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Fusogenic Potency and Pharmacokinetic Properties of <b>1</b> Analogues Bearing Cyclohexane and Triazol Group Substitutions<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0013.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0014.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are mean with 95% confidence limits. Plasma <i>t</i><sub>1/2</sub> is in mice after IV bolus administration. ND means not determined.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Pharmacophore-Guided Optimization of Compound <b>8</b></h3><div class="NLM_p">The published pharmacophore model developed by Gavathiotis,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> together with the above SAR studies, suggested leeway in the identity of the R2 group of small-molecule mitofusin activators. This series of compounds were fusogenic as long as R2 was intensely hydrophobic (mimicking side chains of hMFN2 Val372 and Met 376; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) and optimally spaced from the cyclohexyl/urea moiety (â¼10.8 Ã, or the total distance between three consecutive Î± helix vertices). For example, in <b>8</b>, the 4-phenyl group is shifted to the 3 position of the triazol ring, replacing the cyclopropyl group (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). After adjusting the spacing between R1 and R2 by deleting one carbon from the urea linker (<b>8</b> vs <b>7</b>; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), <b>8</b> exhibited comparable fusogenicity to <b>1</b> (EC<sub>50</sub> â¼ 5 nM) with improved mouse liver microsomal stability (<i>t</i><sub>1/2</sub> 28 min vs 2 min) and adequate PAMPA-BBB permeability (10.3 vs 21.7 nm/s). For these reasons, <b>8</b> was selected as a lead for further optimization.</div><div class="NLM_p">Because the pharmacophore model assigned no clear role for the triazol group, we designed analogues of <b>8</b> lacking this moiety but added two carbons to the linker to optimize functional group spacing (<b>10</b>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compound <b>10</b> was a weak mitofusin activator (EC<sub>50</sub> â¼ 400 nM) but exhibited 15 times greater PAMPA-BBB permeability than <b>8</b>. As the cyclohexyl/urea group of small-molecule mitofusin activators mimics the hydrogen bond donor/acceptor ring structure of the hMFN2 His380 side chain in the parental mitofusin activator peptide (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), we introduced a hydroxyl on carbon 4 of the 2-methyl-cyclohexyl group to improve hydrogen bond donor activity (<b>11</b>), markedly enhancing fusogenecity and increasing microsomal stability at the cost of reducing PAMPA-BBB permeability by an order of magnitude (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Fusogenic Potency and Pharmacokinetic Properties of <b>8</b> Analogues Lacking the Triazol Ring<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are mean with 95% confidence limits.</p></div></div><div></div></div><div class="NLM_p">The <b>1</b> structureâactivity relationships (SAR) studies reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> revealed the 2-methyl residue on the cyclohexyl group to be dispensable for mitofusin activation (<b>6</b> and <b>9</b>; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Accordingly, we deleted this methyl group to make <b>12</b>, which stabilized the compound in the liver microsome assay and maintained marginal PAMPA-BBB permeability. Compound <b>12</b> had the most favorable combination of microsomal stability and PAMPA-BBB permeability of any mitofusin activator but suffered from a modest reduction in mitofusin agonist potency compared to <b>1</b> and <b>8</b> and its immediate precursor <b>11</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_p last">According to the pharmacophore model, a urea group linked to the R1 cyclohexanol mimics hydrogen bond donor/acceptor activity of the hMFN2 His380 side chain.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, it was not clear whether both NH groups were necessary for the mitofusin activator function. Moreover, the greater topological polar surface area of the urea (<b>12</b>, tPSA = 61.36) compared to the amide (<b>13</b>; tPSA = 49.33) could impair passive membrane permeability and CNS penetration.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> In support of this notion, the amide <b>13</b> exhibited 4-fold greater potency for mitofusin activation and PAMPA-BBB permeability than its urea parent (<b>12</b>), while retaining a high degree of liver microsome stability (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> SAR of <b>13</b> and Its Analogues</h3><div class="NLM_p">We reasoned that the optimal screening profile for a clinically translatable small-molecule mitofusin activator included high potency for inducing mitochondrial fusion (EC<sub>50</sub> < 30 nM), stability (<i>t</i><sub>1/2</sub> > 100 min) in human and mouse liver microsome assays, and high passive artificial bloodâbrain barrier membrane permeability (PAMPA-BBB Pe > 10 nm/s). The results described above pointed to the R2 phenyl group of this class of mitofusin activators as a central mediator of PAMPA-BBB permeability, while the R1 cyclohexanol group appeared to be a major determinant of liver microsomal stability. Accordingly, our early SAR studies of <b>13</b> analogues maintained the phenylhexanamide portion constant and generated variants of the cyclohexyl moiety.</div><div class="NLM_p">We first examined how surface charge impacted functional potency and microsomal stability by replacing the 4-hydroxyl cyclohexyl of <b>13</b> with groups conferring a range of tPSA (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Among compounds having higher tPSA values (38â55), the tetrahydropyran (<b>14</b>) and 4-amino (<b>15</b>) analogues were as potent as, but less stable than, parent <b>13</b>. The 4-amide (<b>16</b>) was similarly potent and stable to <b>13</b>, but both the 4-amine and 4-amide analogues exhibited greatly reduced PAMPA-BBB permeability (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). By comparison, the two compounds having lower tPSA values (<30), the 4-methyl (<b>17</b>) and 4,4-difluoro (<b>18</b>) analogues, were poor mitofusin activators and were unstable in the liver microsome assays (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Together, these results suggest that phenylhexanamides with 4-hydroxyl cyclohexyl groups at the R1 position are functionally and pharmacokinetically optimized for mitofusin activation.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. StructureâActivity Relationships of Cyclohexane Group Substitutions in Phenylhexanamides<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0016.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are mean with 95% confidence limits.</p></div></div><div></div></div><div class="NLM_p">To assess functional plasticity of the <b>13</b> R2 phenyl group, we created a series of pyridine and pyrimidine substitutions (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Consistent with prior observations that the phenyl group improves PAMPA-BBB permeability in mitofusin activators (<b>6</b> and <b>9</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), pyridine and pyrimidine variants of <b>13</b> exhibited very low Pe values (i.e., <1.0 nm/s; <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Moreover, plasma protein binding was markedly reduced for the pyridines (<b>19</b>â<b>22</b>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Thus, although N2 and N3 pyridines and the pyrimidine analogue of <b>13</b> exhibit excellent activity as mitofusin activators, they suffer from the same reciprocal relationship between microsomal stability and PAMPA-BBB permeability as did the parent, triazol-group-containing compounds.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Functional and Pharmacokinetic Properties of Pyridine and Pyrimidine Analogues of <b>13</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0017.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are mean with 95% confidence limits.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Mitofusin-Activating Activity of <b>13</b> is Isostereomer-Specific</h3><div class="NLM_p">Of the mitofusin activators created, the combined functional and pharmacokinetic characteristics of <b>13</b> seemed best suited for potential clinical application; it was therefore selected as an advanced lead for further evaluation. The chemical syntheses of candidate mitofusin activators for initial screening sourced starting materials as a mixture of stereoisomers. Since target recognition and biological activity can differ between stereoisomers,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> the cis and trans diastereomers of <b>13</b> (<b>13A</b> and <b>13B</b>) were individually synthesized, validated, and functionally characterized. Remarkably, <b>13A</b> (the cis form) exhibited no measurable mitofusin-activating activity measured as mitochondrial elongation (increase in aspect ratio) in either Mfn1 or Mfn2 null murine embryonic fibroblasts (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B). By contrast, <b>13B</b> (the trans form), which was the dominant form obtained from the original synthesis, was equipotent with the prototype mitofusin agonist, <b>2</b>, exhibiting comparable fusogenic activity in cells expressing only Mfn2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) or only Mfn1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). Fusion-impaired mitochondria typically exhibit dissipation of the inner mitochondrial membrane electrochemical gradient that drives ATP production, referred to as âdepolarizationâ.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compounds <b>2</b> and <b>13B</b>, but not <b>13A</b>, also reversed this respiratory defect (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). The relative abilities of <b>13A</b> and <b>13B</b> to provoke the characteristic open/active MFN2 conformation<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> likewise paralleled their fusogenic activities (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), mechanistically linking biological effects to target protein engagement. The cis and trans stereoisomers had similar <i>in vitro</i> pharmacokinetic profiles (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Diastereomer-selective correction of mitochondrial fragmentation and depolarization in Mfn knockout cells for <b>13</b>. (A, B) Doseâresponse curves for <b>13</b> stereoisomers increasing mitochondrial aspect ratio in cells expressing only Mfn2 (A) or only Mfn1 (B). Prototype mitofusin activator <b>2</b> data are shown for comparison. (C) Effects of compounds on mitochondrial inner membrane polarization in Mfn1 knockout (KO; top) and Mfn2 KO (bottom) cells. (D) Representative confocal imaging of mitochondrial morphology and polarization status in Mfn2 null mouse embryonic fibroblasts (MEFs) treated with different compounds (1 Î¼M, 24 h). Green mitochondria are depolarized and have damaged respiratory function. Scale bars are 10 Î¼m. MT Green (MitoTracker Green), tetramethylrhodamine ethyl ester (TMRE, red), and nuclear Hoechst (blue) were used for staining. Data are means Â± SEM of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Diastereomer-selective MFN2 conformational switching by <b>13</b>. (A) FÃ¶rster resonance energy transfer (FRET) emission spectra of MFN2 in open active (white) and closed inactive (black) conformations. Schematic to the right depicts FRET-labeled MFN2 protein in closed (top) and open (bottom) conformations. C is N-terminus fluorophore Cerulean; V is C-terminus fluorophore mVenus. (B) FRET analysis of conformational switching provoked by mitofusin activators. âPeptideâ is MP1 mitofusin agonist peptide described in ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and depicted in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A inset, used as a positive control. Data are mean Â± SEM of six experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <i>In Vitro</i> Functional and Pharmacokinetic Properties of <b>13</b> Diastereomers<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0018.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are mean with 95% confidence limits.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Effects of Oxy-Substituted Linkers on Compound <b>13B</b> SAR</h3><div class="NLM_p">Our early SAR studies of <b>1</b> revealed that an ether linker (<b>3</b>) had similar potency for mitofusin activation with greater PAMPA-BBB permeability, compared to the straight carbon linker (<b>2</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Accordingly, we synthesized the complete series of oxy-substituted linker analogues for <b>13B</b> as trans diastereomers (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). All of these analogues retained excellent fusogenic activity, but the position of the oxygen within the linker had substantial effects on passive membrane permeability, with <b>27</b>, the carbamate, having 10-fold greater PAMPA-BBB permeability compared to parent <b>13B</b></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Functional and Pharmacokinetic Properties of Oxy-Substituted Linker <b>13B</b> Analogues<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0019.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are mean with 95% confidence limits.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>In Vitro</i> and <i>In Vivo</i> Functional and Pharmacological Profiling of <b>13B</b></h3><div class="NLM_p">The above results demonstrate that <b>13B</b> engages its mitofusin protein target, exhibits low nM fusogenic potency in cultured cells, and has sufficiently high microsomal stability and passive membrane permeability to enter the central and peripheral nervous systems. <b>13B</b> also exhibited a low efflux ratio in NIH MDR1 cells that did not change in the presence of the P-gp inhibitor GF120918 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Table S9</a>), indicating that it is not a P-gp substrate.</div><div class="NLM_p">Closely related mitofusin agonists <b>11</b>, <b>12</b>, and <b>13</b> exhibited a range of <i>in vitro</i> mouse liver microsomal stabilities (from 24 to >145 s) and passive membrane permeability (PAMPA-BBB Pe from 7.96 to 26.28 nm/s) (see <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). We had envisioned that microsomal stability would correlate with <i>in vivo</i> plasma <i>t</i><sub>1/2</sub> and passive permeability with CNS levels. This notion was examined by <i>in vivo</i> PK studies of the trans diastereomers of these three compounds. <i>In vivo</i> PK was performed in mice, the only species on which preclinical models of human CMT2A have been published.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27â29)</a> We assigned target therapeutic brain levels of 10 times the <i>in vitro</i> EC<sub>50</sub> for each compound or 30 ng/g (â¼100 nM) for <b>11</b> and <b>13B</b> and 120 ng/g (â¼400 nM) for <b>12</b>.</div><div class="NLM_p">Comparative mouse plasma and brain levels were determined at increasing times after a single 10 mg/kg intravenous (IV) dose of the three compounds; calculated PK results are listed in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. Consistent with its more rapid microsomal degradation, <b>11</b> plasma <i>t</i><sub>1/2</sub> was shorter than that of the other two compounds, evoking lower peak plasma and brain levels; <b>11</b> peak levels in the brain were only 366 ng/g and fell below the target level of 30 ng/g after 1 h. <b>12</b>, which was stable in the liver microsome assay but had the lowest PAMPA-BBB Pe of the three compounds, achieved a â¼4-fold higher peak brain level of 1268 ng/g. However, because it was less potent than the other two compounds as a mitofusin activator (EC<sub>50</sub> of â¼40 vs â¼10 nM), it also fell below its target therapeutic level after 1 h. <b>11</b> and <b>12</b> exhibited similar volumes of distribution (<i>V</i><sub>dss</sub>), â¼2 L/kg, while the <i>V</i><sub>dss</sub> of <b>13B</b> was only 0.35 L/kg. Moreover, <b>13B</b> peak brain levels after single dose IV bolus were 2793 ng/g and therapeutic levels (of 30 ng/g) were maintained for greater than 2 h after the single IV dose (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>13B</b> PK studies in mice. (A) Total plasma and brain concentrations after single dose IV injections. (B) Steady-state elimination kinetics after 3 days continuous subcutaneous infusion. Data are means Â± differences of results from two mice of each time point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. <i>In Vivo</i> Pharmacokinetic Properties of Mitofusin Activators in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sample site</td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL or ng/g)</td><td class="colsep0 rowsep0" align="left">AUC (ngÂ h/mL or ngÂ h/g)</td><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">brain/plasma (total)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Cpd 11 Single Dose; 10Â mg/kgÂ IV</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">3647</td><td class="colsep0 rowsep0" align="left">2564</td><td class="colsep0 rowsep0" align="left">63.9</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">1.62</td><td class="colsep0 rowsep0" align="left">366</td><td class="colsep0 rowsep0" align="left">207</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.081</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Cpd 12 Single Dose; 10Â mg/kgÂ IV</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">1.15</td><td class="colsep0 rowsep0" align="left">6100</td><td class="colsep0 rowsep0" align="left">4860</td><td class="colsep0 rowsep0" align="left">29.5</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">1.74</td><td class="colsep0 rowsep0" align="left">1268</td><td class="colsep0 rowsep0" align="left">829</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.171</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Cpd 13 Single Dose; 10Â mg/kgÂ IV</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">15â¯400</td><td class="colsep0 rowsep0" align="left">11â¯657</td><td class="colsep0 rowsep0" align="left">14.3</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">1.06</td><td class="colsep0 rowsep0" align="left">2793</td><td class="colsep0 rowsep0" align="left">1199</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Cpd 13 Steady State; 60Â mg/kg/dayÂ xÂ 3Â days sc</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">1.33</td><td class="colsep0 rowsep0" align="left">710</td><td class="colsep0 rowsep0" align="left">926</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">3.37</td><td class="colsep0 rowsep0" align="left">340</td><td class="colsep0 rowsep0" align="left">342</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.37</td></tr></tbody></table></div></div><div class="NLM_p">Because of its low <i>V</i><sub>dss</sub>, high Pe, and low efflux in NIH MDR1 cells, we surmised that <b>13B</b> might accumulate in brains over time. If this were so, then brain levels after single dose administration might not reflect therapeutic efficacy during repeated dosing. To test this idea, we used osmotic mini-pumps to deliver <b>13B</b> subcutaneously (sc) at a daily dose of 60 mg/kg/day for 3 days to achieve steady state, removed the mini-pumps, and defined its elimination kinetics thereafter (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). <b>13B</b> plasma half-lives were similar after bolus IV and chronic sc administration (1.1 and 1.33 h, respectively), but brain half-life was substantially longer after chronic infusion (3.37 vs 1.06 h after IV). Accordingly, the brain/(total) plasma ratio was 3-fold higher for <b>13B</b> than for <b>11</b> and <b>12</b> (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Because it is 96.7% plasma protein bound in mice (see <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), the unbound fraction (fu) of <b>13B</b> is 0.033. Using this factor to convert plasma [<b>13B</b>]<sub>total</sub> into plasma [<b>13B</b>]<sub>free/unbound</sub>, the calculated ratio of brain to free plasma level is 10.8 after chronic infusion.</div><div class="NLM_p">Together, the above results suggested that <b>13B</b> might have properties enabling it to activate mitofusins of neuronal mitochondria in CMT2A mice <i>in vivo</i>. In the only published study of a mitofusin activator, the prototype compound chimera B-A/l (<b>1</b>) increased neuronal mitochondrial motility after topical <i>ex vivo</i> application to mouse sciatic nerves in short-term organ culture.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><i>In vivo</i> effects of a mitofusin activator on CMT2A neuronal mitochondria have not been reported, likely because this class of mitofusin agonists has a very short <i>in vivo</i> plasma half-life of â¼0.2 h (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Thus, we determined that <b>13B</b> was >75% orally bioavailable (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A) and tested its ability to engage mitochondrial targets <i>in vivo</i> after a single oral dose. Transgenic mice expressing the human MFN2 T105M mutation in motor neurons<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> received a single 50 mg/kg dose of <b>13B</b> (5 mg/mL in 10% dimethyl sulfoxide (DMSO)/90% [30%HP-b-CP]) administered by oral gavage. Mitochondrial motility in sciatic nerve neuronal axons, assessed by a blinded investigator 6 h thereafter, was markedly increased as measured by both the number and velocity of motile mitochondria (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Oral bioavailability and <i>in vivo</i> target engagement of <b>13B</b> in mice. (A) Plasma levels after single dose IV (closed circles) or oral (open circles) administration. Data are means Â± SD of results from three mice for each condition. (B) (left) Kymographs demonstrating mitochondrial motility in sciatic nerves of CMT2A mice 6 h after oral administration as in (A). Motile mitochondria exhibit horizontal displacement. To the right are group quantitative data. Results are means Â± SD, each dot representing one axon from two mice per condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Off-target, specificity, and safety studies performed to determine the suitability of <b>13B</b> for possible clinical translation (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>) demonstrated that it is a potent and selective mitofusin activator with a favorable drug profile. It has sub-10 nM potency for both Mfn1 and Mfn2, with very low inhibitory activity for cytochrome P450 enzymes, indicating a small likelihood for drugâdrug interactions. Activity screening against hERG, hNAV1.5, hKCNQ, and a panel of 44 receptors/kinases revealed only mild inhibition of dopamine amino transferase (DAT) and monoamine oxidase (MAO-A; â¼30% inhibition at 10 Î¼M) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Table S1</a>), indicating a safety window of 1000-fold compared to on-target efficacy and a correspondingly limited potential for off-target side effects.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Summary of Key Properties of <b>13B</b><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">On-Target Potency</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC50 Mfn1 KO cells (nM)</td><td class="colsep0 rowsep0" align="left">9.5 (7.0â12.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC50 Mfn2 KO cells (nM)</td><td class="colsep0 rowsep0" align="left">7.7 (5.4â10.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Physical Properties</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW/cLogP/TPSA</td><td class="colsep0 rowsep0" align="left">289/3.22/49.33A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinetic solubility (Î¼M)</td><td class="colsep0 rowsep0" align="left">175</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fsp3 (%)</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Selectivity and Safety Profiles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNav1.5 (%Â <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c2abacaaaba082f3f2">[emailÂ protected]</a>Â Î¼M)</td><td class="colsep0 rowsep0" align="left">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hKCNQ (%Â <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="caa3a4a2a3a88afbfa">[emailÂ protected]</a>Â Î¼M)</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG patch clamp IC<sub>50</sub> (Î¼M)</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">44 receptor/kinase panel (10Â Î¼M)</td><td class="colsep0 rowsep0" align="left">DAT and MAO-A > 30% inhib</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP1A2/2C9/2C19/2D6/3A4-M IC50 (Î¼M)</td><td class="colsep0 rowsep0" align="left">>50/>50/>50/>50/>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMES test</td><td class="colsep0 rowsep0" align="left">negative</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> are reported as mean value with 95% confidence limits of fitting curve from three independent experiments; the AMES test was done in triplicate.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p">The syntheses of the compounds were accomplished as outlined in <a class="ref internalNav" href="#sch1" aria-label="scheme 1">scheme 1</a>â<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> includes compounds <b>2</b> and <b>3</b> isosters of <b>1</b>, the prototype small-molecule mitofusin activator.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Compounds <b>2</b> and <b>3</b> were synthesized by a similar route as reported for <b>1</b> but with replacement of the sulfur-linked intermediate <b>1b</b> with either carbon- or oxygen-linked analogues. For <b>3</b>, synthesis of intermediate <b>3b</b> was required, and it was prepared from commercially available <b>3c</b>, 3-cyclopropyl-4-phenyl-4,5-dihydro-1H-1,2,4-triazol-5-one  by coupling with a protected 2-hydroxyethanamine, as outlined. Commercially available 2b and intermediate <b>3b</b> were coupled with 1-isocyanato-2-methylcyclohexane to afford the targets.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1 and Its Backbone Variants<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>tert</i>-butyl (2-hydroxyethyl)carbamate, diethyl azodicarboxylate (DEAD), triphenylphosphine (PPh3), tetrahydrofuran (THF), room temperature (r.t.), 1 h. (b) HCl/dioxane, r.t., 18 h. (c) <b>1</b> and <b>2</b>: dichloromethane (DCM), r.t., 18 h; <b>3</b>: DCM, r.t., 30 min.</p></p></figure><div class="NLM_p">The syntheses of the urea derivatives <b>4</b>â<b>9</b> outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> were all accomplished in one step by coupling of amino-triazoles with amines as indicated. The amino-triazoles are either commercially available, <b>6a</b>, <b>7a</b>, <b>8a</b>, <b>9a</b>, or were prepared according to a reported procedure, <b>4a</b> and <b>5a</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The two cyclohexanamines <b>4b</b>/<b>7b</b>/<b>8b</b> and <b>5b</b> and the 4-amino-tetrahydropyran <b>6b</b>/<b>9b</b> are all commercially available. The coupling conditions used either Troc-Cl and DIPEA or 1,1â²-carbonyldiimidazole (CDI) and TEA and proceeded via formation of an intermediate carbamoyl chloride that was not isolated.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>4</b>â<b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>4</b>: Troc-Cl, DIPEA, DMAP, DCM, 40 Â°C, 12 h, N2, 95 Â°C, 10 h. <b>5</b>: TEA, DCM, CDI, 0â20 Â°C, 14 h. <b>6</b> and <b>7</b>: TEA, DCM, CDI, 5â10 Â°C, 3 h, 10â15 Â°C, 12 h. <b>8</b>: Troc-Cl, DIEA, DCM, 0â20 Â°C, 1 h, DMF, 90 Â°C, 12 h. <b>9</b>: TEA, DCM, CDI, 5â10 Â°C, 3 h, 10â15 Â°C, 2 h.</p></p></figure><div class="NLM_p">The syntheses of urea derivatives <b>10</b>, <b>11</b>, and <b>12</b> were achieved as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. In all cases, coupling of 4-phenylbutane-1-amine with the appropriate commercially available cyclohexanamine to directly afford the target compounds was achieved by sequential treatment of one amine with CDI and then the second amine, all in the presence of DIPEA.</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>10</b>â<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>10</b> and <b>11</b>: THF, DIPEA, CDI, 25 Â°C, 16 h. <b>12</b>: THF, DIPEA, CDI, 25 Â°C, 23.5 h.</p></p></figure><div class="NLM_p">The syntheses of 6-phenylhexanamide <b>13</b>, its pure stereoisomers, and its cyclohexanamine analogues are shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. In all cases, the amides were formed by coupling of commercially available 6-phenylhexanoic acid and the specified cyclohexanamine with HOBt and EDCI in the presence of DIEA. For compounds <b>13</b>, <b>13A</b>, <b>13B</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b>, the required cyclohexanamines <b>13a</b>, <b>13Aa</b>, <b>13Ba</b>, <b>14a</b>, <b>15a</b>, <b>16a</b>, <b>17a</b> and <b>18a</b>, respectively, were commercially available. For compounds <b>13</b>, <b>13A</b>, <b>13B</b>, <b>14</b>, <b>17</b>, and <b>18</b>, this reaction directly afforded the target compounds. As specified in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, preparation of <b>15</b> and <b>16</b> additionally required treatment of the amide coupling product with methanolic HCl.</div><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>13</b>â<b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>13</b>, <b>13A</b>, <b>13B</b>, <b>14</b>, <b>17</b>, and <b>18</b>: DIEA, DMF, HOBt, EDCI, 25 Â°C, 3â16 h; <b>15</b> and <b>16</b>: DIEA, DMF, HOBt, EDCI, 25 Â°C 12â16 h, followed by HCl/MeOH 15â25 Â°C, 2â16 h.</p></p></figure><div class="NLM_p">The syntheses of compounds <b>19</b>â<b>22</b> are shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. These compounds incorporate pyridine and pyrimidine replacements for the phenyl group of <b>13</b>. In all cases, the desired compounds are formed by coupling of the appropriate 6-heteroaryl-substituted hexanoic acid, <b>19d</b>â<b>22d</b>, with 4-aminocyclohexan-1-ol via use of HOBt, EDCI, and DIEA in DMF. The three isomeric 6-[pyridin-<i>X</i>-yl]hexanoic acids <b>19d</b>â<b>21d</b> were commercially available. However, acid <b>22d</b>, 6-(pyrimidin-4-yl)hexanoic acid, needed to be synthesized as shown in this scheme. Coupling of 4-chloropyrimidine (<b>22a</b>) with methyl hex-5-ynoate in the presence of catalytic amounts of CuI and Pd(PPh3)2Cl2 afforded methyl hex-5-ynoate (<b>22b</b>), catalytic hydrogenation of which over Pd/C, followed by hydrolysis, yielded <b>22d</b>.</div><figure id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>19</b>â<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh3)2Cl2, Cul, TEA, DMF, 20 Â°C,16 h. (b) H2, Pd/C, MeOH, 20 Â°C, 4 h. (c) LiOHÂ·H<sub>2</sub>O, THF, MeOH, 20 Â°C, 16 h. (d) 4-Amino-cyclohexan-1-ol, HOBt, EDCI, DIEA, DMF, 25 Â°C, 16 h.</p></p></figure><div class="NLM_p">The syntheses of compounds <b>23</b>â<b>27</b>, analogues of <b>13</b> in which a single methylene in the pentanyl chain is replaced with oxygen, are shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Compounds <b>23</b>â<b>26</b> were prepared by coupling the commercially available acids <b>23a</b>â<b>26a</b> with (<i>trans</i>)-4-aminocyclohexan-1-ol under the conditions specified in the Scheme. The carbamate <b>27</b> was formed by the coupling of commercially available 4-phenylbutyl chloroformate <b>27a</b> with (<i>trans</i>)-4-aminocyclohexan-1-ol in the presence of DIPEA.</div><figure id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>23</b>â<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>23</b>: dimethylformamide (DMF), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), HOBt, <i>N</i>-ethyl-<i>N</i>â²-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI), 25 Â°C, 2 h; <b>24</b> and <b>25</b>: HOBt, EDCI, DIPEA, DMF, 25 Â°C, 1 h; <b>26</b>: T3P, triethylamine (TEA), DMF, 25 Â°C, 1 h; <b>27</b>: DIPEA, DCM, 25 Â°C, 1 h.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a novel series of 6-phenylhexanamide derivative mitofusin activators was identified as having mitofusin-activating properties. The pharmacophore-based rational design guided functional and pharmacokinetic optimization, leading to compound <b>13</b> that exhibited potent and stereoselective fusogenic effects. The active <i>trans</i> diastereomer, compound <b>13B</b>, had excellent cell permeability, microsomal stability, and <i>in vivo</i> PK, providing greatly improved pharmaceutical properties compared to its precursors. When systemically administered to a preclinical mouse model of CMT2A, compound <b>13B</b> reversed characteristic mitochondrial dysmotility in sciatic nerve neurons, demonstrating <i>in vivo</i> target engagement in the pathophysiological relevant model and tissues. Preclinical profiling of compound <b>13B</b> supports its potential to be the first disease-modifying treatment for CMT2A caused by MFN2 mutations. The discovery and development of pharmaceutically acceptable mitofusin activators unlock the possibility of a previously unexplored therapeutic approach for other mitochondrial diseases, improving the overall mitochondrial function by enhancing mitochondrial dynamics.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11756" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11756" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedures and Instrumentation</h3><div class="NLM_p"><b>1</b>â<b>3</b> were synthesized and analyzed by Paraza Pharm., Inc.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>4</b>â<b>27</b> were synthesized and analyzed by WuXi Apptec Co. Ltd. The NMR spectrometry method for <b>1</b>â<b>3</b> was described previously.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> NMR spectrometry for <b>4</b>â<b>27</b> was carried out on a Bruker AVANCE NEO, 400 MHz, with a 5 mm PABBO BB/19F-1H/D Z-GRD probe. Analytical high-performance liquid chromatography (HPLC) for <b>1</b>â<b>3</b> used a XBridge C18 column (3.5 Î¼m, 4.6 Ã 30 mm<sup>2</sup>); gradient: 0.2 min at 95% A: 5% B, 5% B to 100% B in 1.8 min, 100% B for 1 min; the flow rate was 3 mL/min; mobile phase A: 10 mM ammonium formate in water (pH = 3.8); mobile phase B: acetonitrile (no additive).<a onclick="showRef(event, 'ref18 ref31'); return false;" href="javascript:void(0);" class="ref ref18 ref31">(18,31)</a> Analytical HPLC for <b>4</b>â<b>27</b> used a Kinetex C18 LC column (4.6 Ã 50 mm<sup>2</sup>, 5 Î¼m) that ran at 50 Â°C: mobile phase A: 0.0375% trifluoroacetic acid (TFA) in water (v/v), B: 0.01875% TFA in acetonitrile (v/v). Preparative HPLC methods are described in synthesis procedures for each compound. Liquid chromatography tandem mass spectrometry (LC-MS) of <b>1</b>â<b>3</b> was performed by Paraza Pharm, Inc., as described previously.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> LC-MS/MS (ESI) of <b>4</b>â<b>27</b> was performed using two different systems: (1) Shimadzu LC-MS-2020 instrument and data analyzed with LabSolution version 5.72 software. HPLC used a <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="93d0fbe1fcfefcfffae7fbd3d5fff2e0fb">[emailÂ protected]</a> RP-18E 25 Ã 2.0 mm column that ran at 50 Â°C and a PDA (220 and 254 nm) detector. Data was acquired in scan MS mode (positive mode) and selected with a scan range of <i>m</i>/<i>z</i> = 100â1000. The drying gas (N<sub>2</sub>) flow was 15 L/min, the DL voltage was 120(V), and the Qarray DC voltage was 20(V). (2) Agilent 1200\G6110A instrument and data analyzed with Agilent ChemStation Rev. B. 04.03[54] software. The HPLC contained an Xbridge C18 2.1 Ã 50 mm, 5 Î¼m column that ran at 40 Â°C and a DAD(220 nm)/ELSD detector. Data was acquired in scan MS mode (positive mode) and selected with a scan range of <i>m</i>/<i>z</i> = 100â1000. The drying gas (N<sub>2</sub>) flow was 10 L/min, the capillary voltage was 2500(V), the drying gas temperature was 350 Â°C, and the nebulizer pressure was 35 psi. All compounds are least 95% pure. <b>1</b>â<b>5</b> and <b>8</b>â<b>27</b> were validated from HPLC 220 nm absorbance peaks, and <b>6</b> and <b>7</b> were validated from LC-MS 220 nm absorbance peaks as shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Supporting Information</a>. tPSA values were calculated using ChemDraw 19.0.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Synthesis and Characterization of Compounds <b>1</b>â<b>27</b></h4><div class="NLM_p last">Starting materials whose preparation is not reported in this <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> are known compounds purchased by Paraza Pharm, Inc. and WuXi Apptec Co. Ltd. from third party suppliers or were prepared by them as reported.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(2-((5-Cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)thio)ethyl)-3-(2-methylcyclohexyl)urea (<b>1</b>)</h4><div class="NLM_p last">The synthetic procedure of <b>1</b> has been described previously.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> HPLC: Rt: 1.52 min; purity: 99.4%. LC-MS: MS cal.: 399.55; mass found: [M + H]<sup>+</sup>: 400.2. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.59â7.51 (m, 3H), 7.34â7.30 (m, 2H), 5.63 (s) and 5.56 (s, 1H), 5.04 (s, 1H), 4.75 (s) and 3.79 (s, 1H), 3.57 (dq, <i>J</i> = 12.7, 6.5 Hz, 2H), 3.29â3.09 (m, 2H), 1.98â1.02 (m, 12H), 0.98â0.90 (m, 4H), 0.85 (d, <i>J</i> = 7.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 158.4, 158.2, 157.9, 151.2, 151.0, 133.3, 133.3, 130.0, 127.2, 127.2, 55.0, 50.3, 40.7, 40.6, 38.9, 34.7, 34.5, 34.0, 32.8, 32.5, 30.2, 26.0, 25.8, 19.4, 8.10, 6.14.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-(3-(5-Cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)propyl)-3-(2-methylcyclohexyl)urea (<b>2</b>)</h4><div class="NLM_p last">A DCM (5.84 mL) solution of 1-isocyanato-2-methylcyclohexane (406 mg, 2.92 mmol) was added to a DCM (5.84 mL) solution of 3-(5-cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)propan-1-amine (<b>2b</b>, 708 mg, 2.92 mmol), and the reaction mixture was stirred for 18 h at r.t.; then, water (20 mL) was added, and the organic layer was separated, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified by flash column chromatography (silica 50 g, 5â50% MeOH/DCM) affording <b>2</b> (750 mg, 67% yield) as a white powder. HPLC: Rt: 1.43 min; purity: 98.8%; LC-MS: MS cal.: 381.51; mass found: [M + H]<sup>+</sup>: 382.2. <sup>1</sup>H NMR: (500 MHz, CDCl<sub>3</sub>) Î´ 7.59â7.51 (m, 3H), 7.28â7.26 (m, 1H), 7.26â7.25 (m, 1H), 5.67 (s) and 5.61 (s, 1H), 5.07 (d, <i>J</i> = 8.0 Hz) and 4.87 (d, <i>J</i> = 8.9 Hz, 1H), 3.80 (m) and 3.31â3.16 (m, 3H), 2.60 (td, <i>J</i> = 7.2, 5.1 Hz, 2H), 1.98â1.01 (m, 14H), 0.94â0.86 (m, 4H), 0.84 (d, <i>J</i> = 7.0 Hz, 1H). <sup>13</sup>C NMR: (126 MHz, CDCl<sub>3</sub>) Î´ 158.8, 158.7, 156.5, 154.8, 154.7, 133.7, 133.7, 130.1, 129.9, 127.2, 54.69, 39.5, 39.4, 39.1, 34.7, 34.6, 28.0, 26.0, 25.8, 22.8, 19.4, 7.92, 5.97.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(3-(5-Cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)propyl)-3-(2-methylcyclohexyl)urea (<b>3</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl (2-hydroxyethyl)carbamate (65.1 Î¼L, 0.412 mmol) was added to a THF (2.06 mL) solution of 5-cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-ol (<b>3c</b>, 83.0 mg, 0.412 mmol). Then, PPh3 (162 mg, 0.619 mmol) and DEAD (100 Î¼L, 0.619 mmol) were added, and the reaction mixture was stirred for 1 h at r.t. The resulting mixture was concentrated under reduced pressure, and the crude was purified by flash column chromatography, affording <i>tert</i>-butyl (2-((5-cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)oxy)ethyl)carbamate (<b>3a</b>, 110 mg, 77%) as a yellow oil. A solution of hydrochloric acid (4 M in dioxane, 798 Î¼L, 3.19 mmol) was added to a dioxane (1.60 mL) solution of <i>tert</i>-butyl (2-((5-cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)oxy)ethyl)carbamate (<b>3a</b>), the reaction mixture was stirred at r.t. for 18 h, and the resulting mixture was concentrated under reduced pressure. Before using the material in the next step, an excess of Et3N was added in the crude mixture dissolved in DCM, a DCM (1.0 mL) solution of 1-isocyanato-2-methylcyclohexane (44.4 mg, 0.319 mmol) was added to a DCM (1.0 mL) solution of deprotected amine 2-((5-cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)oxy)ethan-1-amine (<b>3b</b>, 77.9 mg, 0.319 mmol), and the reaction mixture was stirred for 30 min at r.t.. Then, water (10 mL) was added and the organic layer was separated, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by flash column chromatography (silica 25 g, 2â50% MeOH/DCM), affording <b>3</b> (90 mg, 74% yield) as a white powder. HPLC: Rt: 1.47 min; purity: 98.6%; LC-MS: MS cal.: 383.49; mass found: [M + H]<sup>+</sup>: 384.1. <sup>1</sup>H NMR: (500 MHz, CDCl<sub>3</sub>) Î´ 7.55â7.39 (m, 5H), 5.27 (s) and 5.22 (s, 1H), 4.33 (d, <i>J</i> = 9.0 Hz) and 4.07 (d, <i>J</i> = 9.2 Hz, 1H), 3.99â3.92 (m, 2H), 3.73 (s, 0.18H), 3.63â3.54 (m, 2H), 3.20â3.07 (m, 0.69H), 2.01â0.81 (m, 17H). <sup>13</sup>C NMR: (101 MHz, CDCl<sub>3</sub>) Î´ 158.01, 157.96, 153.80, 147.71, 132.84, 129.47, 128.74, 126.84, 54.97, 50.28, 46.04, 45.99, 39.77, 38.84, 34.40, 34.37, 33.90, 30.13, 30.01, 25.71, 25.51, 23.43, 22.16, 19.17, 16.21, 7.21, 6.69.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(3-(5-Cyclopropyl-4-(4-fluorophenyl)-4<i>H</i>-1,2,4-triazol-3-yl)propyl)-3-(2-methylcyclohexyl)urea (<b>4</b>)</h4><div class="NLM_p last">A mixture of 3-(5-cyclopropyl-4-(4-fluorophenyl)-4<i>H</i>-1,2,4-triazol-3-yl)propan-1-amine (<b>4a</b>, 0.600 g, 1.92 mmol, HCl), Troc-Cl (488 mg, 2.30 mmol, 309 Î¼L), DIPEA (745 mg, 5.76 mmol, 1.00 mL), DMAP (11.7 mg, 96.0 Î¼mol, 0.05 equiv), and DCM (20 mL) was stirred at 40 Â°C for 12 h, then filtered, and concentrated in vacuo to afford an intermediate product as a gray solid (0.600 g, 1.28 mmol, 66.5% yield, 92.8% purity). To this was then added 2-methylcyclohexanamine (<b>4b</b>, 181 mg, 1.60 mmol, 211 Î¼L, 1.5 equiv) in DMSO (3 mL), and the mixture was degassed, purged with N<sub>2</sub> three times, then stirred at 95 Â°C for 10 h under N<sub>2</sub>, concentrated, and purified by reverse-phase HPLC (column: Phenomenex Synergi Max-RP 250 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (0.225% FA)-ACN]; B%: 10ACN%â50ACN%, 35 min). The eluent was concentrated to remove most of MeCN, the aqueous phase was adjusted to pH = 8 by addition of NaHCO<sub>3</sub> solution and extracted with DCM (50 mL Ã 3), and the combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford <b>4</b> (0.180 g, 448 Î¼mol, 42.1% yield) as a yellow solid. HPLC: Rt: 2.42 min; purity: 99.4%; LC-MS: MS cal.: 399.55; mass found: [M + H]<sup>+</sup>: 400.2. Structure was confirmed by <sup>1</sup>H NMR and <sup>13</sup>C NMR. <sup>1</sup>H NMR: (400 MHz DMSO-<i>d</i><sub>6</sub>) Î´ 7.61â7.53 (m, 2H), 7.48â7.39 (m, 2H), 5.80â5.53 (m, 2H), 2.99â2.91 (m, 2H), 2.48â2.40 (m, 2H), 1.73â1.44 (m, 6H), 1.41â1.07 (m, 5H), 1.02â0.77 (m, 8H), 0.74 (d, <i>J</i> = 6.8 Hz, 1H). (d, <i>J</i> = 6.8 Hz, 1H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(3-(5-Cyclopropyl-4-(4-fluorophenyl)-4<i>H</i>-1,2,4-triazol-3-yl)propyl)-3-(4-fluorocyclohexyl)urea (<b>5</b>)</h4><div class="NLM_p last">To a solution of 4-fluorocyclohexan-1-amine (<b>5b</b>, 101 mg, 866 Î¼mol, 1.00 equiv, HCl) and TEA (438 mg, 4.33 mmol, 602 Î¼L) in DCM (10.0 mL) was added CDI (182 mg, 1.13 mmol). The reaction mixture was stirred at 0 Â°C for 2 h. Then, a solution of 3-(5-cyclopropyl-4-(4-fluorophenyl)-4<i>H</i>-1,2,4-triazol-3-yl)propan-1-amine (<b>5a</b>, 257 mg, 866 Î¼mol, HCl) and TEA (438 mg, 4.33 mmol, 602 Î¼L) in DCM (10.0 mL) was added to the reaction mixture and stirred at 20 Â°C for 12 h. Furthermore, the reaction mixture was filtered and concentrated under reduced pressure to give a residue, which was purified by reverse-phase HPLC (column: Phenomenex Synergi C18 150 Ã 25 mm Ã 10 Î¼m; mobile phase: [water (0.225% FA)-ACN]; B%: 30â60%, 9 min) to obtain <b>5</b> (190 mg, 54.1% yield) as a yellow solid. HPLC: Rt: 1.596 min, purity: 99.37%. LC-MS: Rt = 0.805 min, MS (M + H<sup>+</sup>): 404.2. <sup>1</sup>H NMR: 400 MHz DMSO. Î´ 7.54â7.58 (m, 2H), 7.41â7.46 (m, 2H), 5.80â5.82 (d, <i>J</i> = 7.6 Hz, 1H), 6.75 (s, 1H), 5.71 (s, 1H), 4.64â4.77 (d, <i>J</i> = 48.8 Hz, 1H), 2.92â2.97 (q, J1 = 6.4 Hz, J2 = 12.8 Hz, 2H), 2.42â2.46 (t, <i>J</i> = 8.0 Hz, 2H), 1.80 (m, 2H), 1.60â1.63 (m, 8H), 1.48â1.54 (m, 2H), 0.88â0.90 (m, 2H), 0.81â0.83 (m, 2H). <sup>13</sup>C NMR: DMSO, <sup>13</sup>C Î´ 163.87, 161.41, 157.82, 155.98, 154.19, 130.61, 130.59, 130.32, 130.23, 117.34, 117.15, 89.74, 88.08, 46.51, 38.93, 29.42, 29.22, 28.02, 27.83, 22.65, 22.47, 7.40, 5.97.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(3-(5-Cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)propyl)-3-(tetrahydro-2<i>H</i>-pyran-4-yl)urea (<b>6</b>)</h4><div class="NLM_p last">To a solution of tetrahydro-2<i>H</i>-pyran-4-amine (<b>6b</b>, 130 mg, 1.29 mmol, 320 Î¼L) and TEA (370 mg, 3.66 mmol, 509 Î¼L) in DCM (5.00 mL) was added CDI (217 mg, 1.34 mmol), and the reaction mixture was stirred at 5â10 Â°C for 3 h. Then, 3-(5-cyclopropyl-4-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)propan-1-amine (<b>6a</b>, 380 mg, 1.36 mmol, HCl) was added to the reaction mixture and stirred at 10â15 Â°C for 12 h. The reaction mixture was concentrated under reduced pressure to give a residue, which was purified by reverse-phase HPLC (column: Xtimate C18 150 Ã 25 mm Ã 10 Î¼m; mobile phase: [water (0.05% ammonia hydroxide v/v)-ACN]; B%: 15â45%, 8 min) to obtain <b>6</b> (85.96 mg, 233 Î¼mol, 17.1% yield) as a white gum. LC-MS: MS cal.: 369.5; mass found: [M + H]<sup>+</sup>: 370.2, Rt: 1.38 min; purity: 99.4% at 220 nm absorbance. <sup>1</sup>H NMR: (400 MHz DMSO) Î´ 7.64â7.57 (m, 3H), 7.49â7.47 (t, <i>J</i> = 4.0 Hz, 3H), 5.81â5.72 (m, 3H), 3.80â3.75 (m, 2H), 3.55â3.45 (m, 1H), 3.32â3.28 (m, 2H), 2.97â2.92 (m, 2H), 2.47â2.43 (t, <i>J</i> = 7.6 Hz, 2H), 1.68â1.61 (m, 2H), 1.30â1.20 (m, 2H), 0.91â0.82 (m, 2H). <sup>13</sup>C NMR: (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 6.05 (s, 1C) 7.55 (s, 1C) 22.52 (s, 1C) 27.76 (s, 1C) 33.90 (s, 1C) 38.67â41.26 (m, 1C) 45.81 (s, 1C) 66.41 (s, 1C) 127.85 (s, 1C) 129.63â130.77 (m, 1C) 134.28 (s, 1C) 153.71â158.20 (m, 1C).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(3-(4-Methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)propyl)-3-(2-methylcyclohexyl)urea (<b>7</b>)</h4><div class="NLM_p last">To a solution of 2-methylcyclohexan-1-amine (<b>7b</b>, 246 mg, 2.17 mmol, 286 Î¼L) and TEA (627 mg, 6.20 mmol, 862 Î¼L) in DCM (10.0 mL) was added CDI (368 mg, 2.27 mmol), and the reaction mixture was stirred at 5â10 Â°C for 3 h. Then, 3-(4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)propan-1-amine (<b>7a</b>, 500 mg, 2.31 mmol, HCl) was added to the reaction mixture and stirred at 10â15 Â°C for 12 h. The reaction mixture was concentrated under reduced pressure to give a residue, which was purified by reverse-phase HPLC (column: Phenomenex Synergi C18 150 Ã 25 mm Ã 10 Î¼m; mobile phase: [water (0.05% HCl)-ACN]; B%: 15â35%, 10 min) to obtain <b>7</b> (171.84 mg, 20.9% yield) as an off-white solid. HPLC: Rt: 2.76 min, purity: 99.7%. LC-MS: Rt: 2.761 min, purity: 99.71% at 220 nm absorbance; Rt: 2.761 min, purity: 99.41% at 254 nm absorbance. <sup>1</sup>H NMR: 400 MHz DMSO. Î´ 7.82â7.80 (t, <i>J</i> = 5.6 Hz, 2H), 7.80â7.68 (m, 3H), 3.76â3.75 (d, <i>J</i> = 4.0 Hz, 3H), 3.17â3.13 (m, 2H), 3.06â3.01 (m, 2H), 1.96â1.90 (m, 2H), 1.66â1.15 (m, 10H), 0.85â0.77 (m, 3H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(2-(4-Methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)ethyl)-3-(2-methylcyclohexyl)urea (<b>8</b>)</h4><div class="NLM_p last">To a solution of Troc-Cl (976 mg, 4.61 mmol, 617 Î¼L) and DIEA (1.35 g, 10.4 mmol, 1.82 mL) in DCM (20 mL) was added 2-(4-methyl-5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)ethan-1-amine (<b>8a</b>,1 g, 4.19 mmol, HCl) at 0 Â°C and stirred at 20 Â°C for 1 h to give an intermediate product, to which was added 2-methylcyclohexan-1-amine (<b>8b</b>, 44.9 mg, 397 Î¼mol, 52.3 Î¼L), in DMF (2 mL) and then stirred at 90 Â°C for 12 h. The reaction mixture was filtered and concentrated to afford a residue, which was purified by reverse-phase HPLC (column: Phenomenex Synergi C18 150 Ã 25 mm Ã 10 Î¼m; mobile phase: [water (0.225% FA)-ACN]; B%: 35â49%, 10 min) to give <b>8</b> (0.152 g, 445 Î¼mol, 77.0% yield) as a white solid. HPLC: Rt: 1.62 min, purity: 99.3%. <sup>1</sup>H NMR: 400 MHz DMSO-<i>d</i><sub>6</sub> Î´ = 7.61â7.73 (m, 2H), 7.49â7.59 (m, 3H), 5.80â6.10 (m, 2H), 3.59 (s, 3H), 3.41â3.45 (m, 1H), 2.95â3.07 (m, 1H), 2.87 (t, <i>J</i> = 6.75 Hz, 2H), 0.95â1.77 (m, 10H), 0.83 (d, <i>J</i> = 6.50 Hz, 2H), 0.74â0.79 (m, 1H).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-(3-(5-Cyclopropyl-4-ethyl-4<i>H</i>-1,2,4-triazol-3-yl)propyl)-3-(tetrahydro-2<i>H</i>-pyran-4-yl)urea (<b>9</b>)</h4><div class="NLM_p last">To a solution of 5-methyl-3,6-dihydro-2<i>H</i>-pyran-4-amine (<b>9b</b>, 260 mg, 2.26 mmol, 320 Î¼L) and TEA (645 mg, 6.37 mmol, 887 Î¼L) in DCM (10.0 mL) was added CDI (379 mg, 2.34 mmol), and the reaction mixture was stirred at 5â10 Â°C for 3 h. Then, 3-(5-cyclopropyl-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)propan-1-amine (<b>9a</b>, 400 mg, 1.73 mmol, HCl) was added to the reaction mixture and stirred at 10â15 Â°C for 12 h, and the reaction mixture was concentrated under reduce pressure to give a residue, which was purified by reverse-phase HPLC to obtain <b>9</b> (162.59 mg, 19.7% yield) as an off-white gum. HPLC: Rt: 1.29 min, purity: 99.0%. <sup>1</sup>H NMR: (400 MHz DMSO) Î´ 3.77 (s, 3H), 3.66â3.64 (m, 1H), 3.43â3.42 (d, <i>J</i> = 4.4 Hz, 2H), 3.11â3.08 (t, <i>J</i> = 6.0 Hz, 2H), 2.28â2.26 (m 1H), 1.85â1.80 (m, 4H), 1.52â1.46 (m, 2H), 1.21â1.14 (m, 4H), 0.80â0.74 (m, 4H). <sup>13</sup>C NMR: (101 MHz, CDCl<sub>3</sub>) Î´ 159.52, 157.03, 154.67, 73.08, 70.74, 67.19, 65.22, 53.40, 48.61, 45.89, 38.58, 37.31, 33.74, 31.69, 29.78, 25.87, 21.47, 13.89, 12.12, 8.63, 8.21, 4.96.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(2-Methylcyclohexyl)-3-(4-phenylbutyl)urea (<b>10</b>)</h4><div class="NLM_p last">To a solution of 2-methylcyclohexan-1-amine (<b>10a</b>, 0.759 g, 6.70 mmol) and DIPEA (0.866 g, 6.70 mmol) in THF (10 mL) was added CDI (1.09 g, 6.70 mmol), and the mixture was stirred at 25 Â°C for 10 min. To it was added 4-phenylbutan-1-amine (1.00 g, 6.70 mmol), and the mixture was stirred at 25 Â°C for 16 h. The crude product was purified by reverse-phase HPLC, the eluent was concentrated under reduced pressure, the mixture was filtered, and then the filter cake was washed with a saturated solution of NaHCO<sub>3</sub> (20 mL Ã 2) and washed with H<sub>2</sub>O (20 mL Ã 2) to give <b>10</b> (110.12 mg, 379.50 Î¼mol, 5.72% yield, 99.4% purity) as a white solid. HPLC: Rt: 2.273 min, purity: 99.4%. LC-MS: RT = 0.823 min, <i>m</i>/<i>z</i> = 289.0 (M + 1) +. <sup>1</sup>H NMR: 400 MHz MeOD Î´: 7.26â7.22 (m, 2H), 7.18â7.13 (m, 3H), 3.14 (t, <i>J</i> = 3.60 Hz, 3H), 2.63 (t, <i>J</i> = 7.6 Hz, 2H), 1.89-1.86 (m, 1H), 1.78â1.53 (m, 5H), 1.53â1.46 (m, 2H), 1.35â1.01 (m, 5H), 1.07â0.91 (m, 3H). <sup>13</sup>C NMR: <sup>13</sup>C MeOD 161.222, 143.825, 129.509, 126.884, 56.169â48.164, 40.875, 40.093, 36.717, 35.935, 35.625, 31.149, 30.106, 27.122, 26.975, 19.809.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(4-Hydroxy-2-methylcyclohexyl)-3-(4-phenylbutyl)urea (<b>11</b>)</h4><div class="NLM_p last">To a solution of 4-amino-3-methylcyclohexan-1-ol (<b>11a</b>, 1.50 g, 11.6 mmol) and DIPEA (1.00 g, 7.74 mmol, 1.35 mL) in THF (10 mL) was added CDI (1.26 g, 7.74 mmol), and the reaction mixture was stirred at 25 Â°C for 10 min. Then, 4-phenylbutan-1-amine (1.16 g, 7.74 mmol, 1.22 mL) was added to the reaction mixture and stirred at 25 Â°C for 16 h; the reaction mixture was poured into H<sub>2</sub>O (10 mL) and extracted with EtOAc (5 mL Ã 3); the organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give a residue, which was purified by reverse-phase HPLC to get <b>11</b> (1.63 g, 5.16 mmol, 66.6% yield) as a light yellow solid. HPLC: Rt: 2.22 min, purity: 96.3%. LC-MS: Rt: 1.988 min, <i>m</i>/<i>z</i> = 305.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz CDCl<sub>3</sub> Î´: 7.20â7.06 (m, 5H), 5.34 (s, 1H), 3.94â3.73 (m, 1H), 3.65â3.50 (m, 1H), 3.10 (t, <i>J</i> = 7.2 Hz, 2H), 2.55 (t, <i>J</i> = 7.2 Hz, 2H), 1.74â1.09 (m, 10H), 0.83 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR: 400 MHz CDCl<sub>3</sub> Î´: 142.13, 142.06, 128.37, 125.80, 77.45â76.61, 69.85, 48.46, 40.46, 38.44, 35.53, 33.79, 29.75, 28.67, 18.41, 18.37.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(4-Hydroxycyclohexyl)-3-(4-phenylbutyl)urea (<b>12</b>)</h4><div class="NLM_p last">To a solution of 4-phenylbutan-1-amine (1.0 g, 6.70 mmol 1.06 mL) and DIPEA (866 mg, 6.70 mmol, 1.17 mL) in THF (10 mL) was added CDI (1.09 g, 6.70 mmol, 1.0 equiv), and the mixture stirred at 25 Â°C for 15 min. To the reaction mixture was added 4-aminocyclohexan-1-ol (<b>12a</b>, 772 mg, 6.70 mmol) and stirred at 25 Â°C for 23.5 h; then, the reaction mixture was concentrated and purified by reverse-phase HPLC (column: Phenomenex luna C18 250 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (0.05% HCl)-ACN]; B%: 25â55%, 25 min) twice. The mixture was concentrated under reduced pressure and filtered, and the filter cake was washed with NaHCO<sub>3</sub> to give <b>12</b> (620 mg, 1.62 mmol, 69.0% yield) as white solid. HPLC: Rt: 1.73 min, purity: 99.8%. LC-MS: Rt = 0.842 min, <i>m</i>/<i>z</i> = 291.1 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz MeOD Î´: 7.26â7.22 (m, 2H), 7.18â7.13 (m, 2H), 3.53â3.42 (m, 2H), 3.12 (t, <i>J</i> = 7.0 Hz, 2H), 2.61 (d, <i>J</i> = 7.6 Hz, 2H), 1.91 (d, <i>J</i> = 10.0 Hz, 3H), 1.65â1.61 (m, 2H), 1.50â1.46 (m, 2H), 1.35â1.33 (m, 2H), 1.25â1.20 (m, 2H). <sup>13</sup>C NMR: 400 MHz MeOD Î´: 160.800, 143.788, 129.554, 129.430, 126.875, 70.654, 40.842, 36.688, 34.998, 32.558, 31.083, 30.069.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(4-Hydroxycyclohexyl)-6-phenylhexanamide (<b>13</b>)</h4><div class="NLM_p last">To a solution of 4-aminocyclohexan-1-ol (<b>13a</b>, 6.00 g, 39.6 mmol, HCl salt) and DIEA (14.0 g, 108 mmol, 18.8 mL) in DMF (60.0 mL) were added 6-phenylhexanoic acid (6.92 g, 36.0 mmol, 6.78 mL, 1.00 equiv), HOBt (5.83 g, 43.2 mmol, 1.20 equiv), and EDCI (10.3 g, 54.0 mmol, 1.50 equiv). Then, the mixture was stirred at 25 Â°C for 16 h, filtered, and concentrated. The residue was purified by reverse-phase HPLC (column: Phenomenex luna C18 250 Ã 80 mm Ã 10 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)âCAN]; B%: 38ACN%â68ACN%, 8.5 min), the appropriate fractions were concentrated, and the residue was triturated with petroleum ether/ethyl acetate = 5:1 (240 mL) at 25 Â°C for 5 min to obtain <b>13</b> as an off-white solid (3.53 g, 12.0 mmol, 33.9% yield). HPLC: Rt = 1.863 min; purity = 96.6% [220 nm, top], 97.3% [254 nm, bottom] as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S2</a>. High-resolution mass spectrometry (HRMS): Rt = 1.884 min, <i>m</i>/<i>z</i> = 290.2128 (M + H)<sup>+</sup> as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S2</a>. <sup>1</sup>H NMR: 400 MHz MeOD Î´ 7.25â7.22 (m, 2H), 7.16â7.11 (m, 3H), 3.59â3.48 (m, 2H), 2.60 (t, <i>J</i> = 7.6 Hz, 2H), 2.13 (t, <i>J</i> = 7.4 Hz, 2H), 1.92â1.65 (m, 4H), 1.65â1.59 (m, 4H), 1.35â1.29 (m, 6H) as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S2</a>. <sup>13</sup>C NMR: 400 MHz MeOD Î´ 175.669, 143.887, 129.595, 126.817, 70.605, 37.240, 36.869, 34.973, 32.517, 31.668, 29.814, 27.102 as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S2</a>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(cis-4-Hydroxycyclohexyl)-6-phenylhexanamide (<b>13A</b>)</h4><div class="NLM_p last">To a solution of 6-phenylhexanoic acid (200 mg, 1.04 mmol, 196 Î¼L, 1.00 equiv) and DIEA (403 mg, 3.12 mmol, 544 Î¼L, 3.00 equiv) in DMF (2.00 mL) were added (cis)-4-aminocyclohexan-1-ol (<b>13A-1</b>, 132 mg, 1.14 mmol), HOBt (169 mg, 1.25 mmol), and EDCI (299 mg, 1.56 mmol), and the mixture was stirred at 25 Â°C for 16 h. LC-MS showed that <b>13A-1</b> was consumed, the desired product MS (Rt = 1.884 min) was detected, and the mixture was filtered and purified over a reverse-phase HPLC (column: Waters Xbridge 150 Ã 25 mm Ã 5 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 26â56%, 10 min). <b>13A</b> was obtained as a light yellow gum (209.9 mg, 701 Î¼mol, 67.4% yield). HPLC: Rt = 1.860 min; purity = 96.8% [220 nm, top], 98.4% [254 nm, bottom] as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S3</a>. LC-MS: Rt = 1.884 min, <i>m</i>/<i>z</i> = 290.1 (M + H)<sup>+</sup> as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S3</a>. <sup>1</sup>H NMR: 400 MHz MeOD Î´ 7.25â7.22 (m, 2H), 7.17â7.11 (m, 3H), 3.84 (s, 1H), 3.70â3.65 (m, 1H), 2.60 (t, <i>J</i> = 7.6 Hz, 2H), 2.16 (t, <i>J</i> = 7.2 Hz, 2H), 1.73â1.65 (m, 3H), 1.65â1.59 (m, 9H), 1.36â1.34 (m, 2H) as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S3</a>. <sup>13</sup>C NMR: 400 MHz MeOD Î´ 175.628, 143.895, 129.579, 129.414, 126.809, 66.945, 37.182, 36.885, 32.558, 32.179, 29.863, 28.074, 27.168 as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S3</a>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(<i>trans</i>-4-Hydroxycyclohexyl)-6-phenylhexanamide (<b>13B</b>)</h4><div class="NLM_p last">To a solution of (<i>trans</i>)-4-aminocyclohexan-1-ol (<b>13B-1</b>, 200 mg, 1.04 mmol, 196 Î¼L) and DIEA (403 mg, 3.12 mmol, 544 Î¼L, 3.00 equiv) in DMF (2.00 mL) were added 6-phenylhexanoic acid (132 mg, 1.14 mmol, 1.10 equiv), HOBt (169 mg, 1.25 mmol, 1.20 equiv), and EDCI (299 mg, 1.56 mmol, 1.50 equiv). The mixture was stirred at 25 Â°C for 16 h. The mixture was filtered and purified by reverse-phase HPLC (column: Waters Xbridge 150 Ã 25 mm Ã 5 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 26â56%, 10 min). <b>13B</b> (243.82 mg, 810 Î¼mol, 77.8% yield) was obtained as a white solid. HPLC: Rt = 1.857 min; purity = 96.1% [220 nm, top], 99.0% [254 nm, bottom] as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S3</a>. LC-MS: Rt = 1.886 min, <i>m</i>/<i>z</i> = 290.2 (M + H)<sup>+</sup> as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">Figure S3</a>. <sup>1</sup>H NMR: EW17569-19-P1B3 400 MHz MeOD Î´ 7.25â7.22 (m, 2H), 7.16â7.13 (m, 3H), 3.63â3.48 (m, 2H), 2.60 (t, <i>J</i> = 7.2 Hz, 2H), 2.13 (t, <i>J</i> = 7.2 Hz, 2H), 1.95â1.83 (m, 4H), 1.63â1.59 (m, 4H), 1.35â1.28 (m, 6H). <sup>13</sup>C NMR: EW17569-19-P1C1 400 MHz MeOD Î´ 175.661, 143.887, 129.587, 129.405, 126.809, 70.597, 37.240, 36.851, 34.973, 32.493, 31.660, 29.814, 27.085.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-Phenyl-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-4-yl)hexanamide (<b>14</b>)</h4><div class="NLM_p last">To a solution of 6-phenylhexanoic acid (0.30 g, 1.56 mmol, 294 Î¼L) in DMF (3.0 mL) were added HOBt (253 mg, 1.87 mmol), EDCI (448 mg, 2.34 mmol), and DIEA (403 mg, 3.12 mmol, 543 Î¼L). Then, tetrahydro-2<i>H</i>-pyran-4-amine (<b>14a</b>, 173 mg, 1.72 mmol) was added to the mixture, the mixture was stirred at 25 Â°C for 3 h and concentrated under reduced pressure to give the residue, the residue was purified by reverse-phase HPLC (column: Phenomenex luna C18 150 Ã 40 mm Ã 15 Î¼m; mobile phase: [water (0.225% FA)-ACN]; B%: 28â58%, 8.5 min) to obtain <b>14</b> (169.36 mg, 713 Î¼mol, 38.7% yield) as a white solid. HPLC: Rt: 2.56 min, purity: 98.3%. LC-MS: Rt = 0.861 min, <i>m</i>/<i>z</i> = 276.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz DMSO-<i>d</i><sub>6</sub> Î´: 7.72 (d, <i>J</i> = 7.58 Hz, 1H) 7.08â7.33 (m, 5H) 3.65â3.86 (m, 3H) 3.31â3.36 (m, 2H) 2.55 (t, <i>J</i> = 7.64 Hz, 2H) 2.03 (t, <i>J</i> = 7.40 Hz, 2H) 1.64 (m, 2H) 1.53 (m, 4H) 1.20â1.40 (m, 4H). <sup>13</sup>C NMR: 400 MHz DMSO Î´: 171.713, 142.682, 128.725â128.651, 126.043, 66.383, 45.129, 35.811â35.526, 33.039, 31.213, 28.661, 25.629.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(4-Aminocyclohexyl)-6-phenylhexanamide (<b>15</b>)</h4><div class="NLM_p last">To a solution of 6-phenylhexanoic acid (500 mg, 2.60 mmol, 490 Î¼L) and <i>tert</i>-butyl(4-aminocyclohexyl)carbamate (<b>15a</b>, 613 mg, 2.86 mmol) in DMF (5.00 mL) were added HOBt (422 mg, 3.12 mmol), DIEA (672 mg, 5.20 mmol, 906 Î¼L), and EDCI (748 mg, 3.90 mmol) at 25 Â°C, the mixture was stirred at 25 Â°C for 12 h, and <i>tert</i>-butyl(4-(6-phenylhexanamido)cyclohexyl)carbamate (782 mg, 2.01 mmol, 77.4% yield) was obtained as a yellow solid. To solution of <i>tert</i>-butyl(4-(6-phenylhexanamido)cyclohexyl)carbamate (300 mg, 772 Î¼mol, 1.00 equiv) in MeOH (3.0 mL) was added HCl/MeOH (4 M, 6.0 mL, 31.1 equiv), and the mixture was stirred at 15 Â°C for 2 h. LC-MS showed that <i>tert</i>-butyl(4-(6-phenylhexanamido)cyclohexyl)carbamate was consumed, desired MS (Rt = 0.921 min) was detected, the mixture was concentrated under reduced pressure to give the residue, and the residue was purified by reverse-phase HPLC (column: Waters Xbridge 150 Ã 25 mm Ã 5 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 14â44%, 10 min) to obtain <b>15</b> (89.4 mg, 309 Î¼mol, 40.1% yield) as a white gum. HPLC: Rt: 1.35 min, purity: 99.8%. LC-MS: Rt = 0.712 min, <i>m</i>/<i>z</i> = 289.1 (M + H)<sup>+</sup>. SFC: Rt = 1.761 and 1.945 min. <sup>1</sup>H NMR: 400 MHz CDCl<sub>3</sub> Î´: 7.19â7.16 (m, 5H), 5.57â5.21 (m, 1H), 3.96â3.70 (m, 1H), 2.95â2.91 (m, 1H), 2.63â2.59 (m, 2H), 2.16â2.12 (m, 2H), 1.68â1.61 (m, 12H), 1.40â1.34 (m, 4H). <sup>13</sup>C NMR: 400 MHz CDCl<sub>3</sub> Î´: 172.155, 142.488, 128.354 -128.224, 125.167, 45.217, 36.962, 35.706, 31.271â31.112, 28.823, 27.935, 25.674.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(4-Phenylbutyl)-3-(piperidin-4-yl)urea (<b>16</b>)</h4><div class="NLM_p last">To a solution of 6-phenylhexanoic acid (500 mg, 2.60 mmol, 490 Î¼L, 1.00 equiv) and <i>tert</i>-butyl 4-aminopiperidine-1-carboxylate (<b>16a</b>, 573 mg, 2.86 mmol, 1.10 equiv) in DMF (3.00 mL) were added HOBt (422 mg, 3.12 mmol, 1.20 equiv), EDCI (748 mg, 3.90 mmol, 1.50 equiv), and DIEA (672 mg, 5.20 mmol, 906 Î¼L, 2.00 equiv) at 25 Â°C, the mixture was stirred at 25 Â°C for 12 h, and the intermediate (740 mg, 1.98 mmol, 76.0% yield) was obtained as a yellow solid. Then, HCl/MeOH (4 M, 12 mL, 24.3 equiv) was added. The mixture was stirred at 25 Â°C for 16 h, and then it was concentrated under reduced pressure to give the residue. The residue was purified by reverse-phase HPLC (column: Waters Xbridge 150 Ã 25 mm Ã 5 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 11â41%, 10 min) to obtain <b>16</b> (418.27 mg, 1.45 mmol, 73.4% yield) as a white solid. HPLC: Rt: 1.42 min, purity: 95.2%. LC-MS: Rt = 0.708 min, <i>m</i>/<i>z</i> = 276.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz MeOD Î´: 7.26â7.22 (m, 2H), 7.18â7.12 (m, 3H), 3.59â3.55 (m, 1 H), 3.12 (t, <i>J</i> = 6.8 Hz, 2H), 3.03â2.99 (m, 2H), 2.67â2.60 (m, 4H), 1.88â1.84 (m, 2H), 1.66â1.62 (m, 2H), 1.50â1.47 (m, 2H), 1.47â1.32 (m, 2H). <sup>13</sup>C NMR: 400 MHz MeOD Î´: 160.610, 143.800, 129.713, 129.582, 128.460, 126.900, 45.946, 40.810, 36.709, 34.337, 31.100, 30.114.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(4-Methylcyclohexyl)-6-phenylhexanamide (<b>17</b>)</h4><div class="NLM_p last">To a solution of 4-methylcyclohexan-1-amine (<b>17a</b>, 194 mg, 1.72 mmol, 227 Î¼L) in DMF (5.0 mL) were added HOBt (253 mg, 1.87 mmol), EDCI (448 mg, 2.34 mmol), and DIEA (403 mg, 3.12 mmol, 543 Î¼L). Then, 6-phenylhexanoic acid (0.30 g, 1.56 mmol, 294 Î¼L, 1.00 equiv) was added to the mixture, and the mixture was stirred at 25 Â°C for 3 h. LC-MS showed that 6-phenylhexanoic acid was consumed, desired MS (Rt = 1.036 min) was detected, the reaction mixture was concentrated under reduced pressure to give a residue, and the residue was purified by reverse-phase HPLC (column: Phenomenex luna C18 150 Ã 40 mm Ã 15 Î¼m; mobile phase: [water (0.225% FA)-ACN]; B%: 52â82%, 8.5 min) to obtain <b>17</b> (67.98 mg, 237 Î¼mol, 15.2% yield) as a white solid. HPLC: Rt: 3.44 min, purity: 98.6%. LC-MS: Rt = 0.999 min, <i>m</i>/<i>z</i> = 288.0 (M + H)<sup>+</sup>. SFC: Rt = 1.177 min, Rt = 1.308 min. <sup>1</sup>H NMR: 400 MHz DMSO Î´: 7.58 (d, <i>J</i> = 7.6 Hz, 5H), 7.27â7.13 (m, 5H), 3.47â3.40 (m, 1H), 2.56â2.50 (m, 2H), 2.10â2.01 (m, 2H), 1.56â1.49 (m, 9H), 1.30â1.25 (m, 5H), 0.89â0.84 (m, 4H). <sup>13</sup>C NMR: 400 MHz DMSO Î´: 171.335â171.050, 142.215, 128.233 -128.152, 125.551, 47.434, 35.108, 33.665, 32.450, 31.553, 30.819, 30.795, 29.401, 28.830, 28.227, 25.251, 22.186.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(4-Fluoro-4-methylcyclohexyl)-6-phenylhexanamide (<b>18</b>)</h4><div class="NLM_p last">To a solution of 6-phenylhexanoic acid (300 mg, 1.56 mmol, 294 Î¼L) in DMF (3.0 mL) were added HOBt (253 mg, 1.87 mmol), EDCI (448 mg, 2.34 mmol), and DIEA (403 mg, 3.12 mmol, 543 Î¼L, 2.00 equiv), Then, 4,4-difluorocyclohexan-1-amine (<b>18a</b>, 232 mg, 1.72 mmol) was added to the mixture and stirred at 25 Â°C for 3 h. LC-MS showed that <b>18a</b> was consumed, desired MS (Rt = 0.986 min) was detected, the mixture was concentrated under reduced pressure to give a residue, and the residue was purified by reverse-phase HPLC (column: Phenomenex Synergi C18 150 Ã 25 mm Ã 10 Î¼m; mobile phase: [water (0.225% FA)-ACN]; B%: 48â78%, 11 min) to obtain <b>18</b> (98.23 mg, 317 Î¼mol, 20.0% yield) as a white solid. HPLC: Rt: 3.09 min, purity: 98.3%. LC-MS: Rt = 0.933 min, <i>m</i>/<i>z</i> = 310.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz DMSO-<i>d</i><sub>6</sub> Î´: 7.72 (d, <i>J</i> = 7.58 Hz, 1H), 7.13â7.28 (m, 5H), 3.72 (d, <i>J</i> = 7.58 Hz, 1H), 2.55 (t, <i>J</i> = 7.58 Hz, 2H), 2.01â2.06 (m, 2H), 1.68â2.00 (m, 6H), 1.48â1.61 (m, 4H), 1.39â1.48 (m, 2H), 1.24 (m, 2H). <sup>13</sup>C NMR: 400 MHz DMSO-<i>d</i><sub>6</sub> Î´: 171.949, 142.682, 128.733â128.659, 126.059, 45.072, 35.778, 35.518, 31.727, 31.197, 28.621, 28.482, 28.384, 25.620.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(4-Hydroxycyclohexyl)-6-(pyridin-2-yl)hexanamide (<b>19</b>)</h4><div class="NLM_p last">To a solution of 6-(pyridin-2-yl)hexanoic acid (<b>19d</b>, 1.09 g, 5.64 mmol) in DMF (10 mL) were added HOBt (914 mg, 6.77 mmol), EDCI (1.62 g, 8.46 mmol), and DIEA (2.19 g, 16.9 mmol, 2.95 mL). Then, 4-aminocyclohexan-1-ol (940 mg, 6.20 mmol, 1.10 equiv, HCl) was added to the mixture and stirred at 25 Â°C for 16 h, and the residue was purified by reverse-phase HPLC (column: Waters Xbridge C18 150 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 7â37%, 10 min) to obtain <b>19</b> (106.1 mg, 355 Î¼mol, 6.30% yield) as an off-white solid. HPLC: Rt: 1.78 min, purity: 97.2%. LC-MS: Rt: 0.752 min, <i>m</i>/<i>z</i> = 291.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz MeOD, Î´ 8.42 (d, <i>J</i> = 4.00 Hz, 1H), 7.77â7.73 (m, 1H), 7.31â7.30 (m, 1H), 7.25â7.23 (m, 1H), 3.61â3.48 (m, 2H), 2.80â2.76 (m, 2H), 2.16â2.12 (m, 2H), 1.91â1.91 (m, 2H), 1.72â1.70 (m, 2H), 1.65â1.63 (m, 2H), 1.61â1.61 (m, 2H), 1.37â1.33 (m, 4H), 1.32â1.26 (m, 2H). <sup>13</sup>C NMR: 400 MHz MeOD. Î´ 175.538, 163.333, 149.597, 138.868, 124.829, 122.881, 70.591, 38.666, 37.133, 34.973, 31.671, 30.954, 29.861, 27.016.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(4-Hydroxycyclohexyl)-6-(pyridin-3-yl)hexanamide (<b>20</b>)</h4><div class="NLM_p last">To a solution of 6-(pyridin-3-yl)hexanoic acid (<b>20d</b>, 594 mg, 3.07 mmol) in DMF (10 mL) were added HOBt (498 mg, 3.69 mmol), EDCI (883 mg, 4.61 mmol), and DIEA (1.19 g, 9.22 mmol, 1.61 mL). Then, 4-aminocyclohexan-1-ol (512 mg, 3.38 mmol, HCl) was added to the mixture, and the mixture was stirred at 25 Â°C for 16 h. LC-MS showed that <b>20d</b> was consumed, desired MS (Rt = 0.790 min) was detected, and the reaction was diluted with H<sub>2</sub>O (20 mL) and extracted with ethyl acetate (10 mL Ã 3). The combined organic layers were washed with brine (10 mL Ã 3), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give a residue, the mixture was purified by reverse-phase HPLC (column: Waters Xbridge C18 150 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 7â37%, 10 min) to afford 20 (100.5 mg, 346 Î¼mol, 11.2% yield) as an off-white solid. HPLC: Rt: 1.53 min, purity: 99.9%. LC-MS: product: Rt = 0.763 min, <i>m</i>/<i>z</i> = 291.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz MeOD, Î´ 8.38â8.37 (m, 1H), 8.35â8.34 (m, 1H), 7.70 (d, <i>J</i> = 8.0 Hz, 1H), 7.36â7.33 (m, 1H), 3.59â3.49 (m, 2H), 2.68â2.65 (m, 2H), 2.16â2.12 (m, 2H), 1.92â1.92 (m, 2H), 1.68â1.65 (m, 2H), 1.65â1.61 (m, 4H), 1.36â1.35 (m, 4H), 1.32â1.26 (m, 2H). <sup>13</sup>C NMR: 400 MHz MeOD Î´ 175.513, 150.200, 147.599, 140.262, 138.436, 125.286, 70.575, 37.109, 34.973, 33.734, 32.038, 31.671, 29.690, 26.926.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(4-Hydroxycyclohexyl)-6-(pyridin-4-yl)hexanamide (<b>21</b>)</h4><div class="NLM_p last">To a solution of 6-(pyridin-4-yl)hexanoic acid (<b>21d</b>, 100 mg, 517 Î¼mol) in DMF (1.00 mL) were added EDCI (149 mg, 776 Î¼mol), HOBt (83.9 mg, 621 Î¼mol), and DIEA (201 mg, 1.55 mmol, 270 Î¼L). Then, 4-aminocyclohexan-1-ol (86.3 mg, 569 Î¼mol, HCl) was added to the mixture and stirred at 25 Â°C for 16 h. LC-MS showed that <b>21d</b> was consumed, desired MS (Rt = 0.758 min) was detected, mixture was purified by reverse-phase HPLC (column: Waters Xbridge C18 150 Ã 25 mm Ã 5 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 8â38%, 10 min), and <b>21</b> (43.73 mg, 149 Î¼mol, 28.9% yield) was obtained as a white solid. HPLC: Rt: 1.50 min, purity: 99.7%. LC-MS: Rt = 0.748 min, <i>m</i>/<i>z</i> = 291.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz MeOD, Î´ 8.40â8.38 (m, 2H), 7.29â7.27 (m, 2H), 3.61â3.48 (m, 2H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H), 2.14 (t, <i>J</i> = 7.2 Hz, 2H), 1.95â1.91 (m, 2H), 1.87â1.84 (m, 2H), 1.68â1.61 (m, 4H), 1.36â1.35 (m, 2H), 1.35â1.26 (m, 4H). <sup>13</sup>C NMR: 400 MHz MeOD, Î´ 175.505, 154.685, 149.937, 125.853, 125. 853, 70.580, 37.100, 36.045, 34.965, 31.668, 31.182, 29.723, 26.896.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(4-Hydroxycyclohexyl)-6-(pyrimidin-4-yl)hexanamide (<b>22</b>)</h4><div class="NLM_p last">To a solution of 4-chloropyrimidine (<b>22a</b>, 1.00 g, 6.62 mmol, HCl), CuI (63.1 mg, 331 Î¼mol), Pd(PPh3)<sub>2</sub>Cl<sub>2</sub> (232 mg, 331 Î¼mol), and TEA (2.01 g, 19.9 mmol, 2.77 mL) in DMF (10.0 mL) was added methyl hex-5-ynoate (835 mg, 6.62 mmol, 1.00 equiv), the mixture was stirred at 20 Â°C for 16 h, and methyl 6-(pyrimidin-4-yl)hex-5-ynoate (<b>22b</b>, 740 mg, 3.33 mmol, 50.3% yield, 91.9% purity) was obtained as a yellow oil. To a solution of 22b (740 mg, 3.33 mmol, 1.00 equiv) in MeOH (10.0 mL) was added Pd/C (74.0 mg, 10% purity) under N<sub>2</sub>, the mixture was stirred at 25 Â°C for 16 h under H<sub>2</sub> (15 psi), and methyl 6-(pyrimidin-4-yl)hexanoate (<b>22c</b>, 734 mg, crude) was obtained as a yellow oil. To a solution of <b>22c</b> (734 mg, 3.52 mmol, 1.00 equiv) in THF (3.00 mL), MeOH (3.00 mL), and H<sub>2</sub>O (3.00 mL) was added LiOHÂ·H<sub>2</sub>O (296 mg, 7.05 mmol, 2.00 equiv), the mixture was stirred at 25 Â°C for 16 h, and 6-(pyrimidin-4-yl)hexanoic acid (<b>22d</b>, 1.20 g, crude) was obtained as a yellow solid. To a solution of <b>22d</b> (1.20 g, 6.18 mmol) in DMF (12.0 mL) were added EDCI (1.78 g, 9.27 mmol), HOBt (1.00 g, 7.41 mmol), and DIPEA (2.40 g, 18.5 mmol, 3.23 mL). Then, 4-aminocyclohexan-1-ol (1.03 g, 6.80 mmol, HCl) was added to the mixture, and the mixture was stirred at 25 Â°C for 16 h. LC-MS showed that <b>22d</b> was consumed, and desired MS (Rt = 0.689 min) was detected. The mixture was diluted with H<sub>2</sub>O (50 mL) and extracted with EtOAc (50 mL Ã 3); the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the residue; the residue was purified by reverse-phase HPLC (column: Phenomenex Gemini C18 250 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 10â30%, 15 min), and <b>22</b> (90.98 mg, 312 Î¼mol, 5.05% yield) was obtained as an off-white solid. HPLC: Rt: 1.14 min, purity: 99.9%. LC-MS: Rt = 0.657 min, <i>m</i>/<i>z</i> = 292.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz MeOD, Î´ 9.02 (s, 1H), 8.65 (d, <i>J</i> = 5.2 Hz, 1H), 7.43 (d, <i>J</i> = 5.2 Hz, 1H), 3.59â3.48 (m, 2H), 2.79 (t, <i>J</i> = 7.6 Hz, 2H), 2.15 (t, <i>J</i> = 7.6 Hz, 2H), 1.95â1.92 (m, 2H), 1.88â1.84 (m, 2H), 1.80â1.72 (m, 2H), 1.68â1.60 (m, 2H), 1.40â1.35 (m, 2H), 1.33â1.19 (m, 4H). <sup>13</sup>C NMR: 400 MHz MeOD, Î´ 175.475, 172.851, 159.152, 158.089, 122.490, 70.588, 38.344, 37.050, 34.965, 31.676, 29.781, 29.682, 26.888.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-((1r,4r)-4-Hydroxycyclohexyl)-5-phenoxypentanamide (<b>23</b>)</h4><div class="NLM_p last">To a mixture of 5-phenoxypentanoic acid (<b>23a</b>, 400 mg, 2.06 mmol) and (<i>trans</i>)-4-aminocyclohexan-1-ol (266 mg, 2.27 mmol) in DMF (4.00 mL) were added DIPEA (532 mg, 4.12 mmol, 717 Î¼L), HOBt (333 mg, 2.47 mmol), and EDCI (592 mg, 3.09 mmol), and then the mixture was stirred at 25 Â°C for 2 h. LC-MS showed that <b>23a</b> was consumed, and the desired MS (Rt = 0.848 min) was detected. The reaction mixture was quenched by addition of water (0.50 mL) and concentrated under vacuum to get a residue, which was purified by reverse-phase HPLC (column: Waters Xbridge C18 150 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 20â50%, 11.5 min) to give <b>23</b> (40.0 mg, 1.48 mmol, 7.17% yield) as an off-white solid. HPLC: Rt: 2.17 min, purity: 99.9%. LC-MS: Rt = 0.830 min, <i>m</i>/<i>z</i> = 292.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: 400 MHz, MeOD. Î´ 7.25 (t, <i>J</i> = 8.0 16.4 Hz, 2H), 6.9 (d, <i>J</i> = 8.4 Hz, 3H), 3.9 (m, 2H), 3.51â3.63 (m, 2H), 2.24 (s, 2H), 1.92â1.97 (m, 4H), 1.77â1.70 (m, 4H), 1.30â1.37 (m, 4H). <sup>13</sup>C NMR: (400 MHz, MeOD) Î´ (176, 161, 131, 122, 116, 71.2, 69.2, 37.6, 35.6, 32.3, 30.7, 24.5) ppm.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(Benzyloxy)-<i>N</i>-((1r,4r)-4-hydroxycyclohexyl)butanamide (<b>24</b>)</h4><div class="NLM_p last">The mixture of 4-(benzyloxy)butanoic acid (<b>24a</b>, 500 mg, 2.57 mmol, 454 Î¼L), DIPEA (664 mg, 5.14 mmol, 895 Î¼L), HOBt (416 mg, 3.08 mmol), EDCI (739 mg, 3.86 mmol), and (<i>trans</i>)-4-aminocyclohexan-1-ol (325 mg, 2.83 mmol) in DMF (2.00 mL) was stirred at 25 Â°C for 1 h. LC-MS showed that <b>24a</b> was consumed, and desired MS (Rt = 0.786 min) was detected. The reaction mixture was quenched with water (0.10 mL), with pH adjusted to 7 with 2 N HCl, and filtered. The filtrate was concentrated, and the crude product was purified by reverse-phase HPLC (column: Waters Xbridge C18 150 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 16â46%,11.5 min) and freeze-dried to afford <b>24</b> (40.0 mg, 137 Î¼mol, 5.33% yield) as an off-white solid. HPLC: Rt: 1.80 min, purity: 99.8%. LC-MS: Rt = 0.802 min, <i>m</i>/<i>z</i> = 292.3 (2M + Na)<sup>+</sup>. <sup>1</sup>H NMR: (400 MHz, MeOD) Î´ 7.25â7.33 (m, 5H), 4.48 (s, 2H), 3.46â3.59 (m, 4H), 2.24 (t, <i>J</i> = 7.2, 2H), 1.82â1.92 (m, 6H), 1.20â1.33 (m, 4H). <sup>13</sup>C NMR: (400 MHz, MeOD) Î´ (175, 139, 130, 129, 128, 74.0, 70.6, 70.5, 34.9, 34.1, 31.6, 27.2) ppm.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-((1r,4r)-4-Hydroxycyclohexyl)-3-phenethoxypropanamide (<b>25</b>)</h4><div class="NLM_p last">The mixture of 3-phenethoxypropanoic acid (<b>25a</b>, 700 mg, 3.60 mmol), (<i>trans</i>)-4-aminocyclohexan-1-ol (621 mg, 5.40 mmol), HOBt (583 mg, 4.32 mmol), EDCI (1.04 g, 5.40 mmol), and DIPEA (930 mg, 7.20 mmol, 1.25 mL) in DMF (7.00 mL) was stirred at 25 Â°C for 1 h. LC-MS showed that <b>25a</b> was consumed, and the desired MS (Rt = 0.794 min) was detected. The reaction mixture was quenched with water (0.10 mL), with pH adjusted to 7 with 2 N HCl, and filtered. The filtrate was concentrated, and the crude product was purified by reverse-phase HPLC (column: Waters Xbridge C18 150 Ã 50 mm Ã 10 Î¼m; mobile phase: [water (10 mM NH<sub>4</sub>HCO<sub>3</sub>)-ACN]; B%: 15â45%,11.5 min) and freeze-dried to afford <b>25</b> (40.0 mg, 133 Î¼mol, 3.72% yield) as a white solid. HPLC: Rt: 1.86 min, purity: 97.6%. LC-MS: Rt = 0.789 min, <i>m</i>/<i>z</i> = 292.4 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: (400 MHz, MeOD) Î´ 7.17â7.27 (m, 5H), 3.66â3.70 (m, 4H), 3.49â3.64 (m, 2H), 2.84 (t, <i>J</i> = 6.8, 2H), 2.37 (t, <i>J</i> = 6.0, 2H), 1.82â1.94 (m, 4H), 1.17â1.34 (m, 4H). <sup>13</sup>C NMR: (400 MHz, MeOD) Î´ (173, 140, 130, 129, 127, 73.0, 70.5, 68.1, 37.9, 37.2, 34.9, 31.5) ppm.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-((1<i>trans</i>,4<i>trans</i>)-4-Hydroxycyclohexyl)-2-(3-phenylpropoxy)acetamide (<b>26</b>)</h4><div class="NLM_p last">The mixture of 2-(3-phenylpropoxy)acetic acid (<b>26a</b>, 1.00 g, 5.15 mmol), (<i>trans</i>)-4-aminocyclohexan-1-ol (652 mg, 5.67 mmol, 1.10 equiv), T3P (2.29 g, 7.21 mmol, 2.14 mL, 1.40 equiv), and TEA (1.56 g, 15.4 mmol, 2.15 mL, 3.00 equiv) in DMF (10.0 mL) was stirred at 25 Â°C for 1 h. LC-MS showed that <b>26a</b> was consumed, and desired MS (Rt = 0.797 min) was detected. The mixture was quenched with water (1.00 mL), with pH adjusted to 7 with 2 N HCl, and filtered. The filtrate was concentrated, and the crude product was purified by reverse-phase HPLC (column: Phenomenex Luna C18 75 Ã 30 mm Ã 3 Î¼m; mobile phase: [water (0.05% HCl)-ACN]; B%: 29â49%, 7.5 min) and freeze-dried to afford <b>26</b> (40.0 mg, 134 Î¼mol, 2.62% yield) as a white solid. HPLC: Rt: 2.24 min, purity: 98.3%. LC-MS: Rt = 0.825 min, <i>m</i>/<i>z</i> = 292.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: (400 MHz, MeOD) Î´ 7.24â7.28 (m, 2H), 7.15â7.20 (m, 3H), 3.88 (s, 2H), 3.68â3.70 (m, 1H), 3.53â3.56 (m, 1H), 3.50 (t, <i>J</i> = 6.4 Hz, 2H), 2.70 (t, <i>J</i> = 7.6 Hz, 2H), 1.91â1.96 (m, 4H), 1.86â1.87 (m, 2H), 1.33â1.38 (m, 4H). <sup>13</sup>C NMR: (400 MHz, MeOD) Î´ (172, 143, 130, 129, 127, 72.1, 71.1, 70.4, 34.9, 33.3, 32.3, 31.4) ppm.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-Phenylbutyl ((1<i>trans</i>,4<i>trans</i>)-4-hydroxycyclohexyl)carbamate (<b>27</b>)</h4><div class="NLM_p last">A solution of 4-phenylbutyl carbonochloridate (<b>27a</b>, 14.2 g, 66.7 mmol), (<i>trans</i>)-4-aminocyclohexan-1-ol (11.5 g, 100 mmol, 1.50 equiv), and DIPEA (17.2 g, 133 mmol, 23.2 mL, 2.00 equiv) in DCM (142 mL) was stirred at 25 Â°C for 1 h. LC-MS showed that <b>27a</b> was consumed, and the desired MS (Rt = 0.884 min) was detected. The reaction mixture was quenched with water (150 mL) and extracted with DCM (100 mL Ã 3). The organic layer was washed with brine (200 mL Ã 4), with pH adjusted to 7 with 1 N HCl; dried over Na<sub>2</sub>SO<sub>4</sub>; and filtered. The filtrate was concentrated, the crude product was purified by reverse-phase HPLC (column: Phenomenex luna C18 150 Ã 40 mm Ã 15 Î¼m; mobile phase: [water (0.05% HCl)-ACN]; B%: 31â61%,11 min) to obtain <b>27</b> (35.0 mg, 119 Î¼mol, 0.20% yield) as a white solid. HPLC: Rt: 2.54 min, purity: 99.7%. LC-MS: Rt = 0.886 min, <i>m</i>/<i>z</i> = 292.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR: (400 MHz, MeOD) Î´ 7.12â7.26 (m, 5H), 4.02 (t, <i>J</i> = 6.0, 2H), 3.47â3.52 (m, 1H), 3.33â3.35 (m, 1H), 2.63 (t, <i>J</i> = 7.2, 2H), 1.88â1.94 (m, 4H), 1.64â1.66 (m, 4H), 1.1.23â1.31 (m, 4H). <sup>13</sup>C NMR: (400 MHz, MeOD) Î´ (158, 143, 130, 129, 126, 70.5, 65.6, 50.7, 36.5, 34.9, 31.9, 29.9, 29.1) ppm.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> PAINS Analysis</h3><div class="NLM_p last">All reported compounds were screened for PAINS through the FAF-Drugs4 website tool (<a href="https://mobyle.rpbs.univ-paris-diderot.fr/cgi-bin/portal.py#welcome" class="extLink">https://mobyle.rpbs.univ-paris-diderot.fr/cgi-bin/portal.py#welcome</a>), and none were identified as pan-assay interference compounds.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Animals</h3><div class="NLM_p last">Rosa-STOP-mMFN Thr105Met (T105M) mice (C57BL/6 Gt(ROSA)26 Sortm1 (CAG-MFN2*T105M)Dple/J) from The Jackson Laboratory (Bar Harbor, Maine; Stock no.: 025322) were crossed to HB9-Cre mice (B6.129S1-Mnx1tm4(cre)Tmj/J) from The Jackson Laboratory (Stock no.: 006600) to generate motor-neuron-targeted MFN2 T105M mice. Mouse procedures were approved by the Institutional Animal Care and Use Committee of Washington University in St. Louis, Protocol ID: 19-0910. <i>In vivo</i> and <i>in vitro</i> pharmacokinetic analyses involving mouse and human tissues were approved by the Institutional Animal Care and Use Committee, Shanghai Site (IACUC-SH) (WuXi Corporate Committee for Animal Research Ethics (WX-CCARE)) and done by WuXi Apptec Co. Ltd. (Shanghai, China). Compounds (2 mg/mL) were dissolved in 10% DMSO/90% (30% HP-b-CD (2-hydroxyproryl-Î²-cyclodextrin; Sigma, 332607)) solution and administered to 7â9 week old male CD-1 mice from SIPPR/BK Laboratory Animal Co. Ltd., Shanghai, China (15 mice per compound) by tail vein (10 mg/kg) or subcutaneously via an osmotic mini-pump (60 mg/kg/day Ã 3 days).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Functional Evaluation of Mitofusin Agonist Fusogenicity</h3><div class="NLM_p">This was performed in MFN1- or MFN2-deficient MEFs purchased from ATCC (Cat: #CRL-2992, CRL-2993) and cultured at 37 Â°C, 5% CO<sub>2</sub>-95% air in Dulbeccoâs minimal essential medium (DMEM) containing glucose (4.5 g/L) with 10% (v/v) fetal bovine serum (FBS; Gibco, 26140-079), 1Ã nonessential amino acids (Gibco, 11130051), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Corning, 34717007), and 1% (v/v) penicillin/streptomycin (Gibco, 15140-122). For screening assays, cells were seeded on day 1 in 6-well plates at a density of 1 Ã 10<sup>4</sup> cells/mL, and small molecules were added at a final concentration of 1 Î¼M (1:1000 dilution from 1 mM stick in DMSO) overnight; 1 Î¼M <b>2</b> was included in all experiments as a positive control. Mitochondria were stained with MitoTracker Orange (200 nM; M7510; Invitrogen, Carlsbad, CA), and nuclei were stained with Hoechst (10 Î¼g/mL; Invitrogen, Thermo Fisher Scientific Cat: #H3570). Images were acquired at room temperature as previously described<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> on a Nikon Ti confocal microscope using a 60 Ã 1.3 NA oil-immersion objective in KrebsâHenseleit buffer (138 NaCl, 3.7 nM KCL, 1.2 nM KH<sub>2</sub>PO<sub>4</sub>, 15 nM glucose, 20 nM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>â²-ethanesulfonic acid (HEPES), pH 7.2â7.5, and 1 mM CaCl<sub>2</sub>). Laser excitation was 549 nm with emission at 590 nm for MitoTracker Orange and 306 nm with emission at 405 nm for Hoechst. Images were analyzed using ImageJ,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and fusogenicity was quantified as mitochondrial aspect ratios (length/width).</div><div class="NLM_p last">Doseâresponse studies were performed using eight compound concentrations (0.5 nMâ5 Î¼M). Mitochondrial aspect ratios were indexed to the maximal response elicited by <b>2</b> or <b>13</b>, and response curves were interpolated by the sigmoidal model using Prism 8 software. EC<sub>50</sub> values are reported as mean with 95% confidence limits for three or four experiments assessing â¼300 mitochondria per condition.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Functional Evaluation of Mitofusin Agonist Effect on Mitochondrial Depolarization</h3><div class="NLM_p last">Cultured WT, Mfn2 KO, Mfn1 KO, and DKO MEFs (Cat: #CRL-2994) were treated with different compounds (1 Î¼M) for 24 h; then stained with tetramethylrhodamine ethyl ester (TMRE, 200 nM, Invitrogen Thermo Fisher Scientific Cat: #T669), MitoTracker Green (200 nM; Invitrogen, Thermo Fisher Scientific Cat: #M7514), and Hoechst (10 Î¼g/mL; Invitrogen, Thermo Fisher Scientific Cat: #H3570) for 30 min at 37 Â°C in 5% CO<sub>2</sub>â95% air; and washed twice in phosphate-buffered saline (PBS). Images were acquired at room temperature on a Nikon Ti confocal microscope using either 60 Ã 1.3 NA oil-immersion objective, in KrebsâHenseleit buffer (138 NaCl, 3.7 nM KCL, 1.2 nM KH<sub>2</sub>PO<sub>4</sub>, 15 nM glucose, 20 nM HEPES, pH 7.2â7.5, and 1 mM CaCl<sub>2</sub>); laser excitation was 488 nm with emission at 510 nm for MitoTracker Green, 549 nm with emission at 590 nm for TMRE, and 306 nm with emission 405 nm for Hoecsht. Mitochondrial depolarization was reported as % number of green mitochondria/number of yellow + green mitochondria using ImageJ.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> HB9-Cre/Mfn2 T105M Mouse Nerve Motility Studies</h3><div class="NLM_p last">With all investigators blinded, 12â14 week old male HB9-Cre/Mfn2 T105M CMT2A mice<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> received <b>13</b> (50 mg/kg, 10% DMSO/90% (30% HP-b-CD), <i>N</i> = 2) or vehicle (<i>N</i> = 2) by oral gavage using sterile animal feeding needles (20G Ã 1.2â³, Cadence Science, Cat: #9931). After 6 h, the mice were sacrificed and their sciatic nerves were dissected and placed in organ culture (Neurobasal medium without phenol red, Thermo Fisher Scientific; room temp.). Axonal mitochondria were labeled with tetramethylrhodamine ethyl ester (TMRE, Thermo Fisher Scientific, Cat: #T669; 200 Î¼M, 30 min, room temp.), and time-lapse (1 frame/5 s) confocal microscopy images were acquired at 37 Â°C on a Nikon A1Rsi confocal microscope using a 40Ã oil-immersion objective. Kymographs and quantitative data were generated using an ImageJ plug-in.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Data are mean Â± SD; <i>p</i> values were calculated using Studentâs <i>t</i>-test.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> FRET Studies of MFN2 Conformation</h3><div class="NLM_p last">These studies were performed as described<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> using hMFN2-FRET expressing mitochondria isolated from Mfn1 and Mfn2 double-null MEFs in a total volume of 100 Î¼L of 10 mM Tris-MOPS (pH 7.4), 10 mM EGTA/Tris, and 200 mM sucrose in a 96-well assay plate (Costar 3916). Then, 5 Î¼M mitofusin agonist/antagonist peptides in H20 or 1 Î¼M <b>2</b>, <b>13A</b>, or <b>13B</b> in DMSO was added for 1 and 4 h; untreated mitochondria were controls. FRET (normalized to Cerulean) signals was acquired on a Tecan Safire II multimode plate reader: FRET: excitation, 433/8 nm; emission, 528/8 nm; Cerulean: excitation, 433/8 nm; emission, 475/8 nm.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>In Vitro</i> Pharmacokinetic Analyses</h3><div class="NLM_p last"><i>In vitro</i> pharmacokinetic analyses of mitofusin agonists were performed in duplicate using standard methods by WuXi Apptec Co. Ltd. (Shanghai, China). Kinetic solubility was determined by UV absorbance of 1, 20, and 200 Î¼M solutions in 50 mM phosphate buffer, pH 7.4, shaken for 24 h at room temperature. Plasma protein binding was measured by equilibrium dialysis; % bound = (1 â [free compound in dialysate]/[total compound in retentate]) Ã 100. Plasma stability of 2 Î¼M compounds in clarified freezeâthawed plasma was assessed by LC-MS/MS of supernatants after protein precipitation; 120 min data were reported for studies including 0, 10, 30, 60, and 120 min. Microsome stability of 1 Î¼M compounds in liver microsomes (0.5 mg/mL) after 0, 5, 10, 20, 30, and 60 min incubation was assessed by LC-MS/MS of reaction extracts. The passive artificial bloodâbrain barrier membrane permeability assay (PAMPA-BBB) was performed using 150 Î¼L of 10 Î¼M compounds (5% DMSO) added to poly(vinylidene difluoride) (PVDF) membranes precoated with 5 Î¼L of 1% brain polar lipid extract (Porcine)/dodecane mixture and incubated for 4 h at room temperature with shaking at 300 rpm. Donor and acceptor samples were analyzed by LC-MS/MS.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>In Vivo</i> Pharmacokinetic Analyses</h3><div class="NLM_p last"><i>In vivo</i> pharmacokinetic analyses were performed in duplicate or triplicate using standard methods by WuXi Apptec Co. Ltd. (Shanghai, China). Compounds were dissolved (2 mg/mL) in 10% DMSO/90% (30% HP-b-CD) and administered by tail vein (10 mg/kg) or subcutaneously via an osmotic mini-pump (60 mg/kg/day Ã 3 days) to 7â9 week old male CD-1 mice (SLAC Laboratory Animal Co. Ltd., Shanghai, China or SIPPR/BK Laboratory Animal Co. Ltd., Shanghai, China; 15 mice were used for each compound). Blood and brain samples were analyzed in duplicate by LC-MS/MS. Plasma and brain concentration vs time data were analyzed by noncompartmental approaches using the Phoenix WinNonlin 6.3 software program, data are presented as mean from at least three mice for each condition.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Study of <i>In Vitro</i> Bidirectional Permeability across the MDR1-MDCKI Cell Monolayer</h3><div class="NLM_p last">Test compounds were diluted with the transport buffer (Hankâs balanced salt solution (HBSS) with 10 mM HEPES) from DMSO stock solution to a concentration of 2 Î¼M (DMSO < 1%) and applied to the apical or basolateral side of the cell monolayer. Reference compounds were diluted with the transport buffer (HBSS with 10 mM HEPES, pH 7.4) from stock solution to a concentration of 2 Î¼M (DMSO < 1%) and applied to the apical or basolateral side of the cell monolayer. Permeation of the test compounds from the A to B direction or the B to A direction was determined in duplicate with/without the P-gp inhibitor (GF120918, 10 Î¼M). Digoxin was tested at 10 Î¼M in the presence or absence of 10 Î¼M GF120918 bidirectionally as well, while nadolol and metoprolol were tested at 2 Î¼M in the absence of GF120918 in the A to B direction in duplicate. The plate was incubated for 1.5 h in a CO<sub>2</sub> incubator at 37 Â± 1 Â°C with 5% CO<sub>2</sub> at saturated humidity without shaking. In addition, the efflux ratio of each compound was also determined. Test and reference compounds were quantified by LC-MS/MS analysis based on the peak area ratio of analyte/IS. After the transport assay, the Lucifer yellow rejection assay was applied to determine the cell monolayer integrity. Buffers were removed from both apical and basolateral chambers, followed by the addition of 75 Î¼L of 100 Î¼M lucifer yellow in transport buffer and 250 Î¼L of transport buffer in apical and basolateral chambers, respectively. The plate was incubated for 30 min at 37 Â°C with 5% CO<sub>2</sub> and 95% relative humidity without shaking. After 30 min incubation, 20 Î¼L of lucifer yellow samples was taken from the apical sides, followed by the addition of 60 Î¼L of transport buffer. Then, 80 Î¼L of lucifer yellow samples was taken from the basolateral sides. The relative fluorescence unit (RFU) of lucifer yellow was measured at 425/528 nm (excitation/emission) with an Envision plate reader, and data were presented as mean from two independent experiments.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00366" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00366?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00366</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Correlation between <i>in vitro</i> human liver microsome stability and PAMPA-BBB Pe of <b>1</b> analogues (Figure S1); HPLCâHRMSâNMR chromatography of <b>13</b> (Figure S2); HPLCâLC-MSâNMR chromatography of <b>13A</b> and <b>13B</b> (Figure S3); <b>13B</b> selectivity mini-panel assay (Table S1), CYP inhibition by <b>13B</b> in human liver microsomes (Tables S2âS7), <b>13B</b> AMES test (Table S8), P-gp studies of <b>13B</b> (Table S9); HPLC (<b>1â5</b> and <b>8â27</b>) or LC-MS (<b>6</b> and <b>7</b>) chromatography (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula string for all of the final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf">jm0c00366_si_001.pdf (6.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_002.csv">jm0c00366_si_002.csv (1.88 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00366" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerald W. Dorn</span> - <span class="hlFld-Affiliation affiliation">Center
for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Mitochondria
in Motion, Inc. 4340
Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United
States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0c6b68637e624c7b797f786022696879"><span class="__cf_email__" data-cfemail="bfd8dbd0cdd1ffc8cacccbd391dadbca">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiawei Dang</span> - <span class="hlFld-Affiliation affiliation">Department
of Cardiology, The First Affiliated Hospital
of Xiâan Jiao Tong University, Xiâan 710061, Shaanxi, China</span>;Â 
    <span class="hlFld-Affiliation affiliation">Center
for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0343-7107" title="Orcid link">http://orcid.org/0000-0002-0343-7107</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lihong Zhang</span> - <span class="hlFld-Affiliation affiliation">Center
for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonietta Franco</span> - <span class="hlFld-Affiliation affiliation">Center
for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Mitochondria
in Motion, Inc. 4340
Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiajia Li</span> - <span class="hlFld-Affiliation affiliation">Center
for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agostinho G. Rocha</span> - <span class="hlFld-Affiliation affiliation">Center
for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, Missouri 63110, United States</span>;Â 
    <span>Present Address:
                        (A.G.R.) Syneos Health, 301D College Road East, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sriram Devanathan</span> - <span class="hlFld-Affiliation affiliation">Mitochondria
in Motion, Inc. 4340
Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland E. Dolle</span> - <span class="hlFld-Affiliation affiliation">Mitochondria
in Motion, Inc. 4340
Duncan Avenue, Suite 216, St. Louis, Missouri 63110, United
States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, 660 S. Euclid Ave. St. Louis, Missouri 63110, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5574-6019" title="Orcid link">http://orcid.org/0000-0001-5574-6019</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter R. Bernstein</span> - <span class="hlFld-Affiliation affiliation">Harrington
Discovery Institute at University Hospitals, 11407 Euclid Ave, Cleveland, Ohio 44106, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0407-9150" title="Orcid link">http://orcid.org/0000-0003-0407-9150</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>G.W.D. conceived of the compounds. G.W.D. and P.R.B. designed the research. G.W.D., P.R.B. and X.D. wrote the manuscript. X.D. and L.Z. performed in vitro fusogenicity studies. A.F. performed MFN2 FRET studies. A.F. and J.L. performed ex vivo sciatic nerve studies. A.G.R., S.D., R.E.D., and P.R.B. provided input into compound analysis.</p></li><li><span class="author-information-subsection-header">Funding</span><p>X.D. was supported by the China Scholarship Council and G.W.D. by NIH R41NS113642, R41NS115184, R35135736, and Research Grant 628906 from the Muscular Dystrophy Association. G.W.D. is the Philip and Sima K. Needleman-endowed Professor at Washington University in St. Louis and a Scholar Innovator awardee of the Harrington Discovery Institute.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): G.W.D. is an inventor on patent applications PCT/US18/028514 submitted by Washington University and PCT/US19/46356 submitted by Mitochondria Emotion, Inc that cover the use of small molecule mitofusin agonists to treat chronic neurodegenerative diseases, and is the founder of Mitochondria in Motion, Inc., a Saint Louis based biotech R&D company focused on enhancing mitochondrial trafficking and fitness in neurodegenerative diseases. The other authors declare no competing interests. Studies were performed under terms of an MTA between Mitochondria in Motion, Inc. and Washington University in St. Louis.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">MFN</td><td class="NLM_def"><p class="first last">mitofusin</p></td></tr><tr><td class="NLM_term">CMT2A</td><td class="NLM_def"><p class="first last">Charcot-Marie-Tooth disease type 2A</p></td></tr><tr><td class="NLM_term">PPIs</td><td class="NLM_def"><p class="first last">peptideâpeptide interactions</p></td></tr><tr><td class="NLM_term">PAMPA-BBB</td><td class="NLM_def"><p class="first last">passive artificial bloodâbrain barrier membrane permeability assay</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">s.c.</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine amino transferase</p></td></tr><tr><td class="NLM_term">MAO-A</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">PPh3</td><td class="NLM_def"><p class="first last">triphenylphosphine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">r.t.</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">1,1â²-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-<i>N</i>â²-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">MEFs</td><td class="NLM_def"><p class="first last">mouse embryonic fibroblasts</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">FÃ¶rster resonance energy transfer</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">LC-MS</td><td class="NLM_def"><p class="first last">liquid chromatography tandem mass spectrometry</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Emerging functions of mammalian mitochondrial fusion and fission</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R283</span>â <span class="NLM_lpage">R289</span>, <span class="refDoi">Â DOI: 10.1093/hmg/ddi270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1093%2Fhmg%2Fddi270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=16244327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=R283-R289&author=H.+Chenauthor=D.+C.+Chan&title=Emerging+functions+of+mammalian+mitochondrial+fusion+and+fission&doi=10.1093%2Fhmg%2Fddi270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging functions of mammalian mitochondrial fusion and fission</span></div><div class="casAuthors">Chen, Hsiuchen; Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">Rev. Issue 2</span>),
    <span class="NLM_cas:pages">R283-R289</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria provide a myriad of services to the cell, including energy prodn., calcium buffering and regulation of apoptosis.  How these diverse functions are coordinated among the hundreds of mitochondria in a given cell is largely unknown, but is probably dependent on the dynamic nature of mitochondria.  In this review, we explore the latest developments in mitochondrial dynamics in mammals.  These studies indicate that mitofusins and OPA1 are essential for mitochondrial fusion, whereas Fis1 and Drp1 are essential for mitochondrial fission.  The overall morphol. of the mitochondrial population depends on the relative activities of these two sets of proteins.  In addn. to the regulation of mitochondrial shape, these mols. also play important roles in cell and tissue physiol.  Perturbation of mitochondrial fusion results in defects in mitochondrial membrane potential and respiration, poor cell growth and increased susceptibility to cell death.  These cellular observations may explain why mitochondrial fusion is essential for embryonic development.  Two inherited neuropathies, Charcot-Marie-Tooth type 2A and autosomal dominant optic atrophy, are caused by mutations in mitofusin 2 and OPA1, suggesting that proper regulation of mitochondrial dynamics is particularly vital to neurons.  Mitochondrial fission accompanies several types of apoptotic cell death and appears important for progression of the apoptotic pathway.  These studies provide insight into how mitochondria communicate with one another to coordinate mitochondrial function and morphol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8a4G4OhRQBbVg90H21EOLACvtfcHk0lhjLatzjI365w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL3K&md5=f5fd80818370c580070e9adf12d8cce3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi270%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DEmerging%2520functions%2520of%2520mammalian%2520mitochondrial%2520fusion%2520and%2520fission%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2005%26volume%3D14%26spage%3DR283%26epage%3DR289%26doi%3D10.1093%2Fhmg%2Fddi270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebastian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacin, M.</span></span> <span> </span><span class="NLM_article-title">The molecular machinery of mitochondrial fusion and fission: An opportunity for drug discovery?</span>. <i>Curr. Opin. Drug Discovery Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">597</span>â <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=19736619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=597-606&author=A.+Zorzanoauthor=D.+Sebastianauthor=J.+Segalesauthor=M.+Palacin&title=The+molecular+machinery+of+mitochondrial+fusion+and+fission%3A+An+opportunity+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular machinery of mitochondrial fusion and fission: an opportunity for drug discovery?</span></div><div class="casAuthors">Zorzano, Antonio; Sebastian, David; Segales, Jessica; Palacin, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The mitochondria form dynamic organized networks or filaments that are controlled by fusion and fission events.  A balance between mitochondrial fusion and fission is crucial for the correct function of these organelles.  Thus, a detailed characterization of the proteins involved in mitochondrial fusion and fission, and the study of the mechanisms that regulate these two processes, would contribute to elucidating how this balance is achieved.  In this regard, alterations in some of the proteins that participate in mitochondrial dynamics are linked to human pathol.  In addn., exptl. data support the view that mitochondrial metab. is regulated via the manipulation of the proteins involved in mitochondrial dynamics, particularly the mitofusin 2 protein.  This review evaluates the potential of mitochondrial fusion and fission proteins as targets for drug discovery, with an emphasis on mitofusin 2.  The pharmacol. modulation of mitochondrial dynamics may be beneficial for the treatment of specific disorders of mitochondrial dynamics and mitochondrial-inherited diseases, as well as in complex diseases with a central mitochondrial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsB7tv-bara7Vg90H21EOLACvtfcHk0lhjLatzjI365w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL7N&md5=067c76ea35c2676128a142f728367d4b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZorzano%26aufirst%3DA.%26aulast%3DSebastian%26aufirst%3DD.%26aulast%3DSegales%26aufirst%3DJ.%26aulast%3DPalacin%26aufirst%3DM.%26atitle%3DThe%2520molecular%2520machinery%2520of%2520mitochondrial%2520fusion%2520and%2520fission%253A%2520An%2520opportunity%2520for%2520drug%2520discovery%253F%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muyderman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">2191</span>â <span class="NLM_lpage">2205</span>, <span class="refDoi">Â DOI: 10.1111/bph.12476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1111%2Fbph.12476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=24148000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFaqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=2191-2205&author=H.+Muydermanauthor=T.+Chen&title=Mitochondrial+dysfunction+in+amyotrophic+lateral+sclerosis+-+a+valid+pharmacological+target%3F&doi=10.1111%2Fbph.12476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?</span></div><div class="casAuthors">Muyderman, H.; Chen, T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2191-2205</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by the selective death of upper and lower motor neurons which ultimately leads to paralysis and ultimately death.  Pathol. changes in ALS are closely assocd. with pronounced and progressive changes in mitochondrial morphol., bioenergetics and calcium homeostasis.  Converging evidence suggests that impaired mitochondrial function could be pivotal in the rapid neurodegeneration of this condition.  In this review, we provide an update of recent advances in understanding mitochondrial biol. in the pathogenesis of ALS and highlight the therapeutic value of pharmacol. targeting mitochondrial biol. to slow disease progression.  Linked Articles : This article is part of a themed issue on Mitochondrial Pharmacol.: Energy, Injury & Beyond.  To view the other articles in this issue visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Ehlm2clcO7Vg90H21EOLACvtfcHk0ljMpO5Pb35lfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFaqu7w%253D&md5=e91a269ad2bbac0704c01d31a76b186a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12476%26sid%3Dliteratum%253Aachs%26aulast%3DMuyderman%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DMitochondrial%2520dysfunction%2520in%2520amyotrophic%2520lateral%2520sclerosis%2520-%2520a%2520valid%2520pharmacological%2520target%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D2191%26epage%3D2205%26doi%3D10.1111%2Fbph.12476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ZÃ¼chner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mersiyanova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissar-Tadmouri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dadali, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zappia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patitucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evgrafov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonghe, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pericak-Vance, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quattrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span> <span> </span><span class="NLM_article-title">Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">449</span>â <span class="NLM_lpage">451</span>, <span class="refDoi">Â DOI: 10.1038/ng1341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fng1341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=15064763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFSntrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=449-451&author=S.+Z%C3%BCchnerauthor=I.+V.+Mersiyanovaauthor=M.+Mugliaauthor=N.+Bissar-Tadmouriauthor=J.+Rochelleauthor=E.+L.+Dadaliauthor=M.+Zappiaauthor=E.+Nelisauthor=A.+Patitucciauthor=J.+Senderekauthor=Y.+Parmanauthor=O.+Evgrafovauthor=P.+D.+Jongheauthor=Y.+Takahashiauthor=S.+Tsujiauthor=M.+A.+Pericak-Vanceauthor=A.+Quattroneauthor=E.+Battalogluauthor=A.+V.+Polyakovauthor=V.+Timmermanauthor=J.+M.+Schroderauthor=J.+M.+Vance&title=Mutations+in+the+mitochondrial+GTPase+mitofusin+2+cause+Charcot-Marie-Tooth+neuropathy+type+2A&doi=10.1038%2Fng1341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A</span></div><div class="casAuthors">Zuechner, Stephan; Mersiyanova, Irina V.; Muglia, Maria; Bissar-Tadmouri, Nisrine; Rochelle, Julie; Dadali, Elena L.; Zappia, Mario; Nelis, Eva; Patitucci, Alessandra; Senderek, Jan; Parman, Yesim; Evgrafov, Oleg; De Jonghe, Peter; Takahashi, Yuji; Tsuji, Shoij; Pericak-Vance, Margaret A.; Quattrone, Aldo; Battologlu, Esra; Polyakov, Alexander V.; Timmerman, Vincent; Schroeder, J. Michael; Vance, Jeffery M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-451</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report missense mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) in seven large pedigrees affected with Charcot-Marie-Tooth neuropathy type 2A (CMT2A).  Although a mutation in kinesin family member 1B-Î² (KIF1B) was assocd. with CMT2A in a single Japanese family, we found no mutations in KIF1B in these seven families.  Because these families include all published pedigrees with CMT2A and are ethnically diverse, we conclude that the primary gene mutated in CMT2A is MFN2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE2APEzpgnCLVg90H21EOLACvtfcHk0ljMpO5Pb35lfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFSntrY%253D&md5=d7b2202b474ec9be9238300cd77861f3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fng1341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1341%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCchner%26aufirst%3DS.%26aulast%3DMersiyanova%26aufirst%3DI.%2BV.%26aulast%3DMuglia%26aufirst%3DM.%26aulast%3DBissar-Tadmouri%26aufirst%3DN.%26aulast%3DRochelle%26aufirst%3DJ.%26aulast%3DDadali%26aufirst%3DE.%2BL.%26aulast%3DZappia%26aufirst%3DM.%26aulast%3DNelis%26aufirst%3DE.%26aulast%3DPatitucci%26aufirst%3DA.%26aulast%3DSenderek%26aufirst%3DJ.%26aulast%3DParman%26aufirst%3DY.%26aulast%3DEvgrafov%26aufirst%3DO.%26aulast%3DJonghe%26aufirst%3DP.%2BD.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DS.%26aulast%3DPericak-Vance%26aufirst%3DM.%2BA.%26aulast%3DQuattrone%26aufirst%3DA.%26aulast%3DBattaloglu%26aufirst%3DE.%26aulast%3DPolyakov%26aufirst%3DA.%2BV.%26aulast%3DTimmerman%26aufirst%3DV.%26aulast%3DSchroder%26aufirst%3DJ.%2BM.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26atitle%3DMutations%2520in%2520the%2520mitochondrial%2520GTPase%2520mitofusin%25202%2520cause%2520Charcot-Marie-Tooth%2520neuropathy%2520type%25202A%26jtitle%3DNat.%2520Genet.%26date%3D2004%26volume%3D36%26spage%3D449%26epage%3D451%26doi%3D10.1038%2Fng1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feely, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siskind, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sottile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shy, M. E.</span></span> <span> </span><span class="NLM_article-title">MFN2 mutations cause severe phenotypes in most patients with CMT2A</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1690</span>â <span class="NLM_lpage">1696</span>, <span class="refDoi">Â DOI: 10.1212/WNL.0b013e31821a441e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1212%2FWNL.0b013e31821a441e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=21508331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFajtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=1690-1696&author=S.+M.+Feelyauthor=M.+Lauraauthor=C.+E.+Siskindauthor=S.+Sottileauthor=M.+Davisauthor=V.+S.+Gibbonsauthor=M.+M.+Reillyauthor=M.+E.+Shy&title=MFN2+mutations+cause+severe+phenotypes+in+most+patients+with+CMT2A&doi=10.1212%2FWNL.0b013e31821a441e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">MFN2 mutations cause severe phenotypes in most patients with CMT2A</span></div><div class="casAuthors">Feely S M E; Laura M; Siskind C E; Sottile S; Davis M; Gibbons V S; Reilly M M; Shy M E</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1690-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Charcot-Marie-Tooth disease type 2A (CMT2A), the most common form of CMT2, is caused by mutations in the mitofusin 2 gene (MFN2), a nuclear encoded gene essential for mitochondrial fusion and tethering the endoplasmic reticulum to mitochondria.  Published CMT2A phenotypes have differed widely in severity.  METHODS:  To determine the prevalence and phenotypes of CMT2A within our clinics we performed genetic testing on 99 patients with CMT2 evaluated at Wayne State University in Detroit and on 27 patients with CMT2 evaluated in the National Hospital for Neurology and Neurosurgery in London.  We then preformed a cross-sectional analysis on our patients with CMT2A.  RESULTS:  Twenty-one percent of patients had MFN2 mutations.  Most of 27 patients evaluated with CMT2A had an earlier onset and more severe impairment than patients without CMT2A.  CMT2A accounted for 91% of all our severely impaired patients with CMT2 but only 11% of mildly or moderately impaired patients.  Twenty-three of 27 patients with CMT2A were nonambulatory prior to age 20 whereas just one of 78 non-CMT2A patients was nonambulatory after this age.  Eleven patients with CMT2A had a pure motor neuropathy while another 5 also had profound proprioception loss.  MFN2 mutations were in the GTPase domain, the coiled-coil domains, or the highly conserved R3 domain of the protein.  CONCLUSIONS:  We find MFN2 mutations particularly likely to cause severe neuropathy that may be primarily motor or motor accompanied by prominent proprioception loss.  Disruption of functional domains of the protein was particularly likely to cause neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSO2mnZh2OgS0fW6udTcc2eaUdXZ0jh5V1rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFajtA%253D%253D&md5=43dce23aa6d6c0fab2e68b85d90551d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1212%2FWNL.0b013e31821a441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0b013e31821a441e%26sid%3Dliteratum%253Aachs%26aulast%3DFeely%26aufirst%3DS.%2BM.%26aulast%3DLaura%26aufirst%3DM.%26aulast%3DSiskind%26aufirst%3DC.%2BE.%26aulast%3DSottile%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DGibbons%26aufirst%3DV.%2BS.%26aulast%3DReilly%26aufirst%3DM.%2BM.%26aulast%3DShy%26aufirst%3DM.%2BE.%26atitle%3DMFN2%2520mutations%2520cause%2520severe%2520phenotypes%2520in%2520most%2520patients%2520with%2520CMT2A%26jtitle%3DNeurology%26date%3D2011%26volume%3D76%26spage%3D1690%26epage%3D1696%26doi%3D10.1212%2FWNL.0b013e31821a441e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fusion is essential for organelle function and cardiac homeostasis</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1327</span>â <span class="NLM_lpage">1331</span>, <span class="refDoi">Â DOI: 10.1161/CIRCRESAHA.111.258723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1161%2FCIRCRESAHA.111.258723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22052916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsF2jsrrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2011&pages=1327-1331&author=Y.+Chenauthor=Y.+Liuauthor=G.+W.+Dorn&title=Mitochondrial+fusion+is+essential+for+organelle+function+and+cardiac+homeostasis&doi=10.1161%2FCIRCRESAHA.111.258723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Fusion is Essential for Organelle Function and Cardiac Homeostasis</span></div><div class="casAuthors">Chen, Yun; Liu, Yingqiu; Dorn, Gerald W., II</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1327-1331</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: Mitochondria constitute 30% of myocardial mass.  Mitochondrial fusion and fission appear essential for health of most tissues.  Mitochondrial fission occurs in neonatal cardiomyocyte and is implicated in cardiomyocyte death.  Mitochondrial fusion has not been obsd. in postmitotic myocytes of adult hearts, and its occurrence and function in this context are controversial.  Objective: Det. the consequences on organelle and organ function of disrupting cardiomyocyte mitochondrial fusion in vivo.  Methods and results: The murine mfn1 and mfn2 genes, encoding mitofusins (Mfn) 1 and 2 that mediate mitochondrial tethering and outer mitochondrial membrane fusion, were interrupted by Cre-mediated excision of essential exons in neonatal (Nkx2.5-Cre) and adult (MYH6 modified estrogen receptor-Cre-modified estrogen receptor plus tamoxifen or Raloxifene) hearts.  Embryonic combined Mfn1/Mfn2 ablation was lethal after e9.5.  Conditional combined Mfn1/Mfn2 ablation in adult hearts induced mitochondrial fragmentation, cardiomyocyte and mitochondrial respiratory dysfunction, and rapidly progressive and lethal dilated cardiomyopathy.  Before heart failure developed, cardiomyocyte shortening and calcium cycling were unaffected by absence of Mfn1 and Mfn2.  Based on the time course over which fusion-defective mitochondrial size decreases, a mitochondrial fusion/fission cycle in adult mouse hearts occurs approx. every 16 days.  Conclusions: Mitochondrial fusion in adult cardiac myocytes is necessary to maintain normal mitochondrial morphol. and is essential for normal cardiac respiratory and contractile function.  Interruption of mitochondrial fusion causes lethal cardiac failure at a time corresponding to 3 or 4 cycles of unopposed mitochondrial fission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNIgpkMtE3ELVg90H21EOLACvtfcHk0lhdVCnG5F1kUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsF2jsrrN&md5=86b79fe444ca6fbe81c99e1d7286e04b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.111.258723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.111.258723%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMitochondrial%2520fusion%2520is%2520essential%2520for%2520organelle%2520function%2520and%2520cardiac%2520homeostasis%26jtitle%3DCirc.%2520Res.%26date%3D2011%26volume%3D109%26spage%3D1327%26epage%3D1331%26doi%3D10.1161%2FCIRCRESAHA.111.258723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papanicolaou, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngoh, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coughlan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K.</span></span> <span> </span><span class="NLM_article-title">Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1012</span>â <span class="NLM_lpage">1026</span>, <span class="refDoi">Â DOI: 10.1161/CIRCRESAHA.112.274142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1161%2FCIRCRESAHA.112.274142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22904094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWmt77I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2012&pages=1012-1026&author=K.+N.+Papanicolaouauthor=R.+Kikuchiauthor=G.+A.+Ngohauthor=K.+A.+Coughlanauthor=I.+Dominguezauthor=W.+C.+Stanleyauthor=K.+Walsh&title=Mitofusins+1+and+2+are+essential+for+postnatal+metabolic+remodeling+in+heart&doi=10.1161%2FCIRCRESAHA.112.274142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mitofusins 1 and 2 Are Essential for Postnatal Metabolic Remodeling in Heart</span></div><div class="casAuthors">Papanicolaou, Kyriakos N.; Kikuchi, Ryosuke; Ngoh, Gladys A.; Coughlan, Kimberly A.; Dominguez, Isabel; Stanley, William C.; Walsh, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1012-1026</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: At birth, there is a switch from placental to pulmonary circulation and the heart commences its aerobic metab.  In cardiac myocytes, this transition is marked by increased mitochondrial biogenesis and remodeling of the intracellular architecture.  The mechanisms governing the formation of new mitochondria and their expansion within myocytes remain largely unknown.  Mitofusins (Mfn-1 and Mfn-2) are known regulators of mitochondrial networks, but their role during perinatal maturation of the heart has yet to be examd.  Objective: The objective of this study was to det. the significance of mitofusins during early postnatal cardiac development.  Methods and results: We genetically inactivated Mfn-1 and Mfn-2 in midgestational and postnatal cardiac myocytes using a loxP/Myh6-cre approach.  At birth, cardiac morphol. and function of double-knockout (DKO) mice are normal.  At that time, DKO mitochondria increase in nos., appear to be spherical and heterogeneous in size, but exhibit normal electron d.  By postnatal day 7, the mitochondrial nos. in DKO myocytes remain abnormally expanded and many lose matrix components and membrane organization.  At this time point, DKO mice have developed cardiomyopathy.  This leads to a rapid decline in survival and all DKO mice die before 16 days of age.  Gene expression anal. of DKO hearts shows that mitochondria biogenesis genes are downregulated, the mitochondrial DNA is reduced, and mitochondrially encoded transcripts and proteins are also reduced.  Furthermore, mitochondrial turnover pathways are dysregulated.  Conclusions: Our findings establish that Mfn-1 and Mfn-2 are essential in mediating mitochondrial remodeling during postnatal cardiac development, a time of dramatic transitions in the bioenergetics and growth of the heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFC6h4vRUWwbVg90H21EOLACvtfcHk0lhdVCnG5F1kUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWmt77I&md5=c72d341f882ea81cbd089466c6ccfbcb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.112.274142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.112.274142%26sid%3Dliteratum%253Aachs%26aulast%3DPapanicolaou%26aufirst%3DK.%2BN.%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3DNgoh%26aufirst%3DG.%2BA.%26aulast%3DCoughlan%26aufirst%3DK.%2BA.%26aulast%3DDominguez%26aufirst%3DI.%26aulast%3DStanley%26aufirst%3DW.%2BC.%26aulast%3DWalsh%26aufirst%3DK.%26atitle%3DMitofusins%25201%2520and%25202%2520are%2520essential%2520for%2520postnatal%2520metabolic%2520remodeling%2520in%2520heart%26jtitle%3DCirc.%2520Res.%26date%3D2012%26volume%3D111%26spage%3D1012%26epage%3D1026%26doi%3D10.1161%2FCIRCRESAHA.112.274142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipolat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">734</span>â <span class="NLM_lpage">737</span>, <span class="refDoi">Â DOI: 10.1126/science.1241359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.1241359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=24091702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWlsLrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=734-737&author=A.+Kasaharaauthor=S.+Cipolatauthor=Y.+Chenauthor=G.+W.+Dornauthor=L.+Scorrano&title=Mitochondrial+fusion+directs+cardiomyocyte+differentiation+via+calcineurin+and+Notch+signaling&doi=10.1126%2Fscience.1241359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling</span></div><div class="casAuthors">Kasahara, Atsuko; Cipolat, Sara; Chen, Yun; Dorn, Gerald W., II; Scorrano, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6159</span>),
    <span class="NLM_cas:pages">734-737</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitochondrial morphol. is crucial for tissue homeostasis, but its role in cell differentiation is unclear.  Here, the authors found that mitochondrial fusion was required for proper cardiomyocyte development.  Ablation of mitochondrial fusion proteins mitofusin 1 and mitofusin 2 in embryonic mouse heart, or gene-trapping of mitofusin 2 or optic atrophy 1 in mouse embryonic stem cells (ESCs), arrested mouse heart development and impaired the differentiation of ESCs into cardiomyocytes.  Gene expression profiling revealed decreased levels of the transcription factors, transforming growth factor-Î²/bone morphogenetic protein, serum response factor, GATA4, and myocyte enhancer factor 2, linked to increased Ca2+-dependent calcineurin activity and Notch 1 signaling that impaired ESC differentiation.  Orchestration of cardiomyocyte differentiation by mitochondrial morphol. revealed how mitochondria, Ca2+, and calcineurin interact to regulate Notch 1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojm3gp1TnyPbVg90H21EOLACvtfcHk0lhdVCnG5F1kUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWlsLrI&md5=a99dc48d0135e2fb4c16bfd2cd2200ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241359%26sid%3Dliteratum%253Aachs%26aulast%3DKasahara%26aufirst%3DA.%26aulast%3DCipolat%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26aulast%3DScorrano%26aufirst%3DL.%26atitle%3DMitochondrial%2520fusion%2520directs%2520cardiomyocyte%2520differentiation%2520via%2520calcineurin%2520and%2520Notch%2520signaling%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D734%26epage%3D737%26doi%3D10.1126%2Fscience.1241359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csordas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matkovich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>, <span class="NLM_elocation-id">aad2459</span> <span class="refDoi">Â DOI: 10.1126/science.aad2459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.aad2459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=26785495" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&author=G.+Gongauthor=M.+Songauthor=G.+Csordasauthor=D.+P.+Kellyauthor=S.+J.+Matkovichauthor=G.+W.+Dorn&title=Parkin-mediated+mitophagy+directs+perinatal+cardiac+metabolic+maturation+in+mice&doi=10.1126%2Fscience.aad2459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.aad2459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aad2459%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DG.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DCsordas%26aufirst%3DG.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26aulast%3DMatkovich%26aufirst%3DS.%2BJ.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DParkin-mediated%2520mitophagy%2520directs%2520perinatal%2520cardiac%2520metabolic%2520maturation%2520in%2520mice%26jtitle%3DScience%26date%3D2015%26volume%3D350%26doi%3D10.1126%2Fscience.aad2459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">273</span>â <span class="NLM_lpage">285</span>, <span class="refDoi">Â DOI: 10.1016/j.cmet.2014.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.cmet.2014.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=25600785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Ois7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=273-285&author=M.+Songauthor=K.+Miharaauthor=Y.+Chenauthor=L.+Scorranoauthor=G.+W.+Dorn&title=Mitochondrial+fission+and+fusion+factors+reciprocally+orchestrate+mitophagic+culling+in+mouse+hearts+and+cultured+fibroblasts&doi=10.1016%2Fj.cmet.2014.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Fission and Fusion Factors Reciprocally Orchestrate Mitophagic Culling in Mouse Hearts and Cultured Fibroblasts</span></div><div class="casAuthors">Song, Moshi; Mihara, Katsuyoshi; Chen, Yun; Scorrano, Luca; Dorn, Gerald W., II</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-285</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">How mitochondrial dynamism (fission and fusion) affects mitochondrial quality control is unclear.  We uncovered distinct effects on mitophagy of inhibiting Drp1-mediated mitochondrial fission vs. mitofusin-mediated mitochondrial fusion.  Conditional cardiomyocyte-specific Drp1 ablation evoked mitochondrial enlargement, lethal dilated cardiomyopathy, and cardiomyocyte necrosis.  Conditionally ablating cardiomyocyte mitofusins (Mfn) caused mitochondrial fragmentation with eccentric remodeling and no cardiomyocyte dropout.  Parallel studies in cultured murine embryonic fibroblasts (MEFs) and in vivo mouse hearts revealed that Mfn1/Mfn2 deletion provoked accumulation of defective mitochondria exhibiting an unfolded protein response, without appropriately increasing mitophagy.  Conversely, interrupting mitochondrial fission by Drp1 ablation increased mitophagy and caused a generalized loss of mitochondria.  Mitochondrial permeability transition pore (MPTP) opening in Drp1 null mitochondria was assocd. with mitophagy in MEFs and contributed to cardiomyocyte necrosis and dilated cardiomyopathy in mice.  Drp1, MPTP, and cardiomyocyte mitophagy are functionally integrated.  Mitochondrial fission and fusion have opposing roles during in vivo cardiac mitochondrial quality control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkfihVf0YED7Vg90H21EOLACvtfcHk0lhOQ_jff4dxXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Ois7s%253D&md5=45eef28c556025f047bcadccb8673f0e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2014.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2014.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DScorrano%26aufirst%3DL.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMitochondrial%2520fission%2520and%2520fusion%2520factors%2520reciprocally%2520orchestrate%2520mitophagic%2520culling%2520in%2520mouse%2520hearts%2520and%2520cultured%2520fibroblasts%26jtitle%3DCell%2520Metab.%26date%3D2015%26volume%3D21%26spage%3D273%26epage%3D285%26doi%3D10.1016%2Fj.cmet.2014.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Abrogating mitochondrial dynamics in mouse hearts accelerates mitochondrial senescence</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">872.e5</span>â <span class="NLM_lpage">883.e5</span>, <span class="refDoi">Â DOI: 10.1016/j.cmet.2017.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.cmet.2017.09.023" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=872.e5-883.e5&author=M.+Songauthor=A.+Francoauthor=J.+A.+Fleischerauthor=L.+Zhangauthor=G.+W.+Dorn&title=Abrogating+mitochondrial+dynamics+in+mouse+hearts+accelerates+mitochondrial+senescence&doi=10.1016%2Fj.cmet.2017.09.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DFleischer%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DAbrogating%2520mitochondrial%2520dynamics%2520in%2520mouse%2520hearts%2520accelerates%2520mitochondrial%2520senescence%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D26%26spage%3D872.e5%26epage%3D883.e5%26doi%3D10.1016%2Fj.cmet.2017.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koshiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Detmer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaffery, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis of mitochondrial tethering by mitofusin complexes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">858</span>â <span class="NLM_lpage">862</span>, <span class="refDoi">Â DOI: 10.1126/science.1099793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.1099793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=15297672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Krsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=858-862&author=T.+Koshibaauthor=S.+A.+Detmerauthor=J.+T.+Kaiserauthor=H.+Chenauthor=J.+M.+McCafferyauthor=D.+C.+Chan&title=Structural+basis+of+mitochondrial+tethering+by+mitofusin+complexes&doi=10.1126%2Fscience.1099793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Mitochondrial Tethering by Mitofusin Complexes</span></div><div class="casAuthors">Koshiba, Takumi; Detmer, Scott A.; Kaiser, Jens T.; Chen, Hsiuchen; McCaffery, J. Michael; Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5685</span>),
    <span class="NLM_cas:pages">858-862</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Vesicle fusion involves vesicle tethering, docking, and membrane merger.  We show that mitofusin, an integral mitochondrial membrane protein, is required on adjacent mitochondria to mediate fusion, which indicates that mitofusin complexes act in trans (i.e., between adjacent mitochondria).  A heptad repeat region (HR2) mediates mitofusin oligomerization by assembling a dimeric, antiparallel coiled coil.  The transmembrane segments are located at opposite ends of the 95 angstrom coiled coil and provide a mechanism for organelle tethering.  Consistent with this proposal, truncated mitofusin, in an HR2-dependent manner, causes mitochondria to become apposed with a uniform gap.  Our results suggest that HR2 functions as a mitochondrial tether before fusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeA17zSrs_ALVg90H21EOLACvtfcHk0lhOQ_jff4dxXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Krsb0%253D&md5=f1ab19e9c4838ea79e91ec997bf5b341</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099793%26sid%3Dliteratum%253Aachs%26aulast%3DKoshiba%26aufirst%3DT.%26aulast%3DDetmer%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMcCaffery%26aufirst%3DJ.%2BM.%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DStructural%2520basis%2520of%2520mitochondrial%2520tethering%2520by%2520mitofusin%2520complexes%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D858%26epage%3D862%26doi%3D10.1126%2Fscience.1099793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria: dynamic organelles in disease, aging, and development</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">1241</span>â <span class="NLM_lpage">1252</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2006.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.cell.2006.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=16814712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=1241-1252&author=D.+C.+Chan&title=Mitochondria%3A+dynamic+organelles+in+disease%2C+aging%2C+and+development&doi=10.1016%2Fj.cell.2006.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria: dynamic organelles in disease, aging, and development</span></div><div class="casAuthors">Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1241-1252</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria are the primary energy-generating system in most eukaryotic cells.  Addnl., they participate in intermediary metab., Ca2+ signaling, and apoptosis.  Given these well-established functions, it might be expected that mitochondrial dysfunction would give rise to a simple and predictable set of defects in all tissues.  However, mitochondrial dysfunction has pleiotropic effects in multicellular organisms.  Clearly, much about the basic biol. of mitochondria remains to be understood.  Here, the authors discuss recent work that suggests that the dynamics (fusion and fission) of these organelles is important in development and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHxWfcOENvbVg90H21EOLACvtfcHk0lhOQ_jff4dxXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D&md5=2de7a7341c3294779ad85b276a7d38e5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DMitochondria%253A%2520dynamic%2520organelles%2520in%2520disease%252C%2520aging%252C%2520and%2520development%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D1241%26epage%3D1252%26doi%3D10.1016%2Fj.cell.2006.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Fusion and fission: interlinked processes critical for mitochondrial health</span>. <i>Annu. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">265</span>â <span class="NLM_lpage">287</span>, <span class="refDoi">Â DOI: 10.1146/annurev-genet-110410-132529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1146%2Fannurev-genet-110410-132529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22934639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyktbbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=265-287&author=D.+C.+Chan&title=Fusion+and+fission%3A+interlinked+processes+critical+for+mitochondrial+health&doi=10.1146%2Fannurev-genet-110410-132529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fusion and fission: interlinked processes critical for mitochondrial health</span></div><div class="casAuthors">Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-287</span>CODEN:
                <span class="NLM_cas:coden">ARVGB7</span>;
        ISSN:<span class="NLM_cas:issn">0066-4197</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Mitochondria are dynamic organelles that continually undergo fusion and fission.  These opposing processes work in concert to maintain the shape, size, and no. of mitochondria and their physiol. function.  Some of the major mols. mediating mitochondrial fusion and fission in mammals have been discovered, but the underlying mol. mechanisms are only partially unraveled.  In particular, the cast of characters involved in mitochondrial fission needs to be clarified.  By enabling content mixing between mitochondria, fusion and fission serve to maintain a homogeneous and healthy mitochondrial population.  Mitochondrial dynamics has been linked to multiple mitochondrial functions, including mitochondrial DNA stability, respiratory capacity, apoptosis, response to cellular stress, and mitophagy.  Because of these important functions, mitochondrial fusion and fission are essential in mammals, and even mild defects in mitochondrial dynamics are assocd. with disease.  A better understanding of these processes likely will ultimately lead to improvements in human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2w3YXxkxEobVg90H21EOLACvtfcHk0lh9k8-pccwgUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyktbbE&md5=af26f9e1e56be1748bf960859906bf1c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genet-110410-132529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genet-110410-132529%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DFusion%2520and%2520fission%253A%2520interlinked%2520processes%2520critical%2520for%2520mitochondrial%2520health%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D46%26spage%3D265%26epage%3D287%26doi%3D10.1146%2Fannurev-genet-110410-132529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knott, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzenbacher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossy-Wetzel, E.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fragmentation in neurodegeneration</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">505</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.1038/nrn2417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fnrn2417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=18568013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFChu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=505-518&author=A.+B.+Knottauthor=G.+Perkinsauthor=R.+Schwarzenbacherauthor=E.+Bossy-Wetzel&title=Mitochondrial+fragmentation+in+neurodegeneration&doi=10.1038%2Fnrn2417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial fragmentation in neurodegeneration</span></div><div class="casAuthors">Knott, Andrew B.; Perkins, Guy; Schwarzenbacher, Robert; Bossy-Wetzel, Ella</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">505-518</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is mounting evidence that mitochondrial dysfunction is an early and causal event in neurodegeneration.  Here, Bossy-Wetzel and colleagues discuss how aberrant mitochondrial fission and fusion can contribute to neurodegenerative disease.  Mitochondria are remarkably dynamic organelles that migrate, divide and fuse.  Cycles of mitochondrial fission and fusion ensure metabolite and mitochondrial DNA mixing and dictate organelle shape, no. and bioenergetic functionality.  There is mounting evidence that mitochondrial dysfunction is an early and causal event in neurodegeneration.  Mutations in the mitochondrial fusion GTPases mitofusin 2 and optic atrophy 1, neurotoxins and oxidative stress all disrupt the cable-like morphol. of functional mitochondria.  This results in impaired bioenergetics and mitochondrial migration, and can trigger neurodegeneration.  These findings suggest potential new treatment avenues for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_keURAnRxmrVg90H21EOLACvtfcHk0lh9k8-pccwgUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFChu7c%253D&md5=3ac2e09a3f87fffec2eda84a1187bbbb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrn2417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2417%26sid%3Dliteratum%253Aachs%26aulast%3DKnott%26aufirst%3DA.%2BB.%26aulast%3DPerkins%26aufirst%3DG.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DBossy-Wetzel%26aufirst%3DE.%26atitle%3DMitochondrial%2520fragmentation%2520in%2520neurodegeneration%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D505%26epage%3D518%26doi%3D10.1038%2Fnrn2417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Evolving Concepts of Mitochondrial Dynamics</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1146/annurev-physiol-020518-114358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1146%2Fannurev-physiol-020518-114358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=30256725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslyru7vE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2019&pages=1-17&author=G.+W.+Dorn&title=Evolving+Concepts+of+Mitochondrial+Dynamics&doi=10.1146%2Fannurev-physiol-020518-114358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving Concepts of Mitochondrial Dynamics</span></div><div class="casAuthors">Dorn, Gerald W.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">The concept that mitochondria are highly dynamic is as widely accepted as it is untrue for a no. of important contexts.  Healthy mitochondria of the most energy-dependent and mitochondrial-rich mammalian organ, the heart, only rarely undergo fusion or fission and are seemingly static within cardiac myocytes.  Here, we revisit mitochondrial dynamism with a fresh perspective developed from the recently discovered multifunctionality of mitochondrial fusion proteins and newly defined mechanisms for direct cross talk between mitochondrial dynamics, biogenesis, quality control, and trafficking pathways.  Insights gained from comparing static mitochondrial biol. in cardiac myocytes and dynamic mitochondrial biol. in neurons are reviewed with the goal of understanding contextual fallacies of overly generalized characterizations of these essential and intriguing organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK0eq0xoe8M7Vg90H21EOLACvtfcHk0lh9k8-pccwgUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslyru7vE&md5=1d639123e5676bc097ca80edc587d95e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-020518-114358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-020518-114358%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DEvolving%2520Concepts%2520of%2520Mitochondrial%2520Dynamics%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2019%26volume%3D81%26spage%3D1%26epage%3D17%26doi%3D10.1146%2Fannurev-physiol-020518-114358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornfeld, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biris, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qvit, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochly-Rosen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  II</span></span> <span> </span><span class="NLM_article-title">Correcting mitochondrial fusion by manipulating mitofusin conformations</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>540</i></span>,  <span class="NLM_fpage">74</span>â <span class="NLM_lpage">79</span>, <span class="refDoi">Â DOI: 10.1038/nature20156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fnature20156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=27775718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFylsLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=540&publication_year=2016&pages=74-79&author=A.+Francoauthor=R.+N.+Kitsisauthor=J.+A.+Fleischerauthor=E.+Gavathiotisauthor=O.+S.+Kornfeldauthor=G.+Gongauthor=N.+Birisauthor=A.+Benzauthor=N.+Qvitauthor=S.+K.+Donnellyauthor=Y.+Chenauthor=S.+Mennerickauthor=L.+Hodgsonauthor=D.+Mochly-Rosenauthor=G.+W.+Dorn&title=Correcting+mitochondrial+fusion+by+manipulating+mitofusin+conformations&doi=10.1038%2Fnature20156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Correcting mitochondrial fusion by manipulating mitofusin conformations</span></div><div class="casAuthors">Franco, Antonietta; Kitsis, Richard N.; Fleischer, Julie A.; Gavathiotis, Evripidis; Kornfeld, Opher S.; Gong, Guohua; Biris, Nikolaos; Benz, Ann; Qvit, Nir; Donnelly, Sara K.; Chen, Yun; Mennerick, Steven; Hodgson, Louis; Mochly-Rosen, Daria; Dorn II, Gerald W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">540</span>
        (<span class="NLM_cas:issue">7631</span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondria are dynamic organelles that exchange contents and undergo remodeling during cyclic fusion and fission.  Genetic mutations in MFN2 (the gene encoding mitofusin 2) interrupt mitochondrial fusion and cause the untreatable neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A).  It has not yet been possible to directly modulate mitochondrial fusion, in part because the structural basis of mitofusin function is not completely understood.  Here we show that mitofusins adopt either a fusion-constrained or a fusion-permissive mol. conformation, directed by specific intramol. binding interactions, and demonstrate that mitofusin-dependent mitochondrial fusion can be regulated in mouse cells by targeting these conformational transitions.  On the basis of this model, we engineered a cell-permeant minipeptide to destabilize the fusion-constrained conformation of mitofusin and promote the fusion-permissive conformation, reversing mitochondrial abnormalities in cultured fibroblasts and neurons that harbor CMT2A-assocd. genetic defects.  The relationship between the conformational plasticity of mitofusin 2 and mitochondrial dynamism reveals a central mechanism that regulates mitochondrial fusion, the manipulation of which can correct mitochondrial pathol. triggered by defective or imbalanced mitochondrial dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUsxRhYbt0L7Vg90H21EOLACvtfcHk0lgK8u44tytzQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFylsLbP&md5=187a52b917cbd6a4c7c5c42ba868ddde</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature20156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature20156%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DFleischer%26aufirst%3DJ.%2BA.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DKornfeld%26aufirst%3DO.%2BS.%26aulast%3DGong%26aufirst%3DG.%26aulast%3DBiris%26aufirst%3DN.%26aulast%3DBenz%26aufirst%3DA.%26aulast%3DQvit%26aufirst%3DN.%26aulast%3DDonnelly%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMennerick%26aufirst%3DS.%26aulast%3DHodgson%26aufirst%3DL.%26aulast%3DMochly-Rosen%26aufirst%3DD.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DCorrecting%2520mitochondrial%2520fusion%2520by%2520manipulating%2520mitofusin%2520conformations%26jtitle%3DNature%26date%3D2016%26volume%3D540%26spage%3D74%26epage%3D79%26doi%3D10.1038%2Fnature20156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krezel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biris, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharioudakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloh, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochly-Rosen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">336</span>â <span class="NLM_lpage">341</span>, <span class="refDoi">Â DOI: 10.1126/science.aao1785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.aao1785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=29674596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns12gtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&pages=336-341&author=A.+G.+Rochaauthor=A.+Francoauthor=A.+M.+Krezelauthor=J.+M.+Rumseyauthor=J.+M.+Albertiauthor=W.+C.+Knightauthor=N.+Birisauthor=E.+Zacharioudakisauthor=J.+W.+Janetkaauthor=R.+H.+Balohauthor=R.+N.+Kitsisauthor=D.+Mochly-Rosenauthor=R.+R.+Townsendauthor=E.+Gavathiotisauthor=G.+W.+Dorn&title=MFN2+agonists+reverse+mitochondrial+defects+in+preclinical+models+of+Charcot-Marie-Tooth+disease+type+2A&doi=10.1126%2Fscience.aao1785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A</span></div><div class="casAuthors">Rocha, Agostinho G.; Franco, Antonietta; Krezel, Andrzej M.; Rumsey, Jeanne M.; Alberti, Justin M.; Knight, William C.; Biris, Nikolaos; Zacharioudakis, Emmanouil; Janetka, James W.; Baloh, Robert H.; Kitsis, Richard N.; Mochly-Rosen, Daria; Townsend, R. Reid; Gavathiotis, Evripidis; Dorn, Gerald W., II</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">6386</span>),
    <span class="NLM_cas:pages">336-341</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitofusins (MFNs) promote fusion-mediated mitochondrial content exchange and subcellular trafficking.  Mutations in Mfn2 cause neurodegenerative Charcot-Marie-Tooth disease type 2A (CMT2A).  We showed that MFN2 activity can be detd. by Met376 and His380 interactions with Asp725 and Leu727 and controlled by PINK1 kinase-mediated phosphorylation of adjacent MFN2 Ser378.  Small-mol. mimics of the peptide-peptide interface of MFN2 disrupted this interaction, allosterically activating MFN2 and promoting mitochondrial fusion.  These first-in-class mitofusin agonists overcame dominant mitochondrial defects provoked in cultured neurons by CMT2A mutants MFN2 Arg94âGln94 and MFN2 Thr105âMet105, as demonstrated by amelioration of mitochondrial dysmotility, fragmentation, depolarization, and clumping.  A mitofusin agonist normalized axonal mitochondrial trafficking within sciatic nerves of MFN2 Thr105âMet105 mice, promising a therapeutic approach for CMT2A and other untreatable diseases of impaired neuronal mitochondrial dynamism and/or trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpajd_bDgXFyLVg90H21EOLACvtfcHk0lgK8u44tytzQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns12gtL0%253D&md5=1caad3813ea70d3bcb0d071dcfefa7f1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.aao1785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aao1785%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DA.%2BG.%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DKrezel%26aufirst%3DA.%2BM.%26aulast%3DRumsey%26aufirst%3DJ.%2BM.%26aulast%3DAlberti%26aufirst%3DJ.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BC.%26aulast%3DBiris%26aufirst%3DN.%26aulast%3DZacharioudakis%26aufirst%3DE.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DBaloh%26aufirst%3DR.%2BH.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DMochly-Rosen%26aufirst%3DD.%26aulast%3DTownsend%26aufirst%3DR.%2BR.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMFN2%2520agonists%2520reverse%2520mitochondrial%2520defects%2520in%2520preclinical%2520models%2520of%2520Charcot-Marie-Tooth%2520disease%2520type%25202A%26jtitle%3DScience%26date%3D2018%26volume%3D360%26spage%3D336%26epage%3D341%26doi%3D10.1126%2Fscience.aao1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hefti, F. F.</span></span> <span> </span><span class="NLM_article-title">Requirements for a lead compound to become a clinical candidate</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">S7</span> <span class="refDoi">Â DOI: 10.1186/1471-2202-9-S3-S7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1186%2F1471-2202-9-S3-S7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=19091004" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&author=F.+F.+Hefti&title=Requirements+for+a+lead+compound+to+become+a+clinical+candidate&doi=10.1186%2F1471-2202-9-S3-S7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-9-S3-S7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-9-S3-S7%26sid%3Dliteratum%253Aachs%26aulast%3DHefti%26aufirst%3DF.%2BF.%26atitle%3DRequirements%2520for%2520a%2520lead%2520compound%2520to%2520become%2520a%2520clinical%2520candidate%26jtitle%3DBMC%2520Neurosci.%26date%3D2008%26volume%3D9%26doi%3D10.1186%2F1471-2202-9-S3-S7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for bloodâbrain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>â <span class="NLM_lpage">232</span>, <span class="refDoi">Â DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lgK8u44tytzQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gubernator, K.</span></span> <span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1007</span>â <span class="NLM_lpage">1010</span>, <span class="refDoi">Â DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lhHpvqkj4nLew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span> <span> </span><span class="NLM_article-title">PAMPA--critical factors for better predictions of absorption</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2893</span>â <span class="NLM_lpage">2909</span>, <span class="refDoi">Â DOI: 10.1002/jps.21068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1002%2Fjps.21068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=17803196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2893-2909&author=A.+Avdeefauthor=S.+Bendelsauthor=L.+Diauthor=B.+Fallerauthor=M.+Kansyauthor=K.+Suganoauthor=Y.+Yamauchi&title=PAMPA%2D%2Dcritical+factors+for+better+predictions+of+absorption&doi=10.1002%2Fjps.21068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel artificial membrane permeability assay (PAMPA)-critical factors for better predictions of absorption</span></div><div class="casAuthors">Avdeef, Alex; Bendels, Stefanie; Di, Li; Faller, Bernard; Kansy, Manfred; Sugano, Kiyohiko; Yamauchi, Yukinori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2893-2909</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  PAMPA, log POCT, and Caco-2 are useful tools in drug discovery for the prediction of oral absorption, brain penetration and for the development of structure-permeability relationships.  Each approach has its advantages and limitations.  Selection criteria for methods are based on many different factors: predictability, throughput, cost and personal preferences (people factor).  The PAMPA concerns raised by Galinis-Luciani et al. are answered by experienced PAMPA practitioners, inventors and developers from diverse research organizations.  Guidelines on how to use PAMPA are discussed.  PAMPA and PAMPA-BBB have much better predictivity for oral absorption and brain penetration than log POCT for real-world drug discovery compds.  PAMPA and Caco-2 have similar predictivity for passive oral absorption.  However, it is not advisable to use PAMPA to predict absorption involving transporter-mediated processes, such as active uptake or efflux.  Measurement of PAMPA is much more rapid and cost effective than Caco-2 and log POCT.  PAMPA assay conditions are crit. in order to generate high quality and relevant data, including permeation time, assay pH, stirring, use of cosolvents and selection of detection techniques.  The success of using PAMPA in drug discovery depends on careful data interpretation, use of optimal assay conditions, implementation and integration strategies, and education of users.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobHIlcZw09obVg90H21EOLACvtfcHk0lhHpvqkj4nLew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzM&md5=3b731c4343ef70452dd2f43a225ccfc6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjps.21068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21068%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSugano%26aufirst%3DK.%26aulast%3DYamauchi%26aufirst%3DY.%26atitle%3DPAMPA--critical%2520factors%2520for%2520better%2520predictions%2520of%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2893%26epage%3D2909%26doi%3D10.1002%2Fjps.21068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P.</span></span> <span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3714</span>â <span class="NLM_lpage">3717</span>, <span class="refDoi">Â DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lgSm8XJ_1_XUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>â <span class="NLM_lpage">449</span>, <span class="refDoi">Â DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score â¥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgSm8XJ_1_XUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SundÃ©n, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burstein, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R.</span></span> <span> </span><span class="NLM_article-title">Design of a highly selective and potent class of non-planar estrogen receptor beta agonists</span>. <i>Chem. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1283</span>â <span class="NLM_lpage">1294</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201300175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1002%2Fcmdc.201300175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=23784708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1GhsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1283-1294&author=H.+Sund%C3%A9nauthor=J.+N.+Maauthor=L.+K.+Hansenauthor=A.+L.+Gustavssonauthor=E.+S.+Bursteinauthor=R.+Olsson&title=Design+of+a+highly+selective+and+potent+class+of+non-planar+estrogen+receptor+beta+agonists&doi=10.1002%2Fcmdc.201300175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Highly Selective and Potent Class of Non-planar Estrogen Receptor Î² Agonists</span></div><div class="casAuthors">Sunden, Henrik; Ma, Jian-Nong; Hansen, Lars K.; Gustavsson, Anna-Lena; Burstein, Ethan S.; Olsson, Roger</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1283-1294</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective activation of the estrogen receptor Î² (ERÎ²) could be a safe approach to hormone replacement therapy for both women and men, in contrast to the estrogens currently used for women which activate both ERÎ² and ERÎ±, occasionally causing severe side effects.  The selective ERÎ² agonist AC-131 has shown efficacy in animal models of Parkinson's disease and neuropathic pain.  With the use of AC-131 as template, herein we report the discovery, synthesis, and structure-activity relationship (SAR) study of a new class of dihydrobenzofurans as potent and selective ERÎ² agonists.  The SAR was established by enantioselective synthesis, mol. modeling, and whole-cell-based functional assay.  The most potent diastereomer, I, was shown to have an EC50 value of <1 n, potency 100-fold higher than that of AC-131.  Even more interestingly, compd. II exhibited 1000-fold ERÎ²/ERÎ± selectivity while still maintaining good potency (â¼10 n).  In addn., II showed only partial agonist activity (30-60% Eff.) toward ERÎ± at 10 Î¼.  This unprecedented selectivity could be rationalized by mol. modeling.  Compd. II appears to be the first mol. to take advantage of both conservative amino acid differences found in the Î±- and Î²-faces of the binding cavities of ERÎ± and ERÎ².</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0NnRh2oDK9bVg90H21EOLACvtfcHk0lgSm8XJ_1_XUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1GhsLw%253D&md5=8860023c4fdace5c195aa2a5e8188797</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300175%26sid%3Dliteratum%253Aachs%26aulast%3DSund%25C3%25A9n%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DJ.%2BN.%26aulast%3DHansen%26aufirst%3DL.%2BK.%26aulast%3DGustavsson%26aufirst%3DA.%2BL.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DOlsson%26aufirst%3DR.%26atitle%3DDesign%2520of%2520a%2520highly%2520selective%2520and%2520potent%2520class%2520of%2520non-planar%2520estrogen%2520receptor%2520beta%2520agonists%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2013%26volume%3D8%26spage%3D1283%26epage%3D1294%26doi%3D10.1002%2Fcmdc.201300175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jafurulla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreedevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruysschaert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span> <span> </span><span class="NLM_article-title">Stereospecific requirement of cholesterol in the function of the serotonin1A receptor</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1838</i></span>,  <span class="NLM_fpage">158</span>â <span class="NLM_lpage">163</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamem.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.bbamem.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=24008092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOmtrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=158-163&author=M.+Jafurullaauthor=B.+D.+Raoauthor=S.+Sreedeviauthor=J.+M.+Ruysschaertauthor=D.+F.+Coveyauthor=A.+Chattopadhyay&title=Stereospecific+requirement+of+cholesterol+in+the+function+of+the+serotonin1A+receptor&doi=10.1016%2Fj.bbamem.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecific requirement of cholesterol in the function of the serotonin1A receptor</span></div><div class="casAuthors">Jafurulla, Md.; Rao, Bhagyashree D.; Sreedevi, Sugunan; Ruysschaert, Jean-Marie; Covey, Douglas F.; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">1PB</span>),
    <span class="NLM_cas:pages">158-163</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The serotonin1A receptor is an important member of the G protein-coupled receptor (GPCR) family.  It is involved in the generation and modulation of a variety of cognitive and behavioral functions and serves as a drug target.  Previous work from our lab. has established the sensitivity of the function of the serotonin1A receptor to membrane cholesterol.  Solubilization of the hippocampal serotonin1A receptor utilizing the zwitterionic detergent CHAPS is accompanied by loss of cholesterol and results in redn. in specific ligand binding.  Replenishment of cholesterol to solubilized membranes restores specific ligand binding to the receptor.  We utilized this strategy of sterol replenishment of solubilized membranes to explore the stereospecific stringency of cholesterol for receptor function.  We used two stereoisomers of cholesterol, ent-cholesterol (enantiomer of cholesterol) and epi-cholesterol (a diastereomer of cholesterol), for this purpose.  Importantly, we show here that while ent-cholesterol could replace cholesterol in supporting receptor function, epi-cholesterol could not.  These results imply that the requirement of membrane cholesterol for the serotonin1A receptor function is diastereospecific, yet not enantiospecific.  Our results extend and help define specificity of the interaction of membrane cholesterol with the serotonin1A receptor, and represent the first report utilizing ent-cholesterol to examine stereospecificity of GPCR-cholesterol interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7y7OHHcpqbrVg90H21EOLACvtfcHk0lgwtR4H-Tq_Uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOmtrbJ&md5=435e88aba0024c4429afca0fd061a094</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DJafurulla%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DB.%2BD.%26aulast%3DSreedevi%26aufirst%3DS.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DCovey%26aufirst%3DD.%2BF.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DStereospecific%2520requirement%2520of%2520cholesterol%2520in%2520the%2520function%2520of%2520the%2520serotonin1A%2520receptor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D158%26epage%3D163%26doi%3D10.1016%2Fj.bbamem.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cartoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medard, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirot, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvoisier, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrast, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span> <span> </span><span class="NLM_article-title">Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1460</span>â <span class="NLM_lpage">1469</span>, <span class="refDoi">Â DOI: 10.1093/brain/awq082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1093%2Fbrain%2Fawq082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=20418531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A280%3ADC%252BC3c3oslOnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2010&pages=1460-1469&author=R.+Cartoniauthor=E.+Arnaudauthor=J.+J.+Medardauthor=O.+Poirotauthor=D.+S.+Courvoisierauthor=R.+Chrastauthor=J.+C.+Martinou&title=Expression+of+mitofusin+2%28R94Q%29+in+a+transgenic+mouse+leads+to+Charcot-Marie-Tooth+neuropathy+type+2A&doi=10.1093%2Fbrain%2Fawq082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A</span></div><div class="casAuthors">Cartoni Romain; Arnaud Estelle; Medard Jean-Jacques; Poirot Olivier; Courvoisier Delphine S; Chrast Roman; Martinou Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">1460-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Charcot-Marie-Tooth disease type 2A is an autosomal dominant axonal form of peripheral neuropathy caused by mutations in the mitofusin 2 gene.  Mitofusin 2 encodes a mitochondrial outer membrane protein that participates in mitochondrial fusion in mammalian cells.  How mutations in this protein lead to Charcot-Marie-Tooth disease type 2A pathophysiology remains unclear.  We have generated a transgenic mouse expressing either a mutated (R94Q) or wild-type form of human mitofusin 2 in neurons to evaluate whether the R94Q mutation was sufficient for inducing a Charcot-Marie-Tooth disease type 2A phenotype.  Only mice expressing mitofusin 2(R94Q) developed locomotor impairments and gait defects thus mimicking the Charcot-Marie-Tooth disease type 2A neuropathy.  In these animals, the number of mitochondria per axon was significantly increased in the distal part of the sciatic nerve axons with a diameter smaller than 3.5 microm.  Importantly, the analysis of R94Q transgenic animals also revealed an age-related shift in the size of myelinated axons leading to an over-representation of axons smaller than 3.5 microm.  Together these data suggest a link between an increased number of mitochondria in axons and a shift in axonal size distribution in mitofusin 2(R94Q) transgenic animals that may contribute to their neurological phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwvoj1kpSRiNHxxy173TfNfW6udTcc2ebQaJ2LaPf7_7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3oslOnuw%253D%253D&md5=ecdd7bd8c47ba5e2007988f207717c51</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawq082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawq082%26sid%3Dliteratum%253Aachs%26aulast%3DCartoni%26aufirst%3DR.%26aulast%3DArnaud%26aufirst%3DE.%26aulast%3DMedard%26aufirst%3DJ.%2BJ.%26aulast%3DPoirot%26aufirst%3DO.%26aulast%3DCourvoisier%26aufirst%3DD.%2BS.%26aulast%3DChrast%26aufirst%3DR.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26atitle%3DExpression%2520of%2520mitofusin%25202%2528R94Q%2529%2520in%2520a%2520transgenic%2520mouse%2520leads%2520to%2520Charcot-Marie-Tooth%2520neuropathy%2520type%25202A%26jtitle%3DBrain%26date%3D2010%26volume%3D133%26spage%3D1460%26epage%3D1469%26doi%3D10.1093%2Fbrain%2Fawq082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bannerman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleasure, D.</span></span> <span> </span><span class="NLM_article-title">Mice hemizygous for a pathogenic mitofusin-2 allele exhibit hind limb/foot gait deficits and phenotypic perturbations in nerve and muscle</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0167573</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0167573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1371%2Fjournal.pone.0167573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=27907123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1alsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=P.+Bannermanauthor=T.+Burnsauthor=J.+Xuauthor=L.+Miersauthor=D.+Pleasure&title=Mice+hemizygous+for+a+pathogenic+mitofusin-2+allele+exhibit+hind+limb%2Ffoot+gait+deficits+and+phenotypic+perturbations+in+nerve+and+muscle&doi=10.1371%2Fjournal.pone.0167573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mice hemizygous for a pathogenic mitofusin-2 allele exhibit hind limb/foot gait deficits and phenotypic perturbations in nerve and muscle</span></div><div class="casAuthors">Bannerman, Peter; Burns, Travis; Xu, Jie; Miers, Laird; Pleasure, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e0167573/1-e0167573/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth disease type 2A (CMT2A), the most common axonal form of hereditary sensory motor neuropathy, is caused by mutations of mitofusin-2 (MFN2).  Mitofusin-2 is a GTPase required for fusion of mitochondrial outer membranes, repair of damaged mitochondria, efficient mitochondrial energetics, regulation of mitochondrial-endoplasmic reticulum calcium coupling and axonal transport of mitochondria.  We knocked T105M MFN2 preceded by a loxP-flanked STOP sequence into the mouse Rosa26 locus to permit cell type-specific expression of this pathogenic allele.  Crossing these mice with nestin-Cre transgenic mice elicited T105M MFN2 expression in neuroectoderm, and resulted in diminished nos. of mitochondria in peripheral nerve axons, an alteration in skeletal muscle fiber type distribution, and a gait abnormality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomyEWHwanFmrVg90H21EOLACvtfcHk0lgwtR4H-Tq_Uw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1alsLw%253D&md5=9ab727c21577bba9367fe49ce348930a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0167573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0167573%26sid%3Dliteratum%253Aachs%26aulast%3DBannerman%26aufirst%3DP.%26aulast%3DBurns%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DMiers%26aufirst%3DL.%26aulast%3DPleasure%26aufirst%3DD.%26atitle%3DMice%2520hemizygous%2520for%2520a%2520pathogenic%2520mitofusin-2%2520allele%2520exhibit%2520hind%2520limb%252Ffoot%2520gait%2520deficits%2520and%2520phenotypic%2520perturbations%2520in%2520nerve%2520and%2520muscle%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0167573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landeros, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloh, R. H.</span></span> <span> </span><span class="NLM_article-title">Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1756</span>â <span class="NLM_lpage">1771</span>, <span class="refDoi">Â DOI: 10.1172/JCI124194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1172%2FJCI124194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=30882371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A280%3ADC%252BB3cblt1akuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=1756-1771&author=Y.+Zhouauthor=S.+Carmonaauthor=A.+Muhammadauthor=S.+Bellauthor=J.+Landerosauthor=M.+Vazquezauthor=R.+Hoauthor=A.+Francoauthor=B.+Luauthor=G.+W.+Dornauthor=S.+Wangauthor=C.+M.+Lutzauthor=R.+H.+Baloh&title=Restoring+mitofusin+balance+prevents+axonal+degeneration+in+a+Charcot-Marie-Tooth+type+2A+model&doi=10.1172%2FJCI124194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model</span></div><div class="casAuthors">Zhou Yueqin; Muhammad A K M G; Bell Shaughn; Landeros Jesse; Vazquez Michael; Baloh Robert H; Zhou Yueqin; Carmona Sharon; Muhammad A K M G; Bell Shaughn; Landeros Jesse; Vazquez Michael; Ho Ritchie; Lu Bin; Wang Shaomei; Baloh Robert H; Franco Antonietta; Dorn Gerald W 2nd; Lutz Cathleen M; Baloh Robert H</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1756-1771</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mitofusin-2 (MFN2) is a mitochondrial outer-membrane protein that plays a pivotal role in mitochondrial dynamics in most tissues, yet mutations in MFN2, which cause Charcot-Marie-Tooth disease type 2A (CMT2A), primarily affect the nervous system.  We generated a transgenic mouse model of CMT2A that developed severe early onset vision loss and neurological deficits, axonal degeneration without cell body loss, and cytoplasmic and axonal accumulations of fragmented mitochondria.  While mitochondrial aggregates were labeled for mitophagy, mutant MFN2 did not inhibit Parkin-mediated degradation, but instead had a dominant negative effect on mitochondrial fusion only when MFN1 was at low levels, as occurs in neurons.  Finally, using a transgenic approach, we found that augmenting the level of MFN1 in the nervous system in vivo rescued all phenotypes in mutant MFN2R94Q-expressing mice.  These data demonstrate that the MFN1/MFN2 ratio is a key determinant of tissue specificity in CMT2A and indicate that augmentation of MFN1 in the nervous system is a viable therapeutic strategy for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8Yf-9Da4HGwyMywPm6HgQfW6udTcc2ebPP2RK3CGBJbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cblt1akuw%253D%253D&md5=62862d9c50e379ebd78d13ea0f60fb2f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI124194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI124194%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCarmona%26aufirst%3DS.%26aulast%3DMuhammad%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DS.%26aulast%3DLanderos%26aufirst%3DJ.%26aulast%3DVazquez%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DR.%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLutz%26aufirst%3DC.%2BM.%26aulast%3DBaloh%26aufirst%3DR.%2BH.%26atitle%3DRestoring%2520mitofusin%2520balance%2520prevents%2520axonal%2520degeneration%2520in%2520a%2520Charcot-Marie-Tooth%2520type%25202A%2520model%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D1756%26epage%3D1771%26doi%3D10.1172%2FJCI124194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasband, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliceiri, K. W.</span></span> <span> </span><span class="NLM_article-title">NIH Image to ImageJ: 25 years of image analysis</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">671</span>â <span class="NLM_lpage">675</span>, <span class="refDoi">Â DOI: 10.1038/nmeth.2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fnmeth.2089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22930834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKntb7P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=671-675&author=C.+A.+Schneiderauthor=W.+S.+Rasbandauthor=K.+W.+Eliceiri&title=NIH+Image+to+ImageJ%3A+25+years+of+image+analysis&doi=10.1038%2Fnmeth.2089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">NIH Image to ImageJ: 25 years of image analysis</span></div><div class="casAuthors">Schneider, Caroline A.; Rasband, Wayne S.; Eliceiri, Kevin W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7_part1</span>),
    <span class="NLM_cas:pages">671-675</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For the past 25 years NIH Image and ImageJ software have been pioneers as open tools for the anal. of scientific images.  We discuss the origins, challenges and solns. of these two programs, and how their history can serve to advise and inform other software projects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofzHXrdLwDn7Vg90H21EOLACvtfcHk0lhjPukc-dyVAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKntb7P&md5=85ab928cd79f1e2f2351c834c0c600f0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2089%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DC.%2BA.%26aulast%3DRasband%26aufirst%3DW.%2BS.%26aulast%3DEliceiri%26aufirst%3DK.%2BW.%26atitle%3DNIH%2520Image%2520to%2520ImageJ%253A%252025%2520years%2520of%2520image%2520analysis%26jtitle%3DNat.%2520Methods%26date%3D2012%26volume%3D9%26spage%3D671%26epage%3D675%26doi%3D10.1038%2Fnmeth.2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  II</span></span> <span> </span><span class="NLM_article-title">Mitofusin Modulation Agents and Methods of Use Thereof</span>. Patent <span class="NLM_patent">WO2019/094830A</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=G.+W.+Dorn&title=Mitofusin+Modulation+Agents+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMitofusin%2520Modulation%2520Agents%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  II</span></span> <span> </span><span class="NLM_article-title">Small Molecule Regulators of Mitochondrial Fusion and Methods of Use Thereof</span>. <span class="NLM_patent">, 20190169138A1</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=G.+W.+Dorn&title=Small+Molecule+Regulators+of+Mitochondrial+Fusion+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DSmall%2520Molecule%2520Regulators%2520of%2520Mitochondrial%2520Fusion%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana P  CervantesâSilva</span>, <span class="hlFld-ContribAuthor ">Shannon L  Cox</span>, <span class="hlFld-ContribAuthor ">Annie M  Curtis</span>. </span><span class="cited-content_cbyCitation_article-title">Alterations in mitochondrial morphology as a key driver of immunity and host defence. </span><span class="cited-content_cbyCitation_journal-name">EMBO reports</span><span> <strong>2021,</strong> <em>89 </em><a href="https://doi.org/10.15252/embr.202153086" title="DOI URL">https://doi.org/10.15252/embr.202153086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/embr.202153086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Fembr.202153086%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520reports%26atitle%3DAlterations%252Bin%252Bmitochondrial%252Bmorphology%252Bas%252Ba%252Bkey%252Bdriver%252Bof%252Bimmunity%252Band%252Bhost%252Bdefence%26aulast%3DCervantes%25E2%2580%2590Silva%26aufirst%3DMariana%2BP%26date%3D2021%26date%3D2021%26volume%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Stavrou</span>, <span class="hlFld-ContribAuthor ">Irene  Sargiannidou</span>, <span class="hlFld-ContribAuthor ">Elena  Georgiou</span>, <span class="hlFld-ContribAuthor ">Alexia  Kagiava</span>, <span class="hlFld-ContribAuthor ">Kleopas A.  Kleopa</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6048. <a href="https://doi.org/10.3390/ijms22116048" title="DOI URL">https://doi.org/10.3390/ijms22116048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116048%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEmerging%252BTherapies%252Bfor%252BCharcot-Marie-Tooth%252BInherited%252BNeuropathies%26aulast%3DStavrou%26aufirst%3DMarina%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Bilin  Liu</span>, <span class="hlFld-ContribAuthor ">Yuan  Qin</span>, <span class="hlFld-ContribAuthor ">Anqi  Li</span>, <span class="hlFld-ContribAuthor ">Meng  Gao</span>, <span class="hlFld-ContribAuthor ">Hanyu  Liu</span>, <span class="hlFld-ContribAuthor ">Guohua  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondrial Fusion Protein Mfn2 and Its Role in Heart Failure. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmolb.2021.681237" title="DOI URL">https://doi.org/10.3389/fmolb.2021.681237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2021.681237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2021.681237%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DMitochondrial%252BFusion%252BProtein%252BMfn2%252Band%252BIts%252BRole%252Bin%252BHeart%252BFailure%26aulast%3DChen%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GeraldW  Dorn</span>. </span><span class="cited-content_cbyCitation_article-title">Mitofusin activation enhances mitochondrial motility and promotes neuroregeneration in CMT2A. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2021,</strong> <em>16 </em>
                                    (11)
                                     , 2201. <a href="https://doi.org/10.4103/1673-5374.310684" title="DOI URL">https://doi.org/10.4103/1673-5374.310684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.310684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.310684%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DMitofusin%252Bactivation%252Benhances%252Bmitochondrial%252Bmotility%252Band%252Bpromotes%252Bneuroregeneration%252Bin%252BCMT2A%26aulast%3DDorn%26aufirst%3DGeraldW%26date%3D2021%26volume%3D16%26issue%3D11%26spage%3D2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonietta  Franco</span>, <span class="hlFld-ContribAuthor ">Xiawei  Dang</span>, <span class="hlFld-ContribAuthor ">Emily K  Walton</span>, <span class="hlFld-ContribAuthor ">Joshua N  Ho</span>, <span class="hlFld-ContribAuthor ">Barbara  Zablocka</span>, <span class="hlFld-ContribAuthor ">Cindy  Ly</span>, <span class="hlFld-ContribAuthor ">Timothy M  Miller</span>, <span class="hlFld-ContribAuthor ">Robert H  Baloh</span>, <span class="hlFld-ContribAuthor ">Michael E  Shy</span>, <span class="hlFld-ContribAuthor ">Andrew S  Yoo</span>, <span class="hlFld-ContribAuthor ">Gerald W  Dorn</span>. </span><span class="cited-content_cbyCitation_article-title">Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2020,</strong> <em>9 </em><a href="https://doi.org/10.7554/eLife.61119" title="DOI URL">https://doi.org/10.7554/eLife.61119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.61119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.61119%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DBurst%252Bmitofusin%252Bactivation%252Breverses%252Bneuromuscular%252Bdysfunction%252Bin%252Bmurine%252BCMT2A%26aulast%3DFranco%26aufirst%3DAntonietta%26date%3D2020%26date%3D2020%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of action of mitofusin activators. (A) Computational model of PPI-regulated conformational changes in human MFN2. (Inset) Published pharmacophore model described by Gavathiotis<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> positing specific amino acid interactions of the green MFN2-derived activator minipeptide. (B) Prototype small-molecule mitofusin activator, <b>1</b>, was developed that mimics characteristics of critical amino acid side chains of the mitofusin-activating minipeptide.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Diastereomer-selective correction of mitochondrial fragmentation and depolarization in Mfn knockout cells for <b>13</b>. (A, B) Doseâresponse curves for <b>13</b> stereoisomers increasing mitochondrial aspect ratio in cells expressing only Mfn2 (A) or only Mfn1 (B). Prototype mitofusin activator <b>2</b> data are shown for comparison. (C) Effects of compounds on mitochondrial inner membrane polarization in Mfn1 knockout (KO; top) and Mfn2 KO (bottom) cells. (D) Representative confocal imaging of mitochondrial morphology and polarization status in Mfn2 null mouse embryonic fibroblasts (MEFs) treated with different compounds (1 Î¼M, 24 h). Green mitochondria are depolarized and have damaged respiratory function. Scale bars are 10 Î¼m. MT Green (MitoTracker Green), tetramethylrhodamine ethyl ester (TMRE, red), and nuclear Hoechst (blue) were used for staining. Data are means Â± SEM of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Diastereomer-selective MFN2 conformational switching by <b>13</b>. (A) FÃ¶rster resonance energy transfer (FRET) emission spectra of MFN2 in open active (white) and closed inactive (black) conformations. Schematic to the right depicts FRET-labeled MFN2 protein in closed (top) and open (bottom) conformations. C is N-terminus fluorophore Cerulean; V is C-terminus fluorophore mVenus. (B) FRET analysis of conformational switching provoked by mitofusin activators. âPeptideâ is MP1 mitofusin agonist peptide described in ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and depicted in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A inset, used as a positive control. Data are mean Â± SEM of six experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>13B</b> PK studies in mice. (A) Total plasma and brain concentrations after single dose IV injections. (B) Steady-state elimination kinetics after 3 days continuous subcutaneous infusion. Data are means Â± differences of results from two mice of each time point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Oral bioavailability and <i>in vivo</i> target engagement of <b>13B</b> in mice. (A) Plasma levels after single dose IV (closed circles) or oral (open circles) administration. Data are means Â± SD of results from three mice for each condition. (B) (left) Kymographs demonstrating mitochondrial motility in sciatic nerves of CMT2A mice 6 h after oral administration as in (A). Motile mitochondria exhibit horizontal displacement. To the right are group quantitative data. Results are means Â± SD, each dot representing one axon from two mice per condition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1 and Its Backbone Variants<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>tert</i>-butyl (2-hydroxyethyl)carbamate, diethyl azodicarboxylate (DEAD), triphenylphosphine (PPh3), tetrahydrofuran (THF), room temperature (r.t.), 1 h. (b) HCl/dioxane, r.t., 18 h. (c) <b>1</b> and <b>2</b>: dichloromethane (DCM), r.t., 18 h; <b>3</b>: DCM, r.t., 30 min.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>4</b>â<b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>4</b>: Troc-Cl, DIPEA, DMAP, DCM, 40 Â°C, 12 h, N2, 95 Â°C, 10 h. <b>5</b>: TEA, DCM, CDI, 0â20 Â°C, 14 h. <b>6</b> and <b>7</b>: TEA, DCM, CDI, 5â10 Â°C, 3 h, 10â15 Â°C, 12 h. <b>8</b>: Troc-Cl, DIEA, DCM, 0â20 Â°C, 1 h, DMF, 90 Â°C, 12 h. <b>9</b>: TEA, DCM, CDI, 5â10 Â°C, 3 h, 10â15 Â°C, 2 h.</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>10</b>â<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>10</b> and <b>11</b>: THF, DIPEA, CDI, 25 Â°C, 16 h. <b>12</b>: THF, DIPEA, CDI, 25 Â°C, 23.5 h.</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>13</b>â<b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>13</b>, <b>13A</b>, <b>13B</b>, <b>14</b>, <b>17</b>, and <b>18</b>: DIEA, DMF, HOBt, EDCI, 25 Â°C, 3â16 h; <b>15</b> and <b>16</b>: DIEA, DMF, HOBt, EDCI, 25 Â°C 12â16 h, followed by HCl/MeOH 15â25 Â°C, 2â16 h.</p></p></figure><figure data-id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>19</b>â<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh3)2Cl2, Cul, TEA, DMF, 20 Â°C,16 h. (b) H2, Pd/C, MeOH, 20 Â°C, 4 h. (c) LiOHÂ·H<sub>2</sub>O, THF, MeOH, 20 Â°C, 16 h. (d) 4-Amino-cyclohexan-1-ol, HOBt, EDCI, DIEA, DMF, 25 Â°C, 16 h.</p></p></figure><figure data-id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/medium/jm0c00366_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>23</b>â<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00366/20200701/images/large/jm0c00366_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00366&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>23</b>: dimethylformamide (DMF), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), HOBt, <i>N</i>-ethyl-<i>N</i>â²-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI), 25 Â°C, 2 h; <b>24</b> and <b>25</b>: HOBt, EDCI, DIPEA, DMF, 25 Â°C, 1 h; <b>26</b>: T3P, triethylamine (TEA), DMF, 25 Â°C, 1 h; <b>27</b>: DIPEA, DCM, 25 Â°C, 1 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Emerging functions of mammalian mitochondrial fusion and fission</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R283</span>â <span class="NLM_lpage">R289</span>, <span class="refDoi">Â DOI: 10.1093/hmg/ddi270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1093%2Fhmg%2Fddi270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=16244327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=R283-R289&author=H.+Chenauthor=D.+C.+Chan&title=Emerging+functions+of+mammalian+mitochondrial+fusion+and+fission&doi=10.1093%2Fhmg%2Fddi270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging functions of mammalian mitochondrial fusion and fission</span></div><div class="casAuthors">Chen, Hsiuchen; Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">Rev. Issue 2</span>),
    <span class="NLM_cas:pages">R283-R289</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria provide a myriad of services to the cell, including energy prodn., calcium buffering and regulation of apoptosis.  How these diverse functions are coordinated among the hundreds of mitochondria in a given cell is largely unknown, but is probably dependent on the dynamic nature of mitochondria.  In this review, we explore the latest developments in mitochondrial dynamics in mammals.  These studies indicate that mitofusins and OPA1 are essential for mitochondrial fusion, whereas Fis1 and Drp1 are essential for mitochondrial fission.  The overall morphol. of the mitochondrial population depends on the relative activities of these two sets of proteins.  In addn. to the regulation of mitochondrial shape, these mols. also play important roles in cell and tissue physiol.  Perturbation of mitochondrial fusion results in defects in mitochondrial membrane potential and respiration, poor cell growth and increased susceptibility to cell death.  These cellular observations may explain why mitochondrial fusion is essential for embryonic development.  Two inherited neuropathies, Charcot-Marie-Tooth type 2A and autosomal dominant optic atrophy, are caused by mutations in mitofusin 2 and OPA1, suggesting that proper regulation of mitochondrial dynamics is particularly vital to neurons.  Mitochondrial fission accompanies several types of apoptotic cell death and appears important for progression of the apoptotic pathway.  These studies provide insight into how mitochondria communicate with one another to coordinate mitochondrial function and morphol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8a4G4OhRQBbVg90H21EOLACvtfcHk0lhWSTlh-pj_ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL3K&md5=f5fd80818370c580070e9adf12d8cce3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi270%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DEmerging%2520functions%2520of%2520mammalian%2520mitochondrial%2520fusion%2520and%2520fission%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2005%26volume%3D14%26spage%3DR283%26epage%3DR289%26doi%3D10.1093%2Fhmg%2Fddi270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebastian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacin, M.</span></span> <span> </span><span class="NLM_article-title">The molecular machinery of mitochondrial fusion and fission: An opportunity for drug discovery?</span>. <i>Curr. Opin. Drug Discovery Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">597</span>â <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=19736619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=597-606&author=A.+Zorzanoauthor=D.+Sebastianauthor=J.+Segalesauthor=M.+Palacin&title=The+molecular+machinery+of+mitochondrial+fusion+and+fission%3A+An+opportunity+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular machinery of mitochondrial fusion and fission: an opportunity for drug discovery?</span></div><div class="casAuthors">Zorzano, Antonio; Sebastian, David; Segales, Jessica; Palacin, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The mitochondria form dynamic organized networks or filaments that are controlled by fusion and fission events.  A balance between mitochondrial fusion and fission is crucial for the correct function of these organelles.  Thus, a detailed characterization of the proteins involved in mitochondrial fusion and fission, and the study of the mechanisms that regulate these two processes, would contribute to elucidating how this balance is achieved.  In this regard, alterations in some of the proteins that participate in mitochondrial dynamics are linked to human pathol.  In addn., exptl. data support the view that mitochondrial metab. is regulated via the manipulation of the proteins involved in mitochondrial dynamics, particularly the mitofusin 2 protein.  This review evaluates the potential of mitochondrial fusion and fission proteins as targets for drug discovery, with an emphasis on mitofusin 2.  The pharmacol. modulation of mitochondrial dynamics may be beneficial for the treatment of specific disorders of mitochondrial dynamics and mitochondrial-inherited diseases, as well as in complex diseases with a central mitochondrial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsB7tv-bara7Vg90H21EOLACvtfcHk0lhWSTlh-pj_ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSltL7N&md5=067c76ea35c2676128a142f728367d4b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZorzano%26aufirst%3DA.%26aulast%3DSebastian%26aufirst%3DD.%26aulast%3DSegales%26aufirst%3DJ.%26aulast%3DPalacin%26aufirst%3DM.%26atitle%3DThe%2520molecular%2520machinery%2520of%2520mitochondrial%2520fusion%2520and%2520fission%253A%2520An%2520opportunity%2520for%2520drug%2520discovery%253F%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muyderman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">2191</span>â <span class="NLM_lpage">2205</span>, <span class="refDoi">Â DOI: 10.1111/bph.12476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1111%2Fbph.12476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=24148000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFaqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=2191-2205&author=H.+Muydermanauthor=T.+Chen&title=Mitochondrial+dysfunction+in+amyotrophic+lateral+sclerosis+-+a+valid+pharmacological+target%3F&doi=10.1111%2Fbph.12476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?</span></div><div class="casAuthors">Muyderman, H.; Chen, T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2191-2205</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by the selective death of upper and lower motor neurons which ultimately leads to paralysis and ultimately death.  Pathol. changes in ALS are closely assocd. with pronounced and progressive changes in mitochondrial morphol., bioenergetics and calcium homeostasis.  Converging evidence suggests that impaired mitochondrial function could be pivotal in the rapid neurodegeneration of this condition.  In this review, we provide an update of recent advances in understanding mitochondrial biol. in the pathogenesis of ALS and highlight the therapeutic value of pharmacol. targeting mitochondrial biol. to slow disease progression.  Linked Articles : This article is part of a themed issue on Mitochondrial Pharmacol.: Energy, Injury & Beyond.  To view the other articles in this issue visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Ehlm2clcO7Vg90H21EOLACvtfcHk0liHGZpNfX9MEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFaqu7w%253D&md5=e91a269ad2bbac0704c01d31a76b186a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12476%26sid%3Dliteratum%253Aachs%26aulast%3DMuyderman%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DMitochondrial%2520dysfunction%2520in%2520amyotrophic%2520lateral%2520sclerosis%2520-%2520a%2520valid%2520pharmacological%2520target%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D2191%26epage%3D2205%26doi%3D10.1111%2Fbph.12476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ZÃ¼chner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mersiyanova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissar-Tadmouri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dadali, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zappia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patitucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evgrafov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonghe, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pericak-Vance, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quattrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span> <span> </span><span class="NLM_article-title">Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">449</span>â <span class="NLM_lpage">451</span>, <span class="refDoi">Â DOI: 10.1038/ng1341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fng1341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=15064763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFSntrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=449-451&author=S.+Z%C3%BCchnerauthor=I.+V.+Mersiyanovaauthor=M.+Mugliaauthor=N.+Bissar-Tadmouriauthor=J.+Rochelleauthor=E.+L.+Dadaliauthor=M.+Zappiaauthor=E.+Nelisauthor=A.+Patitucciauthor=J.+Senderekauthor=Y.+Parmanauthor=O.+Evgrafovauthor=P.+D.+Jongheauthor=Y.+Takahashiauthor=S.+Tsujiauthor=M.+A.+Pericak-Vanceauthor=A.+Quattroneauthor=E.+Battalogluauthor=A.+V.+Polyakovauthor=V.+Timmermanauthor=J.+M.+Schroderauthor=J.+M.+Vance&title=Mutations+in+the+mitochondrial+GTPase+mitofusin+2+cause+Charcot-Marie-Tooth+neuropathy+type+2A&doi=10.1038%2Fng1341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A</span></div><div class="casAuthors">Zuechner, Stephan; Mersiyanova, Irina V.; Muglia, Maria; Bissar-Tadmouri, Nisrine; Rochelle, Julie; Dadali, Elena L.; Zappia, Mario; Nelis, Eva; Patitucci, Alessandra; Senderek, Jan; Parman, Yesim; Evgrafov, Oleg; De Jonghe, Peter; Takahashi, Yuji; Tsuji, Shoij; Pericak-Vance, Margaret A.; Quattrone, Aldo; Battologlu, Esra; Polyakov, Alexander V.; Timmerman, Vincent; Schroeder, J. Michael; Vance, Jeffery M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-451</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report missense mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) in seven large pedigrees affected with Charcot-Marie-Tooth neuropathy type 2A (CMT2A).  Although a mutation in kinesin family member 1B-Î² (KIF1B) was assocd. with CMT2A in a single Japanese family, we found no mutations in KIF1B in these seven families.  Because these families include all published pedigrees with CMT2A and are ethnically diverse, we conclude that the primary gene mutated in CMT2A is MFN2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE2APEzpgnCLVg90H21EOLACvtfcHk0liHGZpNfX9MEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFSntrY%253D&md5=d7b2202b474ec9be9238300cd77861f3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fng1341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1341%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCchner%26aufirst%3DS.%26aulast%3DMersiyanova%26aufirst%3DI.%2BV.%26aulast%3DMuglia%26aufirst%3DM.%26aulast%3DBissar-Tadmouri%26aufirst%3DN.%26aulast%3DRochelle%26aufirst%3DJ.%26aulast%3DDadali%26aufirst%3DE.%2BL.%26aulast%3DZappia%26aufirst%3DM.%26aulast%3DNelis%26aufirst%3DE.%26aulast%3DPatitucci%26aufirst%3DA.%26aulast%3DSenderek%26aufirst%3DJ.%26aulast%3DParman%26aufirst%3DY.%26aulast%3DEvgrafov%26aufirst%3DO.%26aulast%3DJonghe%26aufirst%3DP.%2BD.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DS.%26aulast%3DPericak-Vance%26aufirst%3DM.%2BA.%26aulast%3DQuattrone%26aufirst%3DA.%26aulast%3DBattaloglu%26aufirst%3DE.%26aulast%3DPolyakov%26aufirst%3DA.%2BV.%26aulast%3DTimmerman%26aufirst%3DV.%26aulast%3DSchroder%26aufirst%3DJ.%2BM.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26atitle%3DMutations%2520in%2520the%2520mitochondrial%2520GTPase%2520mitofusin%25202%2520cause%2520Charcot-Marie-Tooth%2520neuropathy%2520type%25202A%26jtitle%3DNat.%2520Genet.%26date%3D2004%26volume%3D36%26spage%3D449%26epage%3D451%26doi%3D10.1038%2Fng1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feely, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siskind, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sottile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shy, M. E.</span></span> <span> </span><span class="NLM_article-title">MFN2 mutations cause severe phenotypes in most patients with CMT2A</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1690</span>â <span class="NLM_lpage">1696</span>, <span class="refDoi">Â DOI: 10.1212/WNL.0b013e31821a441e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1212%2FWNL.0b013e31821a441e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=21508331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFajtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=1690-1696&author=S.+M.+Feelyauthor=M.+Lauraauthor=C.+E.+Siskindauthor=S.+Sottileauthor=M.+Davisauthor=V.+S.+Gibbonsauthor=M.+M.+Reillyauthor=M.+E.+Shy&title=MFN2+mutations+cause+severe+phenotypes+in+most+patients+with+CMT2A&doi=10.1212%2FWNL.0b013e31821a441e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">MFN2 mutations cause severe phenotypes in most patients with CMT2A</span></div><div class="casAuthors">Feely S M E; Laura M; Siskind C E; Sottile S; Davis M; Gibbons V S; Reilly M M; Shy M E</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1690-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Charcot-Marie-Tooth disease type 2A (CMT2A), the most common form of CMT2, is caused by mutations in the mitofusin 2 gene (MFN2), a nuclear encoded gene essential for mitochondrial fusion and tethering the endoplasmic reticulum to mitochondria.  Published CMT2A phenotypes have differed widely in severity.  METHODS:  To determine the prevalence and phenotypes of CMT2A within our clinics we performed genetic testing on 99 patients with CMT2 evaluated at Wayne State University in Detroit and on 27 patients with CMT2 evaluated in the National Hospital for Neurology and Neurosurgery in London.  We then preformed a cross-sectional analysis on our patients with CMT2A.  RESULTS:  Twenty-one percent of patients had MFN2 mutations.  Most of 27 patients evaluated with CMT2A had an earlier onset and more severe impairment than patients without CMT2A.  CMT2A accounted for 91% of all our severely impaired patients with CMT2 but only 11% of mildly or moderately impaired patients.  Twenty-three of 27 patients with CMT2A were nonambulatory prior to age 20 whereas just one of 78 non-CMT2A patients was nonambulatory after this age.  Eleven patients with CMT2A had a pure motor neuropathy while another 5 also had profound proprioception loss.  MFN2 mutations were in the GTPase domain, the coiled-coil domains, or the highly conserved R3 domain of the protein.  CONCLUSIONS:  We find MFN2 mutations particularly likely to cause severe neuropathy that may be primarily motor or motor accompanied by prominent proprioception loss.  Disruption of functional domains of the protein was particularly likely to cause neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSO2mnZh2OgS0fW6udTcc2ealsNWM8hppLbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFajtA%253D%253D&md5=43dce23aa6d6c0fab2e68b85d90551d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1212%2FWNL.0b013e31821a441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0b013e31821a441e%26sid%3Dliteratum%253Aachs%26aulast%3DFeely%26aufirst%3DS.%2BM.%26aulast%3DLaura%26aufirst%3DM.%26aulast%3DSiskind%26aufirst%3DC.%2BE.%26aulast%3DSottile%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DGibbons%26aufirst%3DV.%2BS.%26aulast%3DReilly%26aufirst%3DM.%2BM.%26aulast%3DShy%26aufirst%3DM.%2BE.%26atitle%3DMFN2%2520mutations%2520cause%2520severe%2520phenotypes%2520in%2520most%2520patients%2520with%2520CMT2A%26jtitle%3DNeurology%26date%3D2011%26volume%3D76%26spage%3D1690%26epage%3D1696%26doi%3D10.1212%2FWNL.0b013e31821a441e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fusion is essential for organelle function and cardiac homeostasis</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1327</span>â <span class="NLM_lpage">1331</span>, <span class="refDoi">Â DOI: 10.1161/CIRCRESAHA.111.258723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1161%2FCIRCRESAHA.111.258723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22052916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsF2jsrrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2011&pages=1327-1331&author=Y.+Chenauthor=Y.+Liuauthor=G.+W.+Dorn&title=Mitochondrial+fusion+is+essential+for+organelle+function+and+cardiac+homeostasis&doi=10.1161%2FCIRCRESAHA.111.258723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Fusion is Essential for Organelle Function and Cardiac Homeostasis</span></div><div class="casAuthors">Chen, Yun; Liu, Yingqiu; Dorn, Gerald W., II</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1327-1331</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: Mitochondria constitute 30% of myocardial mass.  Mitochondrial fusion and fission appear essential for health of most tissues.  Mitochondrial fission occurs in neonatal cardiomyocyte and is implicated in cardiomyocyte death.  Mitochondrial fusion has not been obsd. in postmitotic myocytes of adult hearts, and its occurrence and function in this context are controversial.  Objective: Det. the consequences on organelle and organ function of disrupting cardiomyocyte mitochondrial fusion in vivo.  Methods and results: The murine mfn1 and mfn2 genes, encoding mitofusins (Mfn) 1 and 2 that mediate mitochondrial tethering and outer mitochondrial membrane fusion, were interrupted by Cre-mediated excision of essential exons in neonatal (Nkx2.5-Cre) and adult (MYH6 modified estrogen receptor-Cre-modified estrogen receptor plus tamoxifen or Raloxifene) hearts.  Embryonic combined Mfn1/Mfn2 ablation was lethal after e9.5.  Conditional combined Mfn1/Mfn2 ablation in adult hearts induced mitochondrial fragmentation, cardiomyocyte and mitochondrial respiratory dysfunction, and rapidly progressive and lethal dilated cardiomyopathy.  Before heart failure developed, cardiomyocyte shortening and calcium cycling were unaffected by absence of Mfn1 and Mfn2.  Based on the time course over which fusion-defective mitochondrial size decreases, a mitochondrial fusion/fission cycle in adult mouse hearts occurs approx. every 16 days.  Conclusions: Mitochondrial fusion in adult cardiac myocytes is necessary to maintain normal mitochondrial morphol. and is essential for normal cardiac respiratory and contractile function.  Interruption of mitochondrial fusion causes lethal cardiac failure at a time corresponding to 3 or 4 cycles of unopposed mitochondrial fission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNIgpkMtE3ELVg90H21EOLACvtfcHk0liV9EzwSZ1RxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsF2jsrrN&md5=86b79fe444ca6fbe81c99e1d7286e04b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.111.258723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.111.258723%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMitochondrial%2520fusion%2520is%2520essential%2520for%2520organelle%2520function%2520and%2520cardiac%2520homeostasis%26jtitle%3DCirc.%2520Res.%26date%3D2011%26volume%3D109%26spage%3D1327%26epage%3D1331%26doi%3D10.1161%2FCIRCRESAHA.111.258723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papanicolaou, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngoh, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coughlan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K.</span></span> <span> </span><span class="NLM_article-title">Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1012</span>â <span class="NLM_lpage">1026</span>, <span class="refDoi">Â DOI: 10.1161/CIRCRESAHA.112.274142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1161%2FCIRCRESAHA.112.274142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22904094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWmt77I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2012&pages=1012-1026&author=K.+N.+Papanicolaouauthor=R.+Kikuchiauthor=G.+A.+Ngohauthor=K.+A.+Coughlanauthor=I.+Dominguezauthor=W.+C.+Stanleyauthor=K.+Walsh&title=Mitofusins+1+and+2+are+essential+for+postnatal+metabolic+remodeling+in+heart&doi=10.1161%2FCIRCRESAHA.112.274142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mitofusins 1 and 2 Are Essential for Postnatal Metabolic Remodeling in Heart</span></div><div class="casAuthors">Papanicolaou, Kyriakos N.; Kikuchi, Ryosuke; Ngoh, Gladys A.; Coughlan, Kimberly A.; Dominguez, Isabel; Stanley, William C.; Walsh, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1012-1026</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: At birth, there is a switch from placental to pulmonary circulation and the heart commences its aerobic metab.  In cardiac myocytes, this transition is marked by increased mitochondrial biogenesis and remodeling of the intracellular architecture.  The mechanisms governing the formation of new mitochondria and their expansion within myocytes remain largely unknown.  Mitofusins (Mfn-1 and Mfn-2) are known regulators of mitochondrial networks, but their role during perinatal maturation of the heart has yet to be examd.  Objective: The objective of this study was to det. the significance of mitofusins during early postnatal cardiac development.  Methods and results: We genetically inactivated Mfn-1 and Mfn-2 in midgestational and postnatal cardiac myocytes using a loxP/Myh6-cre approach.  At birth, cardiac morphol. and function of double-knockout (DKO) mice are normal.  At that time, DKO mitochondria increase in nos., appear to be spherical and heterogeneous in size, but exhibit normal electron d.  By postnatal day 7, the mitochondrial nos. in DKO myocytes remain abnormally expanded and many lose matrix components and membrane organization.  At this time point, DKO mice have developed cardiomyopathy.  This leads to a rapid decline in survival and all DKO mice die before 16 days of age.  Gene expression anal. of DKO hearts shows that mitochondria biogenesis genes are downregulated, the mitochondrial DNA is reduced, and mitochondrially encoded transcripts and proteins are also reduced.  Furthermore, mitochondrial turnover pathways are dysregulated.  Conclusions: Our findings establish that Mfn-1 and Mfn-2 are essential in mediating mitochondrial remodeling during postnatal cardiac development, a time of dramatic transitions in the bioenergetics and growth of the heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFC6h4vRUWwbVg90H21EOLACvtfcHk0liV9EzwSZ1RxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWmt77I&md5=c72d341f882ea81cbd089466c6ccfbcb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.112.274142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.112.274142%26sid%3Dliteratum%253Aachs%26aulast%3DPapanicolaou%26aufirst%3DK.%2BN.%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3DNgoh%26aufirst%3DG.%2BA.%26aulast%3DCoughlan%26aufirst%3DK.%2BA.%26aulast%3DDominguez%26aufirst%3DI.%26aulast%3DStanley%26aufirst%3DW.%2BC.%26aulast%3DWalsh%26aufirst%3DK.%26atitle%3DMitofusins%25201%2520and%25202%2520are%2520essential%2520for%2520postnatal%2520metabolic%2520remodeling%2520in%2520heart%26jtitle%3DCirc.%2520Res.%26date%3D2012%26volume%3D111%26spage%3D1012%26epage%3D1026%26doi%3D10.1161%2FCIRCRESAHA.112.274142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipolat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">734</span>â <span class="NLM_lpage">737</span>, <span class="refDoi">Â DOI: 10.1126/science.1241359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.1241359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=24091702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWlsLrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=734-737&author=A.+Kasaharaauthor=S.+Cipolatauthor=Y.+Chenauthor=G.+W.+Dornauthor=L.+Scorrano&title=Mitochondrial+fusion+directs+cardiomyocyte+differentiation+via+calcineurin+and+Notch+signaling&doi=10.1126%2Fscience.1241359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling</span></div><div class="casAuthors">Kasahara, Atsuko; Cipolat, Sara; Chen, Yun; Dorn, Gerald W., II; Scorrano, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6159</span>),
    <span class="NLM_cas:pages">734-737</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitochondrial morphol. is crucial for tissue homeostasis, but its role in cell differentiation is unclear.  Here, the authors found that mitochondrial fusion was required for proper cardiomyocyte development.  Ablation of mitochondrial fusion proteins mitofusin 1 and mitofusin 2 in embryonic mouse heart, or gene-trapping of mitofusin 2 or optic atrophy 1 in mouse embryonic stem cells (ESCs), arrested mouse heart development and impaired the differentiation of ESCs into cardiomyocytes.  Gene expression profiling revealed decreased levels of the transcription factors, transforming growth factor-Î²/bone morphogenetic protein, serum response factor, GATA4, and myocyte enhancer factor 2, linked to increased Ca2+-dependent calcineurin activity and Notch 1 signaling that impaired ESC differentiation.  Orchestration of cardiomyocyte differentiation by mitochondrial morphol. revealed how mitochondria, Ca2+, and calcineurin interact to regulate Notch 1 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojm3gp1TnyPbVg90H21EOLACvtfcHk0lj7iTP0ORo3_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWlsLrI&md5=a99dc48d0135e2fb4c16bfd2cd2200ea</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241359%26sid%3Dliteratum%253Aachs%26aulast%3DKasahara%26aufirst%3DA.%26aulast%3DCipolat%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26aulast%3DScorrano%26aufirst%3DL.%26atitle%3DMitochondrial%2520fusion%2520directs%2520cardiomyocyte%2520differentiation%2520via%2520calcineurin%2520and%2520Notch%2520signaling%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D734%26epage%3D737%26doi%3D10.1126%2Fscience.1241359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csordas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matkovich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>, <span class="NLM_elocation-id">aad2459</span> <span class="refDoi">Â DOI: 10.1126/science.aad2459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.aad2459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=26785495" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&author=G.+Gongauthor=M.+Songauthor=G.+Csordasauthor=D.+P.+Kellyauthor=S.+J.+Matkovichauthor=G.+W.+Dorn&title=Parkin-mediated+mitophagy+directs+perinatal+cardiac+metabolic+maturation+in+mice&doi=10.1126%2Fscience.aad2459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.aad2459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aad2459%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DG.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DCsordas%26aufirst%3DG.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26aulast%3DMatkovich%26aufirst%3DS.%2BJ.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DParkin-mediated%2520mitophagy%2520directs%2520perinatal%2520cardiac%2520metabolic%2520maturation%2520in%2520mice%26jtitle%3DScience%26date%3D2015%26volume%3D350%26doi%3D10.1126%2Fscience.aad2459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">273</span>â <span class="NLM_lpage">285</span>, <span class="refDoi">Â DOI: 10.1016/j.cmet.2014.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.cmet.2014.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=25600785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Ois7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=273-285&author=M.+Songauthor=K.+Miharaauthor=Y.+Chenauthor=L.+Scorranoauthor=G.+W.+Dorn&title=Mitochondrial+fission+and+fusion+factors+reciprocally+orchestrate+mitophagic+culling+in+mouse+hearts+and+cultured+fibroblasts&doi=10.1016%2Fj.cmet.2014.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Fission and Fusion Factors Reciprocally Orchestrate Mitophagic Culling in Mouse Hearts and Cultured Fibroblasts</span></div><div class="casAuthors">Song, Moshi; Mihara, Katsuyoshi; Chen, Yun; Scorrano, Luca; Dorn, Gerald W., II</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-285</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">How mitochondrial dynamism (fission and fusion) affects mitochondrial quality control is unclear.  We uncovered distinct effects on mitophagy of inhibiting Drp1-mediated mitochondrial fission vs. mitofusin-mediated mitochondrial fusion.  Conditional cardiomyocyte-specific Drp1 ablation evoked mitochondrial enlargement, lethal dilated cardiomyopathy, and cardiomyocyte necrosis.  Conditionally ablating cardiomyocyte mitofusins (Mfn) caused mitochondrial fragmentation with eccentric remodeling and no cardiomyocyte dropout.  Parallel studies in cultured murine embryonic fibroblasts (MEFs) and in vivo mouse hearts revealed that Mfn1/Mfn2 deletion provoked accumulation of defective mitochondria exhibiting an unfolded protein response, without appropriately increasing mitophagy.  Conversely, interrupting mitochondrial fission by Drp1 ablation increased mitophagy and caused a generalized loss of mitochondria.  Mitochondrial permeability transition pore (MPTP) opening in Drp1 null mitochondria was assocd. with mitophagy in MEFs and contributed to cardiomyocyte necrosis and dilated cardiomyopathy in mice.  Drp1, MPTP, and cardiomyocyte mitophagy are functionally integrated.  Mitochondrial fission and fusion have opposing roles during in vivo cardiac mitochondrial quality control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkfihVf0YED7Vg90H21EOLACvtfcHk0lj7iTP0ORo3_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Ois7s%253D&md5=45eef28c556025f047bcadccb8673f0e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2014.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2014.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DScorrano%26aufirst%3DL.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMitochondrial%2520fission%2520and%2520fusion%2520factors%2520reciprocally%2520orchestrate%2520mitophagic%2520culling%2520in%2520mouse%2520hearts%2520and%2520cultured%2520fibroblasts%26jtitle%3DCell%2520Metab.%26date%3D2015%26volume%3D21%26spage%3D273%26epage%3D285%26doi%3D10.1016%2Fj.cmet.2014.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Abrogating mitochondrial dynamics in mouse hearts accelerates mitochondrial senescence</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">872.e5</span>â <span class="NLM_lpage">883.e5</span>, <span class="refDoi">Â DOI: 10.1016/j.cmet.2017.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.cmet.2017.09.023" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=872.e5-883.e5&author=M.+Songauthor=A.+Francoauthor=J.+A.+Fleischerauthor=L.+Zhangauthor=G.+W.+Dorn&title=Abrogating+mitochondrial+dynamics+in+mouse+hearts+accelerates+mitochondrial+senescence&doi=10.1016%2Fj.cmet.2017.09.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DFleischer%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DAbrogating%2520mitochondrial%2520dynamics%2520in%2520mouse%2520hearts%2520accelerates%2520mitochondrial%2520senescence%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D26%26spage%3D872.e5%26epage%3D883.e5%26doi%3D10.1016%2Fj.cmet.2017.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koshiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Detmer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaffery, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis of mitochondrial tethering by mitofusin complexes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">858</span>â <span class="NLM_lpage">862</span>, <span class="refDoi">Â DOI: 10.1126/science.1099793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.1099793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=15297672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Krsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=858-862&author=T.+Koshibaauthor=S.+A.+Detmerauthor=J.+T.+Kaiserauthor=H.+Chenauthor=J.+M.+McCafferyauthor=D.+C.+Chan&title=Structural+basis+of+mitochondrial+tethering+by+mitofusin+complexes&doi=10.1126%2Fscience.1099793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Mitochondrial Tethering by Mitofusin Complexes</span></div><div class="casAuthors">Koshiba, Takumi; Detmer, Scott A.; Kaiser, Jens T.; Chen, Hsiuchen; McCaffery, J. Michael; Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5685</span>),
    <span class="NLM_cas:pages">858-862</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Vesicle fusion involves vesicle tethering, docking, and membrane merger.  We show that mitofusin, an integral mitochondrial membrane protein, is required on adjacent mitochondria to mediate fusion, which indicates that mitofusin complexes act in trans (i.e., between adjacent mitochondria).  A heptad repeat region (HR2) mediates mitofusin oligomerization by assembling a dimeric, antiparallel coiled coil.  The transmembrane segments are located at opposite ends of the 95 angstrom coiled coil and provide a mechanism for organelle tethering.  Consistent with this proposal, truncated mitofusin, in an HR2-dependent manner, causes mitochondria to become apposed with a uniform gap.  Our results suggest that HR2 functions as a mitochondrial tether before fusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeA17zSrs_ALVg90H21EOLACvtfcHk0lj7iTP0ORo3_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Krsb0%253D&md5=f1ab19e9c4838ea79e91ec997bf5b341</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099793%26sid%3Dliteratum%253Aachs%26aulast%3DKoshiba%26aufirst%3DT.%26aulast%3DDetmer%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMcCaffery%26aufirst%3DJ.%2BM.%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DStructural%2520basis%2520of%2520mitochondrial%2520tethering%2520by%2520mitofusin%2520complexes%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D858%26epage%3D862%26doi%3D10.1126%2Fscience.1099793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria: dynamic organelles in disease, aging, and development</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">1241</span>â <span class="NLM_lpage">1252</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2006.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.cell.2006.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=16814712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=1241-1252&author=D.+C.+Chan&title=Mitochondria%3A+dynamic+organelles+in+disease%2C+aging%2C+and+development&doi=10.1016%2Fj.cell.2006.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria: dynamic organelles in disease, aging, and development</span></div><div class="casAuthors">Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1241-1252</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria are the primary energy-generating system in most eukaryotic cells.  Addnl., they participate in intermediary metab., Ca2+ signaling, and apoptosis.  Given these well-established functions, it might be expected that mitochondrial dysfunction would give rise to a simple and predictable set of defects in all tissues.  However, mitochondrial dysfunction has pleiotropic effects in multicellular organisms.  Clearly, much about the basic biol. of mitochondria remains to be understood.  Here, the authors discuss recent work that suggests that the dynamics (fusion and fission) of these organelles is important in development and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHxWfcOENvbVg90H21EOLACvtfcHk0lhdJuhN1Ryeog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D&md5=2de7a7341c3294779ad85b276a7d38e5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DMitochondria%253A%2520dynamic%2520organelles%2520in%2520disease%252C%2520aging%252C%2520and%2520development%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D1241%26epage%3D1252%26doi%3D10.1016%2Fj.cell.2006.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Fusion and fission: interlinked processes critical for mitochondrial health</span>. <i>Annu. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">265</span>â <span class="NLM_lpage">287</span>, <span class="refDoi">Â DOI: 10.1146/annurev-genet-110410-132529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1146%2Fannurev-genet-110410-132529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22934639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyktbbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=265-287&author=D.+C.+Chan&title=Fusion+and+fission%3A+interlinked+processes+critical+for+mitochondrial+health&doi=10.1146%2Fannurev-genet-110410-132529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fusion and fission: interlinked processes critical for mitochondrial health</span></div><div class="casAuthors">Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-287</span>CODEN:
                <span class="NLM_cas:coden">ARVGB7</span>;
        ISSN:<span class="NLM_cas:issn">0066-4197</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Mitochondria are dynamic organelles that continually undergo fusion and fission.  These opposing processes work in concert to maintain the shape, size, and no. of mitochondria and their physiol. function.  Some of the major mols. mediating mitochondrial fusion and fission in mammals have been discovered, but the underlying mol. mechanisms are only partially unraveled.  In particular, the cast of characters involved in mitochondrial fission needs to be clarified.  By enabling content mixing between mitochondria, fusion and fission serve to maintain a homogeneous and healthy mitochondrial population.  Mitochondrial dynamics has been linked to multiple mitochondrial functions, including mitochondrial DNA stability, respiratory capacity, apoptosis, response to cellular stress, and mitophagy.  Because of these important functions, mitochondrial fusion and fission are essential in mammals, and even mild defects in mitochondrial dynamics are assocd. with disease.  A better understanding of these processes likely will ultimately lead to improvements in human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2w3YXxkxEobVg90H21EOLACvtfcHk0lhdJuhN1Ryeog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyktbbE&md5=af26f9e1e56be1748bf960859906bf1c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genet-110410-132529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genet-110410-132529%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DFusion%2520and%2520fission%253A%2520interlinked%2520processes%2520critical%2520for%2520mitochondrial%2520health%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D46%26spage%3D265%26epage%3D287%26doi%3D10.1146%2Fannurev-genet-110410-132529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knott, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzenbacher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossy-Wetzel, E.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial fragmentation in neurodegeneration</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">505</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.1038/nrn2417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fnrn2417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=18568013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFChu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=505-518&author=A.+B.+Knottauthor=G.+Perkinsauthor=R.+Schwarzenbacherauthor=E.+Bossy-Wetzel&title=Mitochondrial+fragmentation+in+neurodegeneration&doi=10.1038%2Fnrn2417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial fragmentation in neurodegeneration</span></div><div class="casAuthors">Knott, Andrew B.; Perkins, Guy; Schwarzenbacher, Robert; Bossy-Wetzel, Ella</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">505-518</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is mounting evidence that mitochondrial dysfunction is an early and causal event in neurodegeneration.  Here, Bossy-Wetzel and colleagues discuss how aberrant mitochondrial fission and fusion can contribute to neurodegenerative disease.  Mitochondria are remarkably dynamic organelles that migrate, divide and fuse.  Cycles of mitochondrial fission and fusion ensure metabolite and mitochondrial DNA mixing and dictate organelle shape, no. and bioenergetic functionality.  There is mounting evidence that mitochondrial dysfunction is an early and causal event in neurodegeneration.  Mutations in the mitochondrial fusion GTPases mitofusin 2 and optic atrophy 1, neurotoxins and oxidative stress all disrupt the cable-like morphol. of functional mitochondria.  This results in impaired bioenergetics and mitochondrial migration, and can trigger neurodegeneration.  These findings suggest potential new treatment avenues for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_keURAnRxmrVg90H21EOLACvtfcHk0lhdJuhN1Ryeog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFChu7c%253D&md5=3ac2e09a3f87fffec2eda84a1187bbbb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrn2417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2417%26sid%3Dliteratum%253Aachs%26aulast%3DKnott%26aufirst%3DA.%2BB.%26aulast%3DPerkins%26aufirst%3DG.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DBossy-Wetzel%26aufirst%3DE.%26atitle%3DMitochondrial%2520fragmentation%2520in%2520neurodegeneration%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D505%26epage%3D518%26doi%3D10.1038%2Fnrn2417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">Evolving Concepts of Mitochondrial Dynamics</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1146/annurev-physiol-020518-114358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1146%2Fannurev-physiol-020518-114358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=30256725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslyru7vE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2019&pages=1-17&author=G.+W.+Dorn&title=Evolving+Concepts+of+Mitochondrial+Dynamics&doi=10.1146%2Fannurev-physiol-020518-114358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving Concepts of Mitochondrial Dynamics</span></div><div class="casAuthors">Dorn, Gerald W.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">The concept that mitochondria are highly dynamic is as widely accepted as it is untrue for a no. of important contexts.  Healthy mitochondria of the most energy-dependent and mitochondrial-rich mammalian organ, the heart, only rarely undergo fusion or fission and are seemingly static within cardiac myocytes.  Here, we revisit mitochondrial dynamism with a fresh perspective developed from the recently discovered multifunctionality of mitochondrial fusion proteins and newly defined mechanisms for direct cross talk between mitochondrial dynamics, biogenesis, quality control, and trafficking pathways.  Insights gained from comparing static mitochondrial biol. in cardiac myocytes and dynamic mitochondrial biol. in neurons are reviewed with the goal of understanding contextual fallacies of overly generalized characterizations of these essential and intriguing organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK0eq0xoe8M7Vg90H21EOLACvtfcHk0liA9_sfJcXVxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslyru7vE&md5=1d639123e5676bc097ca80edc587d95e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-020518-114358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-020518-114358%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DEvolving%2520Concepts%2520of%2520Mitochondrial%2520Dynamics%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2019%26volume%3D81%26spage%3D1%26epage%3D17%26doi%3D10.1146%2Fannurev-physiol-020518-114358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornfeld, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biris, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qvit, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochly-Rosen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  II</span></span> <span> </span><span class="NLM_article-title">Correcting mitochondrial fusion by manipulating mitofusin conformations</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>540</i></span>,  <span class="NLM_fpage">74</span>â <span class="NLM_lpage">79</span>, <span class="refDoi">Â DOI: 10.1038/nature20156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fnature20156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=27775718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFylsLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=540&publication_year=2016&pages=74-79&author=A.+Francoauthor=R.+N.+Kitsisauthor=J.+A.+Fleischerauthor=E.+Gavathiotisauthor=O.+S.+Kornfeldauthor=G.+Gongauthor=N.+Birisauthor=A.+Benzauthor=N.+Qvitauthor=S.+K.+Donnellyauthor=Y.+Chenauthor=S.+Mennerickauthor=L.+Hodgsonauthor=D.+Mochly-Rosenauthor=G.+W.+Dorn&title=Correcting+mitochondrial+fusion+by+manipulating+mitofusin+conformations&doi=10.1038%2Fnature20156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Correcting mitochondrial fusion by manipulating mitofusin conformations</span></div><div class="casAuthors">Franco, Antonietta; Kitsis, Richard N.; Fleischer, Julie A.; Gavathiotis, Evripidis; Kornfeld, Opher S.; Gong, Guohua; Biris, Nikolaos; Benz, Ann; Qvit, Nir; Donnelly, Sara K.; Chen, Yun; Mennerick, Steven; Hodgson, Louis; Mochly-Rosen, Daria; Dorn II, Gerald W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">540</span>
        (<span class="NLM_cas:issue">7631</span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondria are dynamic organelles that exchange contents and undergo remodeling during cyclic fusion and fission.  Genetic mutations in MFN2 (the gene encoding mitofusin 2) interrupt mitochondrial fusion and cause the untreatable neurodegenerative condition Charcot-Marie-Tooth disease type 2A (CMT2A).  It has not yet been possible to directly modulate mitochondrial fusion, in part because the structural basis of mitofusin function is not completely understood.  Here we show that mitofusins adopt either a fusion-constrained or a fusion-permissive mol. conformation, directed by specific intramol. binding interactions, and demonstrate that mitofusin-dependent mitochondrial fusion can be regulated in mouse cells by targeting these conformational transitions.  On the basis of this model, we engineered a cell-permeant minipeptide to destabilize the fusion-constrained conformation of mitofusin and promote the fusion-permissive conformation, reversing mitochondrial abnormalities in cultured fibroblasts and neurons that harbor CMT2A-assocd. genetic defects.  The relationship between the conformational plasticity of mitofusin 2 and mitochondrial dynamism reveals a central mechanism that regulates mitochondrial fusion, the manipulation of which can correct mitochondrial pathol. triggered by defective or imbalanced mitochondrial dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUsxRhYbt0L7Vg90H21EOLACvtfcHk0liA9_sfJcXVxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFylsLbP&md5=187a52b917cbd6a4c7c5c42ba868ddde</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature20156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature20156%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DFleischer%26aufirst%3DJ.%2BA.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DKornfeld%26aufirst%3DO.%2BS.%26aulast%3DGong%26aufirst%3DG.%26aulast%3DBiris%26aufirst%3DN.%26aulast%3DBenz%26aufirst%3DA.%26aulast%3DQvit%26aufirst%3DN.%26aulast%3DDonnelly%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMennerick%26aufirst%3DS.%26aulast%3DHodgson%26aufirst%3DL.%26aulast%3DMochly-Rosen%26aufirst%3DD.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DCorrecting%2520mitochondrial%2520fusion%2520by%2520manipulating%2520mitofusin%2520conformations%26jtitle%3DNature%26date%3D2016%26volume%3D540%26spage%3D74%26epage%3D79%26doi%3D10.1038%2Fnature20156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krezel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biris, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharioudakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloh, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochly-Rosen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span> <span> </span><span class="NLM_article-title">MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">336</span>â <span class="NLM_lpage">341</span>, <span class="refDoi">Â DOI: 10.1126/science.aao1785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1126%2Fscience.aao1785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=29674596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns12gtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&pages=336-341&author=A.+G.+Rochaauthor=A.+Francoauthor=A.+M.+Krezelauthor=J.+M.+Rumseyauthor=J.+M.+Albertiauthor=W.+C.+Knightauthor=N.+Birisauthor=E.+Zacharioudakisauthor=J.+W.+Janetkaauthor=R.+H.+Balohauthor=R.+N.+Kitsisauthor=D.+Mochly-Rosenauthor=R.+R.+Townsendauthor=E.+Gavathiotisauthor=G.+W.+Dorn&title=MFN2+agonists+reverse+mitochondrial+defects+in+preclinical+models+of+Charcot-Marie-Tooth+disease+type+2A&doi=10.1126%2Fscience.aao1785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A</span></div><div class="casAuthors">Rocha, Agostinho G.; Franco, Antonietta; Krezel, Andrzej M.; Rumsey, Jeanne M.; Alberti, Justin M.; Knight, William C.; Biris, Nikolaos; Zacharioudakis, Emmanouil; Janetka, James W.; Baloh, Robert H.; Kitsis, Richard N.; Mochly-Rosen, Daria; Townsend, R. Reid; Gavathiotis, Evripidis; Dorn, Gerald W., II</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">6386</span>),
    <span class="NLM_cas:pages">336-341</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitofusins (MFNs) promote fusion-mediated mitochondrial content exchange and subcellular trafficking.  Mutations in Mfn2 cause neurodegenerative Charcot-Marie-Tooth disease type 2A (CMT2A).  We showed that MFN2 activity can be detd. by Met376 and His380 interactions with Asp725 and Leu727 and controlled by PINK1 kinase-mediated phosphorylation of adjacent MFN2 Ser378.  Small-mol. mimics of the peptide-peptide interface of MFN2 disrupted this interaction, allosterically activating MFN2 and promoting mitochondrial fusion.  These first-in-class mitofusin agonists overcame dominant mitochondrial defects provoked in cultured neurons by CMT2A mutants MFN2 Arg94âGln94 and MFN2 Thr105âMet105, as demonstrated by amelioration of mitochondrial dysmotility, fragmentation, depolarization, and clumping.  A mitofusin agonist normalized axonal mitochondrial trafficking within sciatic nerves of MFN2 Thr105âMet105 mice, promising a therapeutic approach for CMT2A and other untreatable diseases of impaired neuronal mitochondrial dynamism and/or trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpajd_bDgXFyLVg90H21EOLACvtfcHk0liA9_sfJcXVxw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns12gtL0%253D&md5=1caad3813ea70d3bcb0d071dcfefa7f1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.aao1785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aao1785%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DA.%2BG.%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DKrezel%26aufirst%3DA.%2BM.%26aulast%3DRumsey%26aufirst%3DJ.%2BM.%26aulast%3DAlberti%26aufirst%3DJ.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BC.%26aulast%3DBiris%26aufirst%3DN.%26aulast%3DZacharioudakis%26aufirst%3DE.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DBaloh%26aufirst%3DR.%2BH.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DMochly-Rosen%26aufirst%3DD.%26aulast%3DTownsend%26aufirst%3DR.%2BR.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMFN2%2520agonists%2520reverse%2520mitochondrial%2520defects%2520in%2520preclinical%2520models%2520of%2520Charcot-Marie-Tooth%2520disease%2520type%25202A%26jtitle%3DScience%26date%3D2018%26volume%3D360%26spage%3D336%26epage%3D341%26doi%3D10.1126%2Fscience.aao1785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hefti, F. F.</span></span> <span> </span><span class="NLM_article-title">Requirements for a lead compound to become a clinical candidate</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">S7</span> <span class="refDoi">Â DOI: 10.1186/1471-2202-9-S3-S7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1186%2F1471-2202-9-S3-S7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=19091004" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&author=F.+F.+Hefti&title=Requirements+for+a+lead+compound+to+become+a+clinical+candidate&doi=10.1186%2F1471-2202-9-S3-S7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-9-S3-S7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-9-S3-S7%26sid%3Dliteratum%253Aachs%26aulast%3DHefti%26aufirst%3DF.%2BF.%26atitle%3DRequirements%2520for%2520a%2520lead%2520compound%2520to%2520become%2520a%2520clinical%2520candidate%26jtitle%3DBMC%2520Neurosci.%26date%3D2008%26volume%3D9%26doi%3D10.1186%2F1471-2202-9-S3-S7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for bloodâbrain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>â <span class="NLM_lpage">232</span>, <span class="refDoi">Â DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0ljWPZkDrvtGlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gubernator, K.</span></span> <span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1007</span>â <span class="NLM_lpage">1010</span>, <span class="refDoi">Â DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0ljWPZkDrvtGlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span> <span> </span><span class="NLM_article-title">PAMPA--critical factors for better predictions of absorption</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2893</span>â <span class="NLM_lpage">2909</span>, <span class="refDoi">Â DOI: 10.1002/jps.21068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1002%2Fjps.21068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=17803196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2893-2909&author=A.+Avdeefauthor=S.+Bendelsauthor=L.+Diauthor=B.+Fallerauthor=M.+Kansyauthor=K.+Suganoauthor=Y.+Yamauchi&title=PAMPA%2D%2Dcritical+factors+for+better+predictions+of+absorption&doi=10.1002%2Fjps.21068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel artificial membrane permeability assay (PAMPA)-critical factors for better predictions of absorption</span></div><div class="casAuthors">Avdeef, Alex; Bendels, Stefanie; Di, Li; Faller, Bernard; Kansy, Manfred; Sugano, Kiyohiko; Yamauchi, Yukinori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2893-2909</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  PAMPA, log POCT, and Caco-2 are useful tools in drug discovery for the prediction of oral absorption, brain penetration and for the development of structure-permeability relationships.  Each approach has its advantages and limitations.  Selection criteria for methods are based on many different factors: predictability, throughput, cost and personal preferences (people factor).  The PAMPA concerns raised by Galinis-Luciani et al. are answered by experienced PAMPA practitioners, inventors and developers from diverse research organizations.  Guidelines on how to use PAMPA are discussed.  PAMPA and PAMPA-BBB have much better predictivity for oral absorption and brain penetration than log POCT for real-world drug discovery compds.  PAMPA and Caco-2 have similar predictivity for passive oral absorption.  However, it is not advisable to use PAMPA to predict absorption involving transporter-mediated processes, such as active uptake or efflux.  Measurement of PAMPA is much more rapid and cost effective than Caco-2 and log POCT.  PAMPA assay conditions are crit. in order to generate high quality and relevant data, including permeation time, assay pH, stirring, use of cosolvents and selection of detection techniques.  The success of using PAMPA in drug discovery depends on careful data interpretation, use of optimal assay conditions, implementation and integration strategies, and education of users.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobHIlcZw09obVg90H21EOLACvtfcHk0ljWPZkDrvtGlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrzM&md5=3b731c4343ef70452dd2f43a225ccfc6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjps.21068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21068%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSugano%26aufirst%3DK.%26aulast%3DYamauchi%26aufirst%3DY.%26atitle%3DPAMPA--critical%2520factors%2520for%2520better%2520predictions%2520of%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2893%26epage%3D2909%26doi%3D10.1002%2Fjps.21068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P.</span></span> <span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3714</span>â <span class="NLM_lpage">3717</span>, <span class="refDoi">Â DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0ljUxvPp99hU8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>â <span class="NLM_lpage">449</span>, <span class="refDoi">Â DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score â¥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljUxvPp99hU8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SundÃ©n, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burstein, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R.</span></span> <span> </span><span class="NLM_article-title">Design of a highly selective and potent class of non-planar estrogen receptor beta agonists</span>. <i>Chem. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1283</span>â <span class="NLM_lpage">1294</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201300175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1002%2Fcmdc.201300175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=23784708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1GhsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1283-1294&author=H.+Sund%C3%A9nauthor=J.+N.+Maauthor=L.+K.+Hansenauthor=A.+L.+Gustavssonauthor=E.+S.+Bursteinauthor=R.+Olsson&title=Design+of+a+highly+selective+and+potent+class+of+non-planar+estrogen+receptor+beta+agonists&doi=10.1002%2Fcmdc.201300175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Highly Selective and Potent Class of Non-planar Estrogen Receptor Î² Agonists</span></div><div class="casAuthors">Sunden, Henrik; Ma, Jian-Nong; Hansen, Lars K.; Gustavsson, Anna-Lena; Burstein, Ethan S.; Olsson, Roger</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1283-1294</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective activation of the estrogen receptor Î² (ERÎ²) could be a safe approach to hormone replacement therapy for both women and men, in contrast to the estrogens currently used for women which activate both ERÎ² and ERÎ±, occasionally causing severe side effects.  The selective ERÎ² agonist AC-131 has shown efficacy in animal models of Parkinson's disease and neuropathic pain.  With the use of AC-131 as template, herein we report the discovery, synthesis, and structure-activity relationship (SAR) study of a new class of dihydrobenzofurans as potent and selective ERÎ² agonists.  The SAR was established by enantioselective synthesis, mol. modeling, and whole-cell-based functional assay.  The most potent diastereomer, I, was shown to have an EC50 value of <1 n, potency 100-fold higher than that of AC-131.  Even more interestingly, compd. II exhibited 1000-fold ERÎ²/ERÎ± selectivity while still maintaining good potency (â¼10 n).  In addn., II showed only partial agonist activity (30-60% Eff.) toward ERÎ± at 10 Î¼.  This unprecedented selectivity could be rationalized by mol. modeling.  Compd. II appears to be the first mol. to take advantage of both conservative amino acid differences found in the Î±- and Î²-faces of the binding cavities of ERÎ± and ERÎ².</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0NnRh2oDK9bVg90H21EOLACvtfcHk0ljUxvPp99hU8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1GhsLw%253D&md5=8860023c4fdace5c195aa2a5e8188797</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300175%26sid%3Dliteratum%253Aachs%26aulast%3DSund%25C3%25A9n%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DJ.%2BN.%26aulast%3DHansen%26aufirst%3DL.%2BK.%26aulast%3DGustavsson%26aufirst%3DA.%2BL.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DOlsson%26aufirst%3DR.%26atitle%3DDesign%2520of%2520a%2520highly%2520selective%2520and%2520potent%2520class%2520of%2520non-planar%2520estrogen%2520receptor%2520beta%2520agonists%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2013%26volume%3D8%26spage%3D1283%26epage%3D1294%26doi%3D10.1002%2Fcmdc.201300175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jafurulla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreedevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruysschaert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span> <span> </span><span class="NLM_article-title">Stereospecific requirement of cholesterol in the function of the serotonin1A receptor</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1838</i></span>,  <span class="NLM_fpage">158</span>â <span class="NLM_lpage">163</span>, <span class="refDoi">Â DOI: 10.1016/j.bbamem.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1016%2Fj.bbamem.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=24008092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOmtrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=158-163&author=M.+Jafurullaauthor=B.+D.+Raoauthor=S.+Sreedeviauthor=J.+M.+Ruysschaertauthor=D.+F.+Coveyauthor=A.+Chattopadhyay&title=Stereospecific+requirement+of+cholesterol+in+the+function+of+the+serotonin1A+receptor&doi=10.1016%2Fj.bbamem.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecific requirement of cholesterol in the function of the serotonin1A receptor</span></div><div class="casAuthors">Jafurulla, Md.; Rao, Bhagyashree D.; Sreedevi, Sugunan; Ruysschaert, Jean-Marie; Covey, Douglas F.; Chattopadhyay, Amitabha</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">1PB</span>),
    <span class="NLM_cas:pages">158-163</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The serotonin1A receptor is an important member of the G protein-coupled receptor (GPCR) family.  It is involved in the generation and modulation of a variety of cognitive and behavioral functions and serves as a drug target.  Previous work from our lab. has established the sensitivity of the function of the serotonin1A receptor to membrane cholesterol.  Solubilization of the hippocampal serotonin1A receptor utilizing the zwitterionic detergent CHAPS is accompanied by loss of cholesterol and results in redn. in specific ligand binding.  Replenishment of cholesterol to solubilized membranes restores specific ligand binding to the receptor.  We utilized this strategy of sterol replenishment of solubilized membranes to explore the stereospecific stringency of cholesterol for receptor function.  We used two stereoisomers of cholesterol, ent-cholesterol (enantiomer of cholesterol) and epi-cholesterol (a diastereomer of cholesterol), for this purpose.  Importantly, we show here that while ent-cholesterol could replace cholesterol in supporting receptor function, epi-cholesterol could not.  These results imply that the requirement of membrane cholesterol for the serotonin1A receptor function is diastereospecific, yet not enantiospecific.  Our results extend and help define specificity of the interaction of membrane cholesterol with the serotonin1A receptor, and represent the first report utilizing ent-cholesterol to examine stereospecificity of GPCR-cholesterol interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7y7OHHcpqbrVg90H21EOLACvtfcHk0lgaqZXCyvBcuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOmtrbJ&md5=435e88aba0024c4429afca0fd061a094</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DJafurulla%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DB.%2BD.%26aulast%3DSreedevi%26aufirst%3DS.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DCovey%26aufirst%3DD.%2BF.%26aulast%3DChattopadhyay%26aufirst%3DA.%26atitle%3DStereospecific%2520requirement%2520of%2520cholesterol%2520in%2520the%2520function%2520of%2520the%2520serotonin1A%2520receptor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D158%26epage%3D163%26doi%3D10.1016%2Fj.bbamem.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cartoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medard, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirot, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courvoisier, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrast, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span> <span> </span><span class="NLM_article-title">Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1460</span>â <span class="NLM_lpage">1469</span>, <span class="refDoi">Â DOI: 10.1093/brain/awq082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1093%2Fbrain%2Fawq082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=20418531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A280%3ADC%252BC3c3oslOnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2010&pages=1460-1469&author=R.+Cartoniauthor=E.+Arnaudauthor=J.+J.+Medardauthor=O.+Poirotauthor=D.+S.+Courvoisierauthor=R.+Chrastauthor=J.+C.+Martinou&title=Expression+of+mitofusin+2%28R94Q%29+in+a+transgenic+mouse+leads+to+Charcot-Marie-Tooth+neuropathy+type+2A&doi=10.1093%2Fbrain%2Fawq082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A</span></div><div class="casAuthors">Cartoni Romain; Arnaud Estelle; Medard Jean-Jacques; Poirot Olivier; Courvoisier Delphine S; Chrast Roman; Martinou Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">1460-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Charcot-Marie-Tooth disease type 2A is an autosomal dominant axonal form of peripheral neuropathy caused by mutations in the mitofusin 2 gene.  Mitofusin 2 encodes a mitochondrial outer membrane protein that participates in mitochondrial fusion in mammalian cells.  How mutations in this protein lead to Charcot-Marie-Tooth disease type 2A pathophysiology remains unclear.  We have generated a transgenic mouse expressing either a mutated (R94Q) or wild-type form of human mitofusin 2 in neurons to evaluate whether the R94Q mutation was sufficient for inducing a Charcot-Marie-Tooth disease type 2A phenotype.  Only mice expressing mitofusin 2(R94Q) developed locomotor impairments and gait defects thus mimicking the Charcot-Marie-Tooth disease type 2A neuropathy.  In these animals, the number of mitochondria per axon was significantly increased in the distal part of the sciatic nerve axons with a diameter smaller than 3.5 microm.  Importantly, the analysis of R94Q transgenic animals also revealed an age-related shift in the size of myelinated axons leading to an over-representation of axons smaller than 3.5 microm.  Together these data suggest a link between an increased number of mitochondria in axons and a shift in axonal size distribution in mitofusin 2(R94Q) transgenic animals that may contribute to their neurological phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwvoj1kpSRiNHxxy173TfNfW6udTcc2easGkqj-dCEkrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3oslOnuw%253D%253D&md5=ecdd7bd8c47ba5e2007988f207717c51</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawq082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawq082%26sid%3Dliteratum%253Aachs%26aulast%3DCartoni%26aufirst%3DR.%26aulast%3DArnaud%26aufirst%3DE.%26aulast%3DMedard%26aufirst%3DJ.%2BJ.%26aulast%3DPoirot%26aufirst%3DO.%26aulast%3DCourvoisier%26aufirst%3DD.%2BS.%26aulast%3DChrast%26aufirst%3DR.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26atitle%3DExpression%2520of%2520mitofusin%25202%2528R94Q%2529%2520in%2520a%2520transgenic%2520mouse%2520leads%2520to%2520Charcot-Marie-Tooth%2520neuropathy%2520type%25202A%26jtitle%3DBrain%26date%3D2010%26volume%3D133%26spage%3D1460%26epage%3D1469%26doi%3D10.1093%2Fbrain%2Fawq082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bannerman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleasure, D.</span></span> <span> </span><span class="NLM_article-title">Mice hemizygous for a pathogenic mitofusin-2 allele exhibit hind limb/foot gait deficits and phenotypic perturbations in nerve and muscle</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0167573</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0167573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1371%2Fjournal.pone.0167573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=27907123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1alsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=P.+Bannermanauthor=T.+Burnsauthor=J.+Xuauthor=L.+Miersauthor=D.+Pleasure&title=Mice+hemizygous+for+a+pathogenic+mitofusin-2+allele+exhibit+hind+limb%2Ffoot+gait+deficits+and+phenotypic+perturbations+in+nerve+and+muscle&doi=10.1371%2Fjournal.pone.0167573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mice hemizygous for a pathogenic mitofusin-2 allele exhibit hind limb/foot gait deficits and phenotypic perturbations in nerve and muscle</span></div><div class="casAuthors">Bannerman, Peter; Burns, Travis; Xu, Jie; Miers, Laird; Pleasure, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e0167573/1-e0167573/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Charcot-Marie-Tooth disease type 2A (CMT2A), the most common axonal form of hereditary sensory motor neuropathy, is caused by mutations of mitofusin-2 (MFN2).  Mitofusin-2 is a GTPase required for fusion of mitochondrial outer membranes, repair of damaged mitochondria, efficient mitochondrial energetics, regulation of mitochondrial-endoplasmic reticulum calcium coupling and axonal transport of mitochondria.  We knocked T105M MFN2 preceded by a loxP-flanked STOP sequence into the mouse Rosa26 locus to permit cell type-specific expression of this pathogenic allele.  Crossing these mice with nestin-Cre transgenic mice elicited T105M MFN2 expression in neuroectoderm, and resulted in diminished nos. of mitochondria in peripheral nerve axons, an alteration in skeletal muscle fiber type distribution, and a gait abnormality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomyEWHwanFmrVg90H21EOLACvtfcHk0lgaqZXCyvBcuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1alsLw%253D&md5=9ab727c21577bba9367fe49ce348930a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0167573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0167573%26sid%3Dliteratum%253Aachs%26aulast%3DBannerman%26aufirst%3DP.%26aulast%3DBurns%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DMiers%26aufirst%3DL.%26aulast%3DPleasure%26aufirst%3DD.%26atitle%3DMice%2520hemizygous%2520for%2520a%2520pathogenic%2520mitofusin-2%2520allele%2520exhibit%2520hind%2520limb%252Ffoot%2520gait%2520deficits%2520and%2520phenotypic%2520perturbations%2520in%2520nerve%2520and%2520muscle%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0167573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landeros, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloh, R. H.</span></span> <span> </span><span class="NLM_article-title">Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1756</span>â <span class="NLM_lpage">1771</span>, <span class="refDoi">Â DOI: 10.1172/JCI124194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1172%2FJCI124194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=30882371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A280%3ADC%252BB3cblt1akuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=1756-1771&author=Y.+Zhouauthor=S.+Carmonaauthor=A.+Muhammadauthor=S.+Bellauthor=J.+Landerosauthor=M.+Vazquezauthor=R.+Hoauthor=A.+Francoauthor=B.+Luauthor=G.+W.+Dornauthor=S.+Wangauthor=C.+M.+Lutzauthor=R.+H.+Baloh&title=Restoring+mitofusin+balance+prevents+axonal+degeneration+in+a+Charcot-Marie-Tooth+type+2A+model&doi=10.1172%2FJCI124194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model</span></div><div class="casAuthors">Zhou Yueqin; Muhammad A K M G; Bell Shaughn; Landeros Jesse; Vazquez Michael; Baloh Robert H; Zhou Yueqin; Carmona Sharon; Muhammad A K M G; Bell Shaughn; Landeros Jesse; Vazquez Michael; Ho Ritchie; Lu Bin; Wang Shaomei; Baloh Robert H; Franco Antonietta; Dorn Gerald W 2nd; Lutz Cathleen M; Baloh Robert H</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1756-1771</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mitofusin-2 (MFN2) is a mitochondrial outer-membrane protein that plays a pivotal role in mitochondrial dynamics in most tissues, yet mutations in MFN2, which cause Charcot-Marie-Tooth disease type 2A (CMT2A), primarily affect the nervous system.  We generated a transgenic mouse model of CMT2A that developed severe early onset vision loss and neurological deficits, axonal degeneration without cell body loss, and cytoplasmic and axonal accumulations of fragmented mitochondria.  While mitochondrial aggregates were labeled for mitophagy, mutant MFN2 did not inhibit Parkin-mediated degradation, but instead had a dominant negative effect on mitochondrial fusion only when MFN1 was at low levels, as occurs in neurons.  Finally, using a transgenic approach, we found that augmenting the level of MFN1 in the nervous system in vivo rescued all phenotypes in mutant MFN2R94Q-expressing mice.  These data demonstrate that the MFN1/MFN2 ratio is a key determinant of tissue specificity in CMT2A and indicate that augmentation of MFN1 in the nervous system is a viable therapeutic strategy for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8Yf-9Da4HGwyMywPm6HgQfW6udTcc2eZO09SzcJDPrbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cblt1akuw%253D%253D&md5=62862d9c50e379ebd78d13ea0f60fb2f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI124194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI124194%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCarmona%26aufirst%3DS.%26aulast%3DMuhammad%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DS.%26aulast%3DLanderos%26aufirst%3DJ.%26aulast%3DVazquez%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DR.%26aulast%3DFranco%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DDorn%26aufirst%3DG.%2BW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLutz%26aufirst%3DC.%2BM.%26aulast%3DBaloh%26aufirst%3DR.%2BH.%26atitle%3DRestoring%2520mitofusin%2520balance%2520prevents%2520axonal%2520degeneration%2520in%2520a%2520Charcot-Marie-Tooth%2520type%25202A%2520model%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D1756%26epage%3D1771%26doi%3D10.1172%2FJCI124194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasband, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliceiri, K. W.</span></span> <span> </span><span class="NLM_article-title">NIH Image to ImageJ: 25 years of image analysis</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">671</span>â <span class="NLM_lpage">675</span>, <span class="refDoi">Â DOI: 10.1038/nmeth.2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=10.1038%2Fnmeth.2089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=22930834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKntb7P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=671-675&author=C.+A.+Schneiderauthor=W.+S.+Rasbandauthor=K.+W.+Eliceiri&title=NIH+Image+to+ImageJ%3A+25+years+of+image+analysis&doi=10.1038%2Fnmeth.2089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">NIH Image to ImageJ: 25 years of image analysis</span></div><div class="casAuthors">Schneider, Caroline A.; Rasband, Wayne S.; Eliceiri, Kevin W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7_part1</span>),
    <span class="NLM_cas:pages">671-675</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For the past 25 years NIH Image and ImageJ software have been pioneers as open tools for the anal. of scientific images.  We discuss the origins, challenges and solns. of these two programs, and how their history can serve to advise and inform other software projects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofzHXrdLwDn7Vg90H21EOLACvtfcHk0limjcq9chq8JA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKntb7P&md5=85ab928cd79f1e2f2351c834c0c600f0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2089%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DC.%2BA.%26aulast%3DRasband%26aufirst%3DW.%2BS.%26aulast%3DEliceiri%26aufirst%3DK.%2BW.%26atitle%3DNIH%2520Image%2520to%2520ImageJ%253A%252025%2520years%2520of%2520image%2520analysis%26jtitle%3DNat.%2520Methods%26date%3D2012%26volume%3D9%26spage%3D671%26epage%3D675%26doi%3D10.1038%2Fnmeth.2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  II</span></span> <span> </span><span class="NLM_article-title">Mitofusin Modulation Agents and Methods of Use Thereof</span>. Patent <span class="NLM_patent">WO2019/094830A</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=G.+W.+Dorn&title=Mitofusin+Modulation+Agents+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DMitofusin%2520Modulation%2520Agents%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, G. W.,  II</span></span> <span> </span><span class="NLM_article-title">Small Molecule Regulators of Mitochondrial Fusion and Methods of Use Thereof</span>. <span class="NLM_patent">, 20190169138A1</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=G.+W.+Dorn&title=Small+Molecule+Regulators+of+Mitochondrial+Fusion+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DG.%2BW.%26atitle%3DSmall%2520Molecule%2520Regulators%2520of%2520Mitochondrial%2520Fusion%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i68"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00366">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_76048"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00366?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00366</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Correlation between <i>in vitro</i> human liver microsome stability and PAMPA-BBB Pe of <b>1</b> analogues (Figure S1); HPLCâHRMSâNMR chromatography of <b>13</b> (Figure S2); HPLCâLC-MSâNMR chromatography of <b>13A</b> and <b>13B</b> (Figure S3); <b>13B</b> selectivity mini-panel assay (Table S1), CYP inhibition by <b>13B</b> in human liver microsomes (Tables S2âS7), <b>13B</b> AMES test (Table S8), P-gp studies of <b>13B</b> (Table S9); HPLC (<b>1â5</b> and <b>8â27</b>) or LC-MS (<b>6</b> and <b>7</b>) chromatography (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula string for all of the final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_001.pdf">jm0c00366_si_001.pdf (6.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00366/suppl_file/jm0c00366_si_002.csv">jm0c00366_si_002.csv (1.88 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00366&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00366%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00366" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c87f4abe1964","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
